These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
Japan
|
|
|
(Jurisdiction of incorporation or organization)
|
(Address of principal executive offices)
|
Title of Each Class
|
Trading Symbol(s)
|
Name of Each Exchange On Which Registered
|
||
|
|
|
*
|
Not for trading, but only in connection with the registration of the American Depositary Shares, each representing one share of Common Stock.
|
☒
|
Accelerated filer
☐
|
Non-accelerated
filer
☐
|
Emerging growth company
|
☒
|
International Financial Reporting Standards as issued
by the International Accounting Standards Board
☐
|
Other
☐
|
|
|
Page
|
|
|||
|
PART I
|
|
|
|
||
Item 1.
|
2
|
|||||
Item 2.
|
2
|
|||||
Item 3.
|
2
|
|||||
Item 4.
|
20
|
|||||
Item 4A.
|
43
|
|||||
Item 5.
|
43
|
|||||
Item 6.
|
81
|
|||||
Item 7.
|
102
|
|||||
Item 8.
|
103
|
|||||
Item 9.
|
103
|
|||||
Item 10.
|
104
|
|||||
Item 11.
|
112
|
|||||
Item 12.
|
127
|
|||||
|
PART II
|
|
|
|
||
Item 13.
|
129
|
|||||
Item 14.
|
129
|
|||||
Item 15.
|
129
|
|||||
Item 16A.
|
129
|
|||||
Item 16B.
|
130
|
|||||
Item 16C.
|
130
|
|||||
Item 16D.
|
131
|
|||||
Item 16E.
|
131
|
|||||
Item 16F.
|
132
|
|||||
Item 16G.
|
132
|
|||||
Item 16H.
|
133
|
|||||
|
PART III
|
|
|
|
||
Item 17.
|
134
|
|||||
Item 18.
|
134
|
|||||
Item 19.
|
135
|
|||||
F-
1
|
|
Millions of yen, except per share data and percentages
|
|||||||||||||||||||
|
Year ended March 31
|
|||||||||||||||||||
|
2016
|
|
2017
|
|
2018
|
|
2019
|
|
2020
|
|
||||||||||
Statement of income data:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
Revenue
|
¥ |
1,723,096
|
¥ |
1,715,516
|
¥ |
1,972,158
|
¥ |
1,835,118
|
¥ |
1,952,482
|
||||||||||
Interest expense
|
327,415
|
312,319
|
475,189
|
718,348
|
664,653
|
|||||||||||||||
Net revenue
|
1,395,681
|
1,403,197
|
1,496,969
|
1,116,770
|
1,287,829
|
|||||||||||||||
Non-interest
expenses
|
1,230,523
|
1,080,402
|
1,168,811
|
1,154,471
|
1,039,568
|
|||||||||||||||
Income (loss) before income taxes
|
165,158
|
322,795
|
328,158
|
(37,701
|
) |
248,261
|
||||||||||||||
Income tax expense
|
22,596
|
80,229
|
103,866
|
57,010
|
28,894
|
|||||||||||||||
Net income (loss)
|
¥ |
142,562
|
¥ |
242,566
|
¥ |
224,292
|
¥ |
(94,711
|
) | ¥ |
219,367
|
|||||||||
Less: Net income attributable to noncontrolling interests
|
11,012
|
2,949
|
4,949
|
5,731
|
2,369
|
|||||||||||||||
Net income (loss) attributable to Nomura Holdings, Inc. (“NHI”) shareholders
|
¥ |
131,550
|
¥ |
239,617
|
¥ |
219,343
|
¥ |
(100,442
|
) | ¥ |
216,998
|
|||||||||
Balance sheet data (period end):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
Total assets
(1)
|
¥ |
40,934,217
|
¥ |
42,531,972
|
¥ |
40,343,947
|
¥ |
40,969,439
|
¥ |
43,999,815
|
||||||||||
Total NHI shareholders’ equity
|
2,700,239
|
2,789,916
|
2,749,320
|
2,631,061
|
2,653,467
|
|||||||||||||||
Total equity
|
2,743,015
|
2,843,791
|
2,799,824
|
2,680,793
|
2,731,264
|
|||||||||||||||
Common stock
|
594,493
|
594,493
|
594,493
|
594,493
|
594,493
|
|||||||||||||||
Per share data:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
Net income (loss) attributable to NHI shareholders
—
|
¥ |
36.53
|
¥ |
67.29
|
¥ |
63.13
|
¥ |
(29.90
|
) | ¥ |
67.76
|
|||||||||
Net income (loss) attributable to NHI shareholders
—
|
35.52
|
65.65
|
61.88
|
(29.92
|
) |
66.20
|
||||||||||||||
Total NHI shareholders’ equity
(2)
|
748.32
|
790.70
|
810.31
|
794.69
|
873.26
|
|||||||||||||||
Cash dividends
(2)
|
13.00
|
20.00
|
20.00
|
6.00
|
20.00
|
|||||||||||||||
Cash dividends in USD
(3)
|
$ |
0.12
|
$ |
0.18
|
$ |
0.19
|
$ |
0.05
|
$ |
0.19
|
||||||||||
Weighted average number of shares outstanding (in thousands)
(4)
|
3,600,701
|
3,560,776
|
3,474,593
|
3,359,565
|
3,202,370
|
|||||||||||||||
Return on equity
(5)
:
|
4.9
|
% |
8.7
|
% |
7.9
|
% |
(3.7
|
%) |
8.2
|
% |
(1) |
Due to Accounting Standards Update
2014-09,
“
Revenue from Contracts with Customers
|
(2) | Calculated using the number of shares outstanding at year end. |
(3) | Calculated using the Japanese Yen—U.S. Dollar exchange rate as of the respective fiscal year end date, the noon buying rate in New York City for cable transfers in foreign currencies as certified for customs purposes by the Federal Reserve Bank of New York. |
(4) | The number shown is used to calculate basic earnings per share. |
(5) | Calculated as net income (loss) attributable to NHI shareholders divided by total NHI shareholders’ equity. |
• | we incur large trading losses, |
• | the level of our business activity decreases due to a market downturn, |
• | regulatory authorities take significant action against us, or |
• | our credit rating is downgraded. |
• | sudden and significant reductions in credit ratings with regard to financial instruments held by our trading and investment businesses by major rating agencies, |
• | sudden changes in trading, tax, accounting, regulatory requirements, laws and other related rules which may make our trading strategy obsolete, less competitive or no longer viable, or |
• | an unexpected failure in a corporate transaction in which we participate resulting in our not receiving the consideration we should have received, as well as bankruptcy, deliberate acts of fraud, and administrative penalty with respect to the issuers of our trading and investment assets. |
• | holding securities issued by third parties, or |
• | the execution of securities, futures, currency or derivative transactions that fail to settle at the required time due to nondelivery by the counterparty, such as financial institutions and hedge funds which are counterparties to credit default swaps or systems failure by clearing agents, exchanges, clearing houses or other financial infrastructure. |
- | Physical Risk: The risk of physical damage or the impairment of the operating capability of the assets of Nomura Group, customers and business partners due to climate change. This includes the potential impact of extreme weather events, fire and sea level flooding. |
- | Transition Risk: The risks associated with accelerated policy and external changes associated with the move towards addressing Climate Risk. This includes changes in government policies, industrial policy or carbon based taxes, and rapid changes in technologies which have the potential to leave stranded assets that are no longer viable. |
• | the quality, range and prices of our products and services, |
• | our ability to originate and develop innovative client solutions, |
• | our ability to maintain and develop client relationships, |
• | our ability to access and commit capital resources, |
• | our ability to retain and attract qualified employees, and |
• | our general reputation. |
• | the monetary and fiscal policies of national governments and international economic organizations, and |
• | economic, political and social developments both within and between Japan, the U.S., Europe and other major industrialized and developing countries and regions, such as the COVID-19 pandemic in 2020. |
• | Continued to fulfill responsibility as capital market intermediary and liquidity provider in order to maintain the financing required by companies and trading activities by market participants. |
• | Supported the recovery of the economy and corporate activities while ensuring the safety of our clients, communities and employees and their families, Provided remote services to clients and strengthened the infrastructure to keep up business as usual during widespread work-from-home arrangements. |
• | Maintained robust financial position and ensured sufficient liquidity in a highly volatile and stressful market environment. |
• |
Boost profitability and invest in growth areas to lift corporate value
|
• |
Improve operating model to align to new business environment
|
• |
Retail Division
|
• |
Asset Management Division
|
• |
Wholesale Division
|
• |
Merchant Banking Division
|
• |
Risk Management and Compliance, etc.
|
Name
|
Country/Region
|
|
Ownership
Interest
|
|
||||
|
|
|
(%)
|
|
||||
Nomura Holdings, Inc.
|
Japan
|
—
|
||||||
Nomura Securities Co., Ltd.
|
Japan
|
100
|
||||||
Nomura Asset Management Co., Ltd.
|
Japan
|
100
|
||||||
The Nomura Trust & Banking Co., Ltd.
|
Japan
|
100
|
||||||
Nomura Babcock & Brown Co., Ltd.
|
Japan
|
100
|
||||||
Nomura Capital Investment Co., Ltd.
|
Japan
|
100
|
||||||
Nomura Investor Relations Co., Ltd.
|
Japan
|
100
|
||||||
Nomura Funds Research and Technologies Co., Ltd.
|
Japan
|
100
|
||||||
Nomura Research & Advisory Co., Ltd.
|
Japan
|
100
|
||||||
Nomura Business Services Co., Ltd.
|
Japan
|
100
|
||||||
Nomura Facilities, Inc.
|
Japan
|
100
|
||||||
Nomura Institute of Capital Markets Research
|
Japan
|
100
|
||||||
Nomura Healthcare Co., Ltd.
|
Japan
|
100
|
||||||
Nomura Agri Planning & Advisory Co., Ltd.
|
Japan
|
100
|
||||||
Nomura Land and Building Co., Ltd.
|
Japan
|
100
|
||||||
Nomura Financial Products & Services, Inc.
|
Japan
|
100
|
||||||
Nomura Institute of Estate Planning
|
Japan
|
100
|
||||||
N-Village
Co., Ltd.
|
Japan
|
100
|
||||||
Nomura Capital Partners Co., Ltd.
|
Japan
|
100
|
||||||
Nomura Mezzanine Partners Co., Ltd.
|
Japan
|
100
|
||||||
Corporate Design Partners Co., Ltd.
|
Japan
|
100
|
||||||
Nomura Kagayaki Co., Ltd.
|
Japan
|
100
|
||||||
Nomura Asia Pacific Holdings Co., Ltd.
|
Japan
|
100
|
||||||
Nomura International (Hong Kong) Limited
|
Hong Kong
|
100
|
||||||
Nomura Singapore Limited
|
Singapore
|
100
|
||||||
Nomura Securities Singapore Pte. Ltd.
|
Singapore
|
100
|
||||||
Nomura Australia Limited
|
Australia
|
100
|
||||||
PT Nomura Sekuritas Indonesia
|
Indonesia
|
96
|
||||||
Nomura Asia Investment (Fixed Income) Pte. Ltd.
|
Singapore
|
100
|
||||||
Nomura Asia Investment (Singapore) Pte. Ltd.
|
Singapore
|
100
|
||||||
Capital Nomura Securities Public Co., Ltd.
|
Thailand
|
99
|
||||||
Nomura Financial Advisory and Securities (India) Private Limited
|
India
|
100
|
||||||
Nomura Holding America Inc.
|
U.S.
|
100
|
||||||
Nomura Securities International, Inc.
|
U.S.
|
100
|
||||||
Nomura Corporate Research and Asset Management Inc.
|
U.S.
|
100
|
||||||
Nomura Derivative Products Inc.
|
U.S.
|
100
|
||||||
Nomura America Mortgage Finance, LLC
|
U.S.
|
100
|
||||||
Nomura Global Financial Products, Inc.
|
U.S.
|
100
|
||||||
NHI Acquisition Holding, Inc.
|
U.S.
|
100
|
||||||
Instinet Incorporated
|
U.S.
|
100
|
||||||
Nomura Europe Holdings plc
|
U.K.
|
100
|
||||||
Nomura International plc
|
U.K.
|
100
|
||||||
Nomura Bank International plc
|
U.K.
|
100
|
||||||
Nomura Financial Products Europe GmbH
|
Germany
|
100
|
||||||
Banque Nomura France
|
France
|
100
|
||||||
Nomura Bank (Luxembourg) S.A.
|
Luxemburg
|
100
|
||||||
Nomura Bank (Switzerland) Ltd.
|
Switzerland
|
100
|
||||||
Nomura Europe Finance N.V.
|
The Netherlands
|
100
|
||||||
Nomura European Investment Limited
|
U.K.
|
100
|
||||||
Nomura Asia Investment (India Powai) Pte. Ltd.
|
Singapore
|
100
|
||||||
Nomura Services India Private Limited
|
India
|
100
|
||||||
Nomura International Funding Pte. Ltd.
|
Singapore
|
100
|
||||||
Nomura Orient International Securities Co., Ltd.
|
China
|
51
|
(1)
|
Diluted net income attributable to Nomura Holdings’ shareholders per share (loss). |
|
Millions of yen, except percentages
|
|||||||||||||||||||
|
Year ended March 31
|
|||||||||||||||||||
|
2018
|
|
2019
|
|
% Change from
previous year |
|
2020
|
|
% Change from
previous year |
|
||||||||||
Non-interest
revenues:
|
|
|
|
|
|
|||||||||||||||
Commissions
|
¥ |
373,313
|
¥ |
293,069
|
(21.5
|
)% | ¥ |
308,805
|
5.4
|
% | ||||||||||
Fees from investment banking
|
101,663
|
101,521
|
(0.1
|
) |
103,222
|
1.7
|
||||||||||||||
Asset management and portfolio service fees
|
245,616
|
245,519
|
—
|
238,202
|
(3.0
|
) | ||||||||||||||
Net gain on trading
|
442,885
|
342,964
|
(22.6
|
) |
356,609
|
4.0
|
||||||||||||||
Gain (loss) on private equity and debt investments
|
(869
|
) |
1,007
|
—
|
(93
|
) |
—
|
|||||||||||||
Gain (loss) on investments in equity securities
|
2,683
|
(6,983
|
) |
—
|
(14,726
|
) |
—
|
|||||||||||||
Other
|
221,192
|
81,057
|
(63.4
|
) |
165,991
|
104.8
|
||||||||||||||
Total
Non-interest
revenues
|
1,386,483
|
1,058,154
|
(23.7
|
) |
1,158,010
|
9.4
|
||||||||||||||
Net interest revenue
|
110,486
|
58,616
|
(46.9
|
) |
129,819
|
121.5
|
||||||||||||||
Net revenue
|
1,496,969
|
1,116,770
|
(25.4
|
) |
1,287,829
|
15.3
|
||||||||||||||
Non-interest
expenses
|
1,168,811
|
1,154,471
|
(1.2
|
) |
1,039,568
|
(10.0
|
) | |||||||||||||
Income (loss) before income taxes
|
328,158
|
(37,701
|
) |
—
|
248,261
|
—
|
||||||||||||||
Income tax expense
|
103,866
|
57,010
|
(45.1
|
) |
28,894
|
(49.3
|
) | |||||||||||||
Net income (loss)
|
¥ |
224,292
|
¥ |
(94,711
|
) |
—
|
% | ¥ |
219,367
|
—
|
% | |||||||||
Less: Net income attributable to noncontrolling interests
|
4,949
|
5,731
|
15.8
|
2,369
|
(58.7
|
) | ||||||||||||||
Net income (loss) attributable to NHI shareholders
|
¥ |
219,343
|
¥ |
(100,442
|
) |
—
|
% | ¥ |
216,998
|
—
|
% | |||||||||
Return on equity
|
7.9
|
% |
(3.7
|
) % |
|
8.2
|
% |
|
|
Millions of yen
|
|||||||||||||||||||
|
Year ended March 31
|
|||||||||||||||||||
|
2018
|
|
2019
|
|
% Change from
previous year |
|
2020
|
|
% Change from
previous year |
|
||||||||||
Non-interest
revenue
|
¥ |
406,295
|
¥ |
331,743
|
(18.3
|
)% | ¥ |
329,983
|
(0.5
|
)% | ||||||||||
Net interest revenue
|
6,613
|
7,737
|
17.0
|
6,376
|
(17.6
|
) | ||||||||||||||
Net revenue
|
412,908
|
339,480
|
(17.8
|
) |
336,359
|
(0.9
|
) | |||||||||||||
Non-interest
expenses
|
309,771
|
289,990
|
(6.4
|
) |
286,926
|
(1.1
|
) | |||||||||||||
Income before income taxes
|
¥ |
103,137
|
¥ |
49,490
|
(52.0
|
)% | ¥ |
49,433
|
(0.1
|
)% | ||||||||||
|
Millions of yen
|
|||||||||||
|
Year ended March 31
|
|||||||||||
|
2019
|
|
2020
|
|
% Change from
previous year |
|
||||||
Commissions
|
¥ |
142,764
|
¥ |
153,170
|
7.3
|
% | ||||||
Brokerage commissions
|
60,167
|
61,207
|
1.7
|
|||||||||
Commissions for distribution of investment trusts
|
57,880
|
66,940
|
15.7
|
|||||||||
Other commissions
|
24,717
|
25,023
|
1.2
|
|||||||||
Net gain on trading
|
55,829
|
56,756
|
1.7
|
|||||||||
Fees from investment banking
|
33,981
|
23,239
|
(31.6
|
) | ||||||||
Asset management fees
|
95,384
|
92,139
|
(3.4
|
) | ||||||||
Others
|
3,785
|
4,679
|
23.6
|
|||||||||
Non-interest
revenues
|
¥ |
331,743
|
¥ |
329,983
|
(0.5
|
)% | ||||||
|
Trillions of yen
|
|||||||||||||||||||
|
Year ended March 31, 2019
|
|||||||||||||||||||
|
Balance at
beginning of year
|
|
Gross inflows
|
|
Gross outflows
|
|
Market
appreciation /
(depreciation)
|
|
Balance at
end of year
|
|
||||||||||
Equities
|
¥ |
75.7
|
¥ |
22.5
|
¥ |
(21.4
|
) | ¥ |
(4.9
|
) | ¥ |
71.9
|
||||||||
Debt securities
|
17.9
|
29.2
|
(27.2
|
) |
(1.1
|
) |
18.8
|
|||||||||||||
Stock investment trusts
|
9.1
|
2.9
|
(2.7
|
) |
(0.3
|
) |
9.0
|
|||||||||||||
Bond investment trusts
|
7.1
|
0.3
|
(0.7
|
) |
0.1
|
6.8
|
||||||||||||||
Overseas mutual funds
|
1.2
|
—
|
(0.1
|
) |
0.0
|
1.1
|
||||||||||||||
Others
|
6.7
|
0.9
|
(0.6
|
) |
0.1
|
7.1
|
||||||||||||||
Total
|
¥ |
117.7
|
¥ |
55.8
|
¥ |
(52.7
|
) | ¥ |
(6.1
|
) | ¥ |
114.7
|
||||||||
|
Trillions of yen
|
|||||||||||||||||||
|
Year ended March 31, 2020
|
|||||||||||||||||||
|
Balance at
beginning of year
|
|
Gross inflows
|
|
Gross outflows
|
|
Market
appreciation /
(depreciation)
|
|
Balance at
end of year
|
|
||||||||||
Equities
|
¥ |
71.9
|
¥ |
12.4
|
¥ |
(13.4
|
) | ¥ |
(8.2
|
) | ¥ |
62.7
|
||||||||
Debt securities
|
18.8
|
29.3
|
(27.3
|
) |
(2.4
|
) |
18.4
|
|||||||||||||
Stock investment trusts
|
9.0
|
3.1
|
(3.2
|
) |
(1.3
|
) |
7.6
|
|||||||||||||
Bond investment trusts
|
6.8
|
0.9
|
(0.5
|
) |
0.1
|
7.3
|
||||||||||||||
Overseas mutual funds
|
1.1
|
0.1
|
(0.1
|
) |
(0.1
|
) |
1.0
|
|||||||||||||
Others
|
7.1
|
0.8
|
(1.0
|
) |
0.1
|
7.0
|
||||||||||||||
Total
|
¥ |
114.7
|
¥ |
46.6
|
¥ |
(45.5
|
) | ¥ |
(11.8
|
) | ¥ |
104.0
|
||||||||
|
Millions of yen
|
|||||||||||||||||||
|
Year ended March 31
|
|||||||||||||||||||
|
2018
|
|
2019
|
|
% Change from
previous year |
|
2020
|
|
% Change from
previous year |
|
||||||||||
Non-interest
revenue
|
¥ |
118,545
|
¥ |
89,607
|
(24.4
|
)% | ¥ |
85,190
|
(4.9
|
)% | ||||||||||
Net interest revenue
|
8,792
|
8,238
|
(6.3
|
) |
7,415
|
(10.0
|
) | |||||||||||||
Net revenue
|
127,337
|
97,845
|
(23.2
|
) |
92,605
|
(5.4
|
) | |||||||||||||
Non-interest
expenses
|
61,167
|
63,660
|
4.1
|
63,833
|
0.3
|
|||||||||||||||
Income before income taxes
|
¥ |
66,170
|
¥ |
34,185
|
(48.3
|
)% | ¥ |
28,772
|
(15.8
|
)% | ||||||||||
|
Billions of yen
|
|||||||||||||||||||||||
|
Year ended March 31, 2019
|
|||||||||||||||||||||||
|
Balance at
beginning of year
|
|
Adjustment in
beginning balance |
|
Gross inflows
|
|
Gross outflows
|
|
Market
appreciation /
(depreciation)
|
|
Balance at
end of year
|
|
||||||||||||
Nomura Asset Management Co., Ltd .
|
¥ |
52,381
|
¥ |
—
|
¥ |
24,988
|
¥ |
(23,850
|
) | ¥ |
(148
|
) | ¥ |
53,371
|
||||||||||
Nomura Funds Research and Technologies Co., Ltd.
|
2,765
|
(2,765
|
) |
—
|
—
|
—
|
—
|
|||||||||||||||||
Nomura Corporate Research and Asset Management Inc.
|
2,684
|
—
|
902
|
(732
|
) |
157
|
3,011
|
|||||||||||||||||
Combined total
|
57,830
|
(2,765
|
) |
25,890
|
(24,582
|
) |
9
|
56,382
|
||||||||||||||||
Shared across group companies
|
(7,815
|
) |
2,649
|
(1,187
|
) |
1,521
|
(176
|
) |
(5,008
|
) | ||||||||||||||
Total
|
¥ |
50,015
|
¥ |
(116
|
) | ¥ |
24,703
|
¥ |
(23,061
|
) | ¥ |
(167
|
) | ¥ |
51,374
|
|||||||||
|
Billions of yen
|
|||||||||||||||||||||||
|
Year ended March 31, 2020
|
|||||||||||||||||||||||
|
Balance at
beginning of year
|
|
Adjustment in
beginning balance |
|
Gross inflows
|
|
Gross outflows
|
|
Market
appreciation /
(depreciation)
|
|
Balance at
end of year
|
|
||||||||||||
Nomura Asset Management Co., Ltd .
|
¥ |
53,371
|
¥ |
—
|
¥ |
26,098
|
¥ |
(25,076
|
) | ¥ |
(3,745
|
) | ¥ |
50,648
|
||||||||||
Nomura Corporate Research and Asset Management Inc.
|
3,011
|
—
|
568
|
(739
|
) |
(351
|
) |
2,489
|
||||||||||||||||
Combined total
|
56,382
|
—
|
26,666
|
(25,815
|
) |
(4,096
|
) |
53,137
|
||||||||||||||||
Shared across group companies
|
(5,008
|
) |
—
|
(882
|
) |
1,501
|
577
|
(3,812
|
) | |||||||||||||||
Total
|
51,374
|
—
|
25,784
|
(24,314
|
) |
(3,519
|
) |
49,325
|
||||||||||||||||
|
March 31
|
|||||||||||
|
2018
|
|
2019
|
|
2020
|
|
||||||
Total of publicly offered investment trusts
|
27
|
% |
28
|
% |
28
|
% | ||||||
Stock investment trusts
|
25
|
% |
26
|
% |
26
|
% | ||||||
Bond investment trusts
|
44
|
% |
45
|
% |
44
|
% |
|
Millions of yen
|
|||||||||||||||||||
|
Year ended March 31
|
|||||||||||||||||||
|
2018
|
|
2019
|
|
% Change from
previous year |
|
2020
|
|
% Change from
previous year |
|
||||||||||
Non-interest
revenue
|
¥ |
587,474
|
¥ |
496,484
|
(15.5
|
)% | ¥ |
506,203
|
2.0
|
% | ||||||||||
Net interest revenue
|
127,859
|
58,904
|
(53.9
|
) |
142,416
|
141.8
|
||||||||||||||
Net revenue
|
715,333
|
555,388
|
(22.4
|
) |
648,619
|
16.8
|
||||||||||||||
Non-interest
expenses
|
614,745
|
666,787
|
8.5
|
556,399
|
(16.6
|
) | ||||||||||||||
Income (loss) before income taxes
|
¥ |
100,588
|
¥ |
(111,399
|
) |
—
|
% | ¥ |
92,220
|
—
|
% | |||||||||
|
Millions of yen
|
|||||||||||||||||||
|
Year ended March 31
|
|||||||||||||||||||
|
2018
|
|
2019
|
|
% Change from
previous year |
|
2020
|
|
% Change from
previous year |
|
||||||||||
Wholesale net revenue:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
Global Markets net revenue
|
¥ |
603,197
|
¥ |
453,044
|
(24.9
|
)% | ¥ |
562,927
|
24.3
|
% | ||||||||||
Investment Banking net revenue
|
112,136
|
102,344
|
(8.7
|
) |
85,692
|
(16.3
|
) | |||||||||||||
Net revenue
|
¥ |
715,333
|
¥ |
555,388
|
(22.4
|
)% | ¥ |
648,619
|
16.8
|
% | ||||||||||
• | The ability of clients to perform on their contractual obligations to Nomura arising from financial instruments for determination of fair value measurements or allowances for doubtful accounts; |
• | The volatility and dislocation in global financial markets for determination of fair value measurements; |
• | The expected duration of declines in global equity markets for determination of fair value measurements and impairment of equity method investments; |
• | The future use of non-financial assets within Nomura for determination of whether impairments are required; and |
• | The future profitability of Nomura to realize deferred tax assets. |
Critical
accounting policy |
Critical accounting
estimates |
Underlying subjective key
assumptions by management |
Impact of
COVID-19
pandemic
|
|||
Fair value of financial instruments
Note 2
“Fair value measurements”
|
Estimating fair value for financial instruments
|
•
Election of appropriate valuation techniques
•
Principal markets are active or inactive
•
Significance of level 3 inputs
|
•
Dislocated financial markets as a result of the
COVID-19
pandemic has increased market volatility and reduced price transparency for certain financial instruments
•
Updates to inputs used to determine fair value of financial instruments
|
Critical
accounting policy |
Critical accounting
estimates |
Underlying subjective key
assumptions by management |
Impact of
COVID-19
pandemic
|
|||
Allowances for doubtful accounts
Note 7
“Financing receivables”
|
Determination of whether loans, other receivables and loan commitments are impaired and measurement of impairment losses
|
•
Ability of borrowers to pay in accordance with contractual terms of the financial instruments
•
Future cash flows for impaired loans where impairment measurement using a discounted cash flow method.
•
Fair value of collateral in impaired collateral dependent loans.
|
•
Ability of borrowers to pay increasingly subjective as has required consideration both to pay in the short-term while governments imposed lockdowns and similar restrictions on trading, and in the longer-term once the restrictions were lifted and economies were expected to improve.
•
Estimating future cash flows increasingly subjective due to uncertainty in future performance of borrowers
•
Estimating fair value increasingly subjective due to dislocated financial and
non-financial
markets
•
Allowances for credit losses increased to ¥13,012 m as of March 31, 2020 from ¥4,169 m as of March 31, 2019 primarily due to additional impairments identified in the fourth quarter due to the
COVID-19.
|
|||
Goodwill and intangible assets
Note 10
“Other assets—Other/Other liabilities”
|
Determination of whether goodwill and intangible assets are impaired and measurement of any impairment loss.
|
•
Identifying impairment indicators which trigger an impairment test
•
Inputs to the fair value of reporting units which include goodwill and fair value of indefinite-life intangibles.
•
Future cash flows for recoverability of finite-lived intangible assets.
|
•
Annual goodwill impairment test performed in the fourth quarter. No impairment loss recognized as estimated fair value of reporting units exceeded carrying value.
•
Annual impairment test of indefinite-lived intangibles performed in the fourth quarter. No impairment loss recognized as estimated fair value exceeded carrying value.
•
The COVID
-19
pandemic was not considered an impairment indicator for finite-lived intangible assets during the fourth quarter. No impairment testing of the relevant asset groups including these intangible assets was required.
|
Critical
accounting policy |
Critical accounting
estimates |
Underlying subjective key
assumptions by management |
Impact of
COVID-19
pandemic
|
|||
Equity method investees
Note 20
“Affiliated companies and other equity-method investees”
|
Determination of whether equity method investees are impaired.
|
•
When a decline in the share price of listed equity method investees below carrying value is other-than-temporary.
|
•
As a result of significant declines in global equity markets during the fourth quarter due to the
COVID-19
pandemic, we assessed and concluded no other-than-temporary impairment losses were required to be recognized.
|
|||
Litigation provisions
Note 21
“Commitments, contingencies and guarantees”
|
Determination of whether a loss is probable and measurement of provisions
|
•
Likelihood of eventual loss and ability to appeal or recover the loss from other parties
•
Management appetite to settle the matter
•
Loss amounts when claims are substantial, indeterminate or at an early stage
|
•
While the
COVID-19
pandemic has delayed the potential resolution of certain litigation matters, it has not had a direct significant impact on our litigation provisions as of March 31, 2020.
|
|||
Income taxes
Note 16
“Income taxes”
|
Realization of deferred tax assets
|
•
Future profitability of Nomura entities
•
Interpretation of tax rules by courts and regulatory authorities and tax examinations by taxing authorities.
•
Weighting of positive and negative evidence around the likelihood that sufficient future taxable income will be generated to realize deferred tax assets in the relevant tax jurisdiction
|
•
Although estimating future taxable income was increasingly subjective due to uncertainty in future profitability of Nomura, it did not result in a significant impact on our determination of realization of deferred tax assets as of March 31, 2020.
|
|
Billions of yen
|
|||||||||||||||||||
|
March 31, 2020
|
|||||||||||||||||||
|
Level 1
|
|
Level 2
|
|
Level 3
|
|
Counterparty
and Cash
Collateral
Netting
|
|
Total
|
|
||||||||||
Financial assets measured at fair value (Excluding derivative assets)
|
¥ |
6,855
|
¥ |
9,699
|
¥ |
751
|
¥ |
—
|
¥ |
17,305
|
||||||||||
Derivative assets
|
71
|
20,921
|
198
|
(19,248
|
) |
1,942
|
||||||||||||||
Total
|
¥ |
6,926
|
¥ |
30,620
|
¥ |
949
|
¥ |
(19,248
|
) | ¥ |
19,247
|
|||||||||
|
Billions of yen
|
|||||||
|
March 31, 2019
|
|||||||
|
Assets
|
|
Liabilities
|
|
||||
Listed derivatives
|
¥ |
103
|
¥ |
241
|
||||
OTC derivatives
|
749
|
574
|
||||||
|
¥ |
852
|
¥ |
815
|
||||
|
Billions of yen
|
|||||||
|
March 31, 2020
|
|||||||
|
Assets
|
|
Liabilities
|
|
||||
Listed derivatives
|
¥ |
559
|
¥ |
716
|
||||
OTC derivatives
|
1,383
|
1,093
|
||||||
|
¥ |
1,942
|
¥ |
1,809
|
||||
|
Billions of yen
|
|||||||||||||||||||||||||||
|
March 31, 2020
|
|||||||||||||||||||||||||||
|
Years to Maturity
|
|
|
|
|
|||||||||||||||||||||||
|
Less than
1 year
|
|
1 to 3
years
|
|
3 to 5
years
|
|
5 to 7
years
|
|
More than
7 years
|
|
Cross-maturity
netting
(1)
|
|
Total
fair value
|
|
||||||||||||||
OTC derivative assets
|
¥ |
2,026
|
¥ |
1,319
|
¥ |
944
|
¥ |
617
|
¥ |
3,853
|
¥ |
(7,376
|
) | ¥ |
1,383
|
|||||||||||||
OTC derivative liabilities
|
1,748
|
1,256
|
922
|
626
|
3,392
|
(6,851
|
) |
1,093
|
(1) | Represents the impact of netting derivative assets with derivative liabilities for the same counterparty across maturity band categories. Derivative assets and derivative liabilities with the same counterparty in the same maturity category are netted within the maturity category. This column also includes cash collateral netting with the same counterparty. |
|
Millions of yen
|
|||||||||||
|
March 31, 2020
|
|||||||||||
|
Funded
|
|
Unfunded
|
|
Total
|
|
||||||
Europe
|
¥ |
120,362
|
¥ |
71,840
|
¥ |
192,202
|
||||||
Americas
|
53,878
|
57,280
|
111,158
|
|||||||||
Asia and Oceania
|
7,761
|
5,166
|
12,927
|
|||||||||
Total
|
¥ |
182,001
|
¥ |
134,286
|
¥ |
316,287
|
||||||
|
Millions of yen
|
|
||
|
March 31, 2020
|
|
||
Deferred tax assets
|
|
|
|
|
Depreciation, amortization and valuation of fixed assets
|
¥ |
19,932
|
||
Investments in subsidiaries and affiliates
|
1,209
|
|||
Valuation of financial instruments
|
77,054
|
|||
Accrued pension and severance costs
|
24,356
|
|||
Other accrued expenses and provisions
|
51,566
|
|||
Operating losses
|
308,504
|
|||
Lease liabilities
|
47,680
|
|||
Other
|
9,394
|
|||
Gross deferred tax assets
|
539,695
|
|||
Less
—
|
(388,411
|
) | ||
Total deferred tax assets
|
151,284
|
|||
Deferred tax liabilities
|
|
|
|
|
Investments in subsidiaries and affiliates
|
89,630
|
|||
Valuation of financial instruments
|
52,780
|
|||
Undistributed earnings of foreign subsidiaries
|
2,423
|
|||
Valuation of fixed assets
|
9,497
|
|||
Right-of-use
assets
|
47,438
|
|||
Other
|
2,992
|
|||
Total deferred tax liabilities
|
204,760
|
|||
Net deferred tax assets (liabilities)
|
¥ |
(53,476
|
) | |
|
Billions of yen
|
|||||||||||||||
|
Average for
year ended
March 31, 2019
|
|
March 31,
2019
|
|
Average for
year ended
March 31, 2020
|
|
March 31,
2020
|
|
||||||||
Cash, cash equivalents and time deposits
(1)
|
¥ |
2,280.3
|
¥ |
2,113.1
|
¥ |
2,323.6
|
¥ |
2,540.4
|
||||||||
Government debt securities
|
2,553.0
|
2,424.6
|
2,371.5
|
2,412.2
|
||||||||||||
Others
(2)
|
301.1
|
332.8
|
310.6
|
401.8
|
||||||||||||
Total liquidity portfolio
|
¥ |
5,134.4
|
¥ |
4,870.5
|
¥ |
5,005.7
|
¥ |
5,354.4
|
||||||||
(1) | Cash, cash equivalents, and time deposits include nostro balances and deposits with both central banks and market counterparties that are readily available to support the liquidity position of Nomura. |
(2) | Others include other liquid financial assets such as money market funds and U.S. agency securities. |
|
Billions of yen
|
|||||||||||||||
|
Average for
year ended
March 31, 2019
|
|
March 31,
2019
|
|
Average for
year ended
March 31, 2020
|
|
March 31,
2020
|
|
||||||||
Japanese Yen
|
¥ |
1,696.8
|
¥ |
1,570.7
|
¥ |
1,500.6
|
¥ |
1,341.9
|
||||||||
U.S. Dollar
|
2,231.0
|
1,961.7
|
2,219.9
|
2,732.5
|
||||||||||||
Euro
|
734.0
|
898.8
|
818.4
|
789.5
|
||||||||||||
British Pound
|
325.2
|
265.7
|
310.5
|
315.5
|
||||||||||||
Others
(1)
|
147.4
|
173.6
|
156.3
|
175.0
|
||||||||||||
Total liquidity portfolio
|
¥ |
5,134.4
|
¥ |
4,870.5
|
¥ |
5,005.7
|
¥ |
5,354.4
|
||||||||
(1) | Includes other currencies such as the Australian dollar, the Canadian dollar and the Swiss franc. |
|
Billions of yen
|
|||||||
|
March 31, 2019
|
|
March 31, 2020
|
|
||||
NHI and NSC
(1)
|
¥ |
1,142.9
|
¥ |
1,382.9
|
||||
Major broker-dealer subsidiaries
|
2,473.5
|
2,645.8
|
||||||
Bank subsidiaries
(2)
|
799.4
|
775.8
|
||||||
Other affiliates
|
454.7
|
549.9
|
||||||
Total liquidity portfolio
|
¥ |
4,870.5
|
¥ |
5,354.4
|
||||
(1) | NSC, a broker-dealer located in Japan, holds an account with the Bank of Japan (“BOJ”) and has direct access to the BOJ Lombard facility through which same day funding is available for our securities pool. Any liquidity surplus at NHI is lent to NSC via short-term intercompany loans, which can be unwound immediately when needed. |
(2) | Includes Nomura Bank International plc (“NBI”), Nomura Singapore Limited and Nomura Bank Luxembourg S.A. |
|
Billions of yen
|
|||||||
|
March 31, 2019
|
|
March 31, 2020
|
|
||||
Net liquidity value of other unencumbered assets
|
¥ |
2,268.1
|
¥ |
2,573.6
|
||||
Liquidity portfolio
|
4,870.5
|
5,354.4
|
||||||
Total
|
¥ |
7,138.6
|
¥ |
7,928.0
|
||||
|
Billions of yen
|
|||||||
|
March 31, 2019
|
|
March 31, 2020
|
|
||||
Short-term bank borrowings
|
¥ |
107.0
|
¥ |
572.1
|
||||
Other loans
|
231.4
|
154.3
|
||||||
Commercial paper
|
313.0
|
525.1
|
||||||
Deposits at banking entities
|
1,149.1
|
1,116.2
|
||||||
Certificates of deposit
|
11.1
|
12.1
|
||||||
Debt securities maturing within one year
|
707.2
|
692.5
|
||||||
Total short-term unsecured debt
|
¥ |
2,518.8
|
¥ |
3,072.3
|
||||
|
Billions of yen
|
|||||||
|
March 31, 2019
|
|
March 31, 2020
|
|
||||
Long-term deposits at banking entities
|
¥ |
232.5
|
¥ |
147.9
|
||||
Long-term bank borrowings
|
2,727.5
|
2,591.5
|
||||||
Other loans
|
87.9
|
82.5
|
||||||
Debt securities
(1)
|
3,435.6
|
3,522.1
|
||||||
Total long-term unsecured debt
|
¥ |
6,483.5
|
¥ |
6,344.0
|
||||
(1) |
Excludes long-term debt securities issued by consolidated special purpose entities and similar entities that meet the definition of variable interest entities under ASC 810 “
Consolidation
Long-term borrowings
Transfer and Servicing.
|
• | Stressed scenario—To maintain adequate liquidity during a severe market-wide liquidity event without raising funds through unsecured financing or through the liquidation of assets for a year; and |
• | Acute stress scenario—To maintain adequate liquidity during a severe market-wide liquidity event coupled with credit concerns regarding Nomura’s liquidity position, without raising funds through unsecured funding or through the liquidation of assets for 30 days. |
• | No liquidation of assets; |
• | No ability to issue additional unsecured funding; |
• | Upcoming maturities of unsecured debt (maturities less than one year); |
• | Potential buybacks of our outstanding debt; |
• | Loss of secured funding lines particularly for less liquid assets; |
• | Fluctuation of funding needs under normal business circumstances; |
• |
Cash deposits and free collateral
roll-off
in a stress event;
|
• | Widening of haircuts on outstanding repo funding; |
• | Additional collateralization requirements of clearing banks and depositories; |
• | Drawdown on loan commitments; |
• | Loss of liquidity from market losses; |
• |
Assuming a
two-notch
downgrade of our credit ratings, the aggregate fair value of assets that we would be required to post as additional collateral in connection with our derivative contracts; and
|
• | Legal and regulatory requirements that can restrict the flow of funds between entities in the Nomura Group. |
|
Billions of yen
|
|||||||
|
Year Ended March 31
|
|||||||
|
2019
|
|
2020
|
|
||||
Net cash used in operating activities
|
¥ |
(361.2
|
) | ¥ |
(15.9
|
) | ||
Net income (loss)
|
(94.7
|
) |
219.4
|
|||||
Trading assets and private equity and debt investments
|
925.4
|
(2,754.7
|
) | |||||
Trading liabilities
|
(143.1
|
) |
429.0
|
|||||
Securities purchased under agreements to resell, net of securities sold under agreements to repurchase
|
(3,274.9
|
) |
2,224.4
|
|||||
Securities borrowed, net of securities loaned
|
1,987.3
|
291.8
|
||||||
Other, net
|
238.8
|
(425.7
|
) | |||||
Net cash provided by (used in) investing activities
|
(112.5
|
) |
216.3
|
|||||
Net cash provided by financing activities
|
761.2
|
332.1
|
||||||
Long-term borrowings, net
|
516.7
|
(38.4
|
) | |||||
Increase in short-term borrowings, net
|
85.9
|
656.2
|
||||||
Increase (decrease) in deposits received at banks, net
|
257.5
|
(93.3
|
) | |||||
Other, net
|
(98.9
|
) |
(192.5
|
) | ||||
Effect of exchange rate changes on cash, cash equivalents, restricted cash and restricted cash equivalents
|
44.7
|
(27.3
|
) | |||||
Net increase in cash, cash equivalents, restricted cash and restricted cash equivalents
|
332.3
|
505.2
|
||||||
Cash, cash equivalents, restricted cash and restricted cash equivalents at beginning of the year
|
2,354.9
|
2,687.1
|
||||||
Cash, cash equivalents, restricted cash and restricted cash equivalents at end of the year
|
¥ |
2,687.1
|
¥ |
3,192.3
|
||||
|
Billions of yen, except ratios
|
|||||||
|
March 31
|
|||||||
|
2019
|
|
2020
|
|
||||
NHI shareholders’ equity
|
¥ |
2,631.1
|
¥ |
2,653.5
|
||||
Total assets
|
40,969.4
|
43,999.8
|
||||||
Adjusted assets
(1)
|
23,662.5
|
28,092.7
|
||||||
Leverage ratio
(2)
|
15.6 x
|
16.6 x
|
||||||
Adjusted leverage ratio
(3)
|
9.0 x
|
10.6 x
|
(1) |
Represents total assets less
Securities purchased under agreements to resell
Securities borrowed
non-GAAP
financial measure and is calculated as follows:
|
|
Billions of yen
|
|||||||
|
March 31
|
|||||||
|
2019
|
|
2020
|
|
||||
Total assets
|
¥ |
40,969.4
|
¥ |
43,999.8
|
||||
Less:
|
|
|
||||||
Securities purchased under agreements to resell
|
13,194.5
|
12,377.3
|
||||||
Securities borrowed
|
4,112.4
|
3,529.8
|
||||||
Adjusted assets
|
¥ |
23,662.5
|
¥ |
28,092.7
|
||||
(2) | Equals total assets divided by NHI shareholders’ equity. |
(3) | Equals adjusted assets divided by NHI shareholders’ equity. |
Fiscal year ended or ending March 31,
|
First Quarter
|
|
Second Quarter
|
|
Third Quarter
|
|
Fourth Quarter
|
|
Total
|
|
||||||||||
2015
|
¥ |
—
|
¥ |
6.00
|
¥ |
—
|
¥ |
13.00
|
¥ |
19.00
|
||||||||||
2016
|
—
|
10.00
|
—
|
3.00
|
13.00
|
|||||||||||||||
2017
|
—
|
9.00
|
—
|
11.00
|
20.00
|
|||||||||||||||
2018
|
—
|
9.00
|
—
|
11.00
|
20.00
|
|||||||||||||||
2019
|
—
|
3.00
|
—
|
3.00
|
6.00
|
|||||||||||||||
2020
|
—
|
15.00
|
—
|
5.00
|
20.00
|
|
Billions of yen, except ratios
|
|||||||
|
March 31
|
|||||||
|
2019
|
|
2020
|
|
||||
Common equity Tier 1 capital
|
¥ |
2,439.7
|
¥ |
2,404.6
|
||||
Tier 1 capital
|
2,605.9
|
2,571.5
|
||||||
Total capital
|
2,651.9
|
2,602.4
|
||||||
Risk-Weighted Assets
|
|
|
|
|
|
|
||
Credit risk-weighted assets
|
7,527.4
|
7,634.7
|
||||||
Market risk equivalent assets
|
4,211.1
|
5,549.3
|
||||||
Operational risk equivalent assets
|
2,513.1
|
2,490.5
|
||||||
Total risk-weighted assets
|
¥ |
14,251.6
|
¥ |
15,674.5
|
||||
Consolidated Capital Adequacy Ratios
|
|
|
|
|
|
|
||
Common equity Tier 1 capital ratio
|
17.11
|
% |
15.34
|
% | ||||
Tier 1 capital ratio
|
18.28
|
% |
16.40
|
% | ||||
Consolidated capital adequacy ratio
|
18.60
|
% |
16.60
|
% |
Nomura Holdings, Inc.
|
Short-term
Debt
|
|
Long-term
Debt
|
|
||||
S&P Global Ratings
|
A-2
|
BBB+ (Stable)
|
||||||
Moody’s Investors Service
|
—
|
Baa1 (Negative)
|
||||||
Fitch Ratings
|
F1
|
A-
(Stable)
|
||||||
Rating and Investment Information, Inc.
|
a-1
|
A+ (Stable)
|
||||||
Japan Credit Rating Agency, Ltd.
|
—
|
AA-
(Stable)
|
||||||
Nomura Securities Co., Ltd.
|
Short-term Debt
|
|
Long-term Debt
|
|
||||
S&P Global Ratings
|
A-2
|
A-
(Stable)
|
||||||
Moody’s Investors Service
|
P-2
|
A3 (Negative)
|
||||||
Fitch Ratings
|
F1
|
A-
(Stable)
|
||||||
Rating and Investment Information, Inc.
|
a-1
|
A+ (Stable)
|
||||||
Japan Credit Rating Agency, Ltd.
|
—
|
AA-
(Stable)
|
• | an obligation under a guarantee contract; |
• |
a retained or contingent interest in assets transferred to an
off-balance
sheet entity or similar arrangement that serves to provide credit, liquidity or market risk support to such entity;
|
• | any obligation, including a contingent obligation, under a contract that would be accounted for as a derivative instrument; or |
• |
any obligation, including a contingent obligation, arising out of a variable interest in an
off-balance
sheet entity that is held by, and material to, us, where such entity provides financing, liquidity, market risk or credit risk support to, or engages in leasing, hedging or research and development services with, us.
|
• | In connection with our banking and financing activities, we enter into various guarantee arrangements with counterparties in the form of standby letters of credit and other guarantees, which generally have fixed expiration dates. |
• |
In connection with our operating activities, we issue Japanese Yen and
non-Japanese
Yen denominated long-term borrowings which incur variable and fixed interest payments in accordance with our funding policy.
|
• | We lease office space, residential facilities for employees, motor vehicles, equipment and technology assets in the ordinary course of business both in Japan and overseas as lessee. These arrangements predominantly consist of operating leases; |
• | Separately we sublease certain real estate and equipment through operating lease arrangements. |
• | We lease certain equipment and facilities in Japan and overseas which are classified as finance lease agreements. |
• | We have purchase obligations for goods and services which include payments for construction, advertising, and computer and telecommunications maintenance agreements. |
• | In connection with our banking and financing activities, we enter into contractual commitments to extend credit, which generally have fixed expiration dates; |
• | In connection with our investment banking activities, we enter into agreements with clients under which we commit to underwrite securities that may be issued by clients. |
• | As a member of certain central clearing counterparties, Nomura is committed to provide liquidity facilities through entering into reverse repo transactions backed by government and government agency debt securities with those counterparties in a situation where a default of another clearing member occurs. |
• | We have commitments to invest in interests in various partnerships and other entities and commitments to provide financing for investments related to those partnerships. |
|
Millions of yen
|
|||||||||||||||||||
|
Total
contractual
amount
|
|
Years to maturity
|
|||||||||||||||||
Less than
1 year
|
|
1 to 3
years
|
|
3 to 5
years
|
|
More than
5 years
|
|
|||||||||||||
Standby letters of credit and other guarantees
|
¥ |
2,351
|
¥ |
10
|
¥ |
1,184
|
¥ |
1,156
|
¥ |
1
|
||||||||||
Long-term borrowings
(1)
|
7,720,941
|
778,008
|
1,224,258
|
1,645,653
|
4,073,022
|
|||||||||||||||
Contractual interest payments
(2)
|
458,021
|
74,270
|
125,210
|
91,478
|
167,063
|
|||||||||||||||
Operating lease commitments
(3)
|
215,916
|
41,270
|
56,349
|
43,751
|
74,546
|
|||||||||||||||
Purchase obligations
(4)
|
126,949
|
20,523
|
35,720
|
8,392
|
62,314
|
|||||||||||||||
Commitments to extend credit
(5)
|
2,247,433
|
1,399,086
|
139,295
|
167,322
|
541,730
|
|||||||||||||||
Commitments to invest
|
15,278
|
491
|
4
|
5,628
|
9,155
|
|||||||||||||||
Total
|
¥ |
10,786,889
|
¥ |
2,313,658
|
¥ |
1,582,020
|
¥ |
1,963,380
|
¥ |
4,927,831
|
||||||||||
(1) | The amounts disclosed within long-term borrowings exclude financial liabilities recognized within long-term borrowings as a result of transfers of financial assets that are accounted for as financings rather than sales in accordance with ASC 860. These are not borrowings issued for our own funding purposes and therefore do not represent actual contractual obligations by us to deliver cash. |
(2) | The amounts represent estimated future interest payments related to long-time borrowings based on the period through to their maturity and applicable interest rates as of March 31, 2020. |
(3) | The amounts of operating lease commitments are undiscounted future minimum lease payments. The amounts of finance lease contracts were immaterial. |
(4) |
The minimum contractual obligations under enforceable and legally binding contracts that specify all significant terms. Amounts exclude obligations that are already reflected on our consolidated balance sheets as liabilities or payables. Includes the commitment to purchase parts of the redeveloped real estate in Tokyo Nihonbashi district from the redevelopment partnership. See Note 23 “
Significant subsequent events
|
(5) | Contingent liquidity facilities to central clearing counterparties are included. |
Name
(Date of Birth)
|
Responsibilities and Status within Nomura/
Other Principal Business Activities
|
Business Experience
|
||||
Koji Nagai
(Jan. 25, 1959)
|
Director
Chairman of Board Directors
Member of the Nomination Committee
Member of the Compensation Committee
Director and Chairman of Nomura Securities Co., Ltd.
|
Apr. 1981
|
Joined the Company
|
|||
Apr. 2003
|
Director of Nomura Securities Co., Ltd.
|
|||||
Jun. 2003
|
Senior Managing Director of Nomura Securities Co., Ltd.
|
|||||
Apr. 2007
|
Executive Managing Director of Nomura Securities Co., Ltd.
|
|||||
Oct. 2008
|
Senior Corporate Managing Director of Nomura Securities Co., Ltd.
|
|||||
Apr. 2009
|
Executive Managing Director and Executive Vice President of Nomura Securities Co., Ltd.
|
|||||
Apr. 2011
|
Co-COO
and Deputy President of Nomura Securities Co., Ltd.
|
|||||
Apr. 2012
|
Senior Managing Director of the Company
Director and President of Nomura Securities Co., Ltd.
|
|||||
Aug. 2012
|
Representative Executive Officer & Group CEO of the Company
Director and President of Nomura Securities Co., Ltd.
|
|||||
Jun. 2013
|
Director, Representative Executive Officer & Group CEO of the Company
Director and President of Nomura Securities Co., Ltd.
|
|||||
Apr. 2017
|
Director, Representative Executive Officer, President & Group CEO of the Company
Director and Chairman of Nomura Securities Co., Ltd.
|
|||||
Apr. 2020
|
Director and Chairman of the Company (Current)
Director and Chairman of Nomura Securities Co., Ltd. (Current)
|
Name
(Date of Birth)
|
Responsibilities and Status within Nomura/
Other Principal Business Activities
|
Business Experience
|
||||
Kentaro Okuda
(Nov. 7, 1963)
|
Director, Representative Executive Officer, President and Group CEO
Representative Director of Nomura Securities Co., Ltd.
|
Apr. 1987
|
Joined the Company
|
|||
Apr. 2010
|
Senior Managing Director of Nomura Securities Co., Ltd.
|
|||||
Apr. 2012
|
Senior Corporate Managing Director of Nomura Securities Co., Ltd.
|
|||||
Aug. 2012
|
Senior Corporate Managing Director of the Company
Senior Corporate Managing Director of Nomura Securities Co., Ltd.
|
|||||
|
|
Apr. 2013
|
Senior Managing Director of the Company
Senior Corporate Managing Director of Nomura Securities Co., Ltd.
|
|||
|
|
Apr. 2015
|
Senior Managing Director of the Company
Executive Vice President of Nomura Securities Co., Ltd.
|
|||
|
|
Apr. 2016
|
Senior Managing Director of the Company
Executive Managing Director and Executive Vice President of Nomura Securities Co., Ltd.
|
|||
|
|
Apr. 2017
|
Senior Managing Director of the Company
Executive Vice President of Nomura Securities Co., Ltd.
|
|||
|
|
Apr. 2018
|
Executive Managing Director, and Group
Co-COO
and Head of Americas (based in New York) of the Company
Director, Executive Managing Director and Deputy President of Nomura Securities Co., Ltd.
|
|||
|
|
Apr. 2019
|
Executive Managing Director and Deputy President, Group
Co-COO
of the Company
|
|||
|
|
Apr. 2020
|
Representative Executive Officer and President, Group CEO of the Company
Representative Director of Nomura Securities Co., Ltd.
|
|||
|
|
Jun. 2020
|
Director, Representative Executive Officer, President & Group CEO of the Company (Current)
Representative Director of Nomura Securities Co., Ltd. (Current)
|
Name
(Date of Birth)
|
Responsibilities and Status within Nomura/
Other Principal Business Activities
|
Business Experience
|
||||
Toshio Morita
(Apr. 17, 1961)
|
Director, Representative Executive Officer
Representative Director and President of Nomura Securities Co., Ltd.
|
Apr. 1985
|
Joined the Company
|
|||
Apr. 2008
|
Executive Managing Director of Nomura Securities Co., Ltd.
|
|||||
Oct. 2008
|
Senior Managing Director of Nomura Securities Co., Ltd.
|
|||||
Apr. 2010
|
Senior Corporate Managing Director of Nomura Securities Co., Ltd.
|
|||||
|
|
Apr. 2011
|
Senior Corporate Managing Director of the Company
|
|||
|
|
Apr. 2012
|
Senior Corporate Managing Director of the Company
Senior Corporate Managing Director of Nomura Securities Co., Ltd.
|
|||
|
|
Aug. 2012
|
Executive Managing Director of the Company
Executive Vice President of Nomura Securities Co., Ltd.
|
|||
|
|
Apr. 2015
|
Executive Managing Director of the Company
Representative Executive Officer and Executive Vice President of Nomura Securities Co., Ltd.
|
|||
|
|
Apr. 2016
|
Representative Executive Officer and Deputy President of Nomura Securities Co., Ltd.
|
|||
|
|
Apr. 2017
|
Executive Managing Director of the Company
Director, Representative Executive Officer and President of Nomura Securities Co., Ltd.
|
|||
|
|
Apr. 2018
|
Executive Managing Director and Group
Co-COO
of the Company
Director, Representative Executive Officer and President of Nomura Securities Co., Ltd.
|
|||
|
|
Apr. 2019
|
Executive Managing Director and Group
Co-COO
of the Company
Representative Director and President of Nomura Securities Co., Ltd.
|
|||
|
|
Apr. 2020
|
Representative Executive Officer of the Company
Representative Director and President of Nomura Securities Co., Ltd.
|
Name
(Date of Birth)
|
Responsibilities and Status within Nomura/
Other Principal Business Activities
|
Business Experience
|
||||
|
|
Jun. 2020
|
Director, Representative Executive Officer of the Company (Current)
Representative Director and President of Nomura Securities Co., Ltd. (Current)
|
|||
Hisato Miyashita
(Dec. 26, 1958)
|
Director
Member of the Audit Committee
(full-time)
Statutory Auditor of Nomura Financial Products & Services, Inc.
|
Jul. 1987
|
Joined the Company
|
|||
Jun. 1993
|
Joined Union Bank of Switzerland (currently, UBS)
|
|||||
|
Aug. 1996
|
Joined Bankers Trust Asia Securities Ltd.
|
||||
|
Apr. 1998
|
Joined Credit Suisse First Boston Securities (Japan) Limited
|
||||
|
Dec. 1999
|
Joined Nikko Citigroup Limited (currently, Citigroup Global Markets Japan Inc.)
|
||||
|
Mar. 2005
|
Executive Officer of Nikko Citigroup Limited, Internal Control Supervisory Manager
|
||||
|
Jul. 2009
|
Managing Director of Group Compliance Department of the Company
|
||||
|
Apr. 2012
|
Senior Managing Director of the Company, Head of Wholesale Compliance
|
||||
|
|
Jun. 2012
|
Senior Managing Director of the Company, Group Compliance Head Senior Managing Director of Nomura Securities Co., Ltd.
|
|||
|
|
Apr. 2013
|
Senior Managing Director of the Company, Group Compliance Head Representative Executive Officer of Nomura Securities Co., Ltd., Internal Control Supervisory Manager
|
|||
|
|
Apr. 2015
|
Senior Managing Director of the Company, Deputy Chief of Staff and Group Compliance Head
Representative Executive Officer and Senior Corporate Managing Director of Nomura Securities Co., Ltd., Internal Control Supervisory Manager
|
|||
|
|
Apr. 2016
|
Advisor of the Company
|
|||
|
|
Jun. 2016
|
Director of the Company (Current)
|
Name
(Date of Birth)
|
Responsibilities and Status within Nomura/
Other Principal Business Activities
|
Business Experience
|
||||
Hiroshi Kimura
(Apr. 23, 1953)
|
Outside Director
Chairman of the Nomination Committee
Chairman of the Compensation Committee
Honorary Company Fellow of Japan Tobacco Inc.
|
Apr. 1976
|
Joined Japan Tobacco and Salt Public Corporation (currently, Japan Tobacco Inc.) (“JT”)
|
|||
Jun. 1999
|
Director of JT
|
|||||
|
Jun. 2001
|
Resigned as Director of JT
|
||||
|
Jun. 2005
|
Director of JT
|
||||
|
Jun. 2006
|
President and CEO and Representative Director of JT
|
||||
|
Jun. 2012
|
Chairman of the Board of JT
|
||||
|
Jun. 2014
|
Special Advisor of JT
|
||||
|
Jun. 2015
|
Outside Director of the Company (Current)
|
||||
|
|
Jul. 2016
|
Advisor of JT
|
|||
|
|
Mar. 2018
|
Honorary Company Fellow of JT (Current)
|
|||
Kazuhiko Ishimura
(Sep. 18, 1954)
|
Outside Director
Member of the Nomination Committee
Member of the Compensation Committee
Director of AGC Inc.
Outside Director of TDK Corporation
Outside Director of IHI Corporation
President of the National Institute of Advanced Industrial Science and Technology
|
Apr. 1979
|
Joined Asahi Glass Co., Ltd. (currently, AGC Inc.) (“AGC”)
|
|||
|
Jan. 2006
|
Executive Officer and GM of Kansai Plant of AGC
|
||||
|
Jan. 2007
|
Senior Executive Officer and GM of Electronics & Energy General Division of AGC
|
||||
|
Mar. 2008
|
Representative Director and President & COO of AGC
|
||||
|
Jan. 2010
|
Representative Director and President & CEO of AGC
|
||||
|
Jan. 2015
|
Representative Director & Chairman of AGC
|
||||
|
Jan. 2018
|
Director & Chairman of AGC
|
||||
|
Jun. 2018
|
Outside Director of the Company (Current)
|
||||
|
Mar. 2020
|
Director of AGC (Current)
|
||||
|
Apr. 2020
|
President of the National Institute of Advanced Industrial Science and
Technology (Current)
|
||||
Noriaki Shimazaki
(Aug. 19, 1946)
|
Outside Director
Chairman of the Audit Committee
Director of Nomura Securities Co., Ltd.
Outside Director of Loginet Japan Co., Ltd.
|
Apr. 1969
|
Joined Sumitomo Corporation
|
|||
Jun. 1998
|
Director of Sumitomo Corporation
|
|||||
|
Apr. 2002
|
Representative Director and Managing Director of Sumitomo Corporation
|
||||
|
Jan. 2003
|
Member of the Business Accounting Council of the Financial Services Agency
|
||||
|
|
Apr. 2004
|
Representative Director and Senior Managing Executive Officer of Sumitomo Corporation
|
Name
(Date of Birth)
|
Responsibilities and Status within Nomura/
Other Principal Business Activities
|
Business Experience
|
||||
|
|
Apr. 2005
|
Representative Director and Executive Vice President of Sumitomo Corporation
|
|||
|
|
Jan. 2009
|
Trustee of the IASC (currently, IFRS Foundation)
|
|||
|
|
Jul. 2009
|
Special Advisor of Sumitomo Corporation
|
|||
|
|
Jun. 2011
|
Director of the Financial Accounting Standards Foundation
Chairman of Self-regulation Board and Public Governor of the Japan Securities Dealers Association
|
|||
|
|
Sep. 2013
|
Advisor of the IFRS Foundation Asia-Oceania Office (Current)
Advisor of the Japanese Institute of Certified Public Accountants (Current)
|
|||
|
|
Jun. 2016
|
Outside Director of the Company (Current)
Director of Nomura Securities Co., Ltd. (Current)
|
|||
Mari Sono
(Feb. 20, 1952)
|
Outside Director
Member of the Audit Committee
|
Oct. 1976
|
Joined NISSHIN Audit Corporation(*)
|
|||
Mar. 1979
|
Registered as Certified Public Accountant
|
|||||
|
|
Nov. 1988
|
Partner of CENTURY Audit Corporation(*)
|
|||
|
|
Nov. 1990
|
Member of “Certified Public Accountant Examination System Subcommittee”, Certified Public Accountant Examination and Investigation Board, Ministry of Finance
|
|||
|
|
Apr. 1992
|
Member of “Business Accounting Council”, Ministry of Finance
|
|||
|
|
Dec. 1994
|
Senior Partner, CENTURY Audit Corporation(*)
|
|||
|
|
Oct. 2002
|
Member of Secretariat of the Information Disclosure, Cabinet Office (currently, Secretariat of the Information Disclosure and Personal Information Protection Review Board, Ministry of Internal Affairs and Communications)
|
|||
|
|
Apr. 2005
|
External Comprehensive Auditor, Tokyo
|
Name
(Date of Birth)
|
Responsibilities and Status within Nomura/
Other Principal Business Activities
|
Business Experience
|
||||
|
|
Jul. 2008
|
Senior Partner of Ernst & Young ShinNihon LLC
|
|||
|
|
Aug. 2012
|
Retired Ernst & Young ShinNihon LLC
|
|||
|
|
Dec. 2013
|
Commissioner of the Securities and Exchange Surveillance Commission
|
|||
|
|
Jun. 2017
|
Outside Director of the Company (Current)
* Each of the corporation is currently Ernst & Young ShinNihon LLC
|
|||
Michael Lim Choo
San
(Sep. 10, 1946)
|
Outside Director
Non-Executive
Chairman of Fullerton Healthcare Corporation Limited
Non-Executive
Chairman of Nomura Singapore Ltd.
|
Aug. 1972
|
Joined Price Waterhouse, Singapore
|
|||
Jan. 1992
|
Managing Partner of Price Waterhouse, Singapore
|
|||||
|
Oct. 1998
|
Member of the Singapore Public Service Commission (Current)
|
||||
|
|
Jul. 1999
|
Executive Chairman of PricewaterhouseCoopers, Singapore
|
|||
|
|
Sep. 2002
|
Chairman of the Land Transport Authority of Singapore
|
|||
|
|
Sep. 2004
|
Independent Director of Olam International Limited
|
|||
|
|
Jun. 2011
|
Outside Director of the Company (Current)
|
|||
|
|
Nov. 2011
|
Chairman of the Accounting Standards Council, Singapore
|
|||
|
|
Apr. 2013
|
Chairman of the Singapore Accountancy Commission
|
|||
|
|
Sep. 2016
|
Non-Executive
Chairman of Fullerton Healthcare Corporation Limited (Current)
|
|||
Laura Simone Unger
(Jan. 8, 1961)
|
Outside Director
Independent Director of CIT Group Inc.
Independent Director of Navient Corporation
Independent Director of Nomura Securities International, Inc.
|
Jan. 1988
|
Enforcement Attorney of U.S. Securities and Exchange Commission (SEC)
|
|||
|
Oct. 1990
|
Counsel of U.S. Senate Committee on Banking, Housing, and Urban Affairs
|
||||
|
Nov. 1997
|
Commissioner of SEC
|
||||
|
Feb. 2001
|
Acting Chairperson of SEC
|
||||
|
Jul. 2002
|
Regulatory Expert of CNBC
|
||||
|
May 2003
|
Independent Consultant of JPMorgan Chase & Co.
|
||||
|
Aug. 2004
|
Independent Director of CA Inc.
|
Name
(Date of Birth)
|
Responsibilities and Status within Nomura/
Other Principal Business Activities
|
Business Experience
|
||||
|
|
Jan. 2010
|
Special Advisor of Promontory Financial Group
|
|||
|
|
Dec. 2010
|
Independent Director of CIT Group Inc. (Current)
|
|||
|
|
Nov. 2014
|
Independent Director of Navient Corporation (Current)
|
|||
|
|
Jun. 2018
|
Outside Director of the Company (Current)
|
Name
(Date of Birth)
|
Responsibilities and Status within Nomura/
Other Principal Business Activities
|
Business Experience
|
||||
Kentaro Okuda
(Nov. 7, 1963)
|
See “
Directors
|
See “
Directors
|
||||
Toshio Morita
(Apr. 17, 1961)
|
See “
Directors
|
See “
Directors
|
||||
Junko Nakagawa
(Jul. 26, 1965)
|
Executive Managing Director
Head of Asset Management
Representative Director, President and CEO of Nomura Asset Management Co., Ltd.
|
Apr. 1988
|
Joined the Company
|
|||
Mar. 2004
|
Retired Nomura Securities Co., Ltd.
|
|||||
|
|
Jan. 2008
|
Joined Nomura Healthcare Co., Ltd.
|
|||
|
|
Apr. 2008
|
Representative Director and President of Nomura Healthcare Co., Ltd.
|
|||
|
|
Jun. 2010
|
Director of Nomura Healthcare Co., Ltd.
Rejoined Nomura Securities Co., Ltd.
|
|||
|
|
Apr. 2011
|
Executive Managing Director and Chief Financial Officer of the Company
Executive Managing Director and Financial Officer of Nomura Securities Co., Ltd.
|
|||
|
|
Apr. 2013
|
Senior Managing Director of the Company
|
|||
|
|
Apr. 2016
|
Senior Managing Director of the Company
Senior Managing Director of Nomura Securities Co., Ltd.
|
|||
|
|
Apr. 2017
|
Executive Managing Director and Executive Vice President of Nomura Asset Management Co., Ltd.
|
|||
|
|
Apr. 2019
|
Executive Managing Director and Head of Asset Management of the Company (Current)
Representative Director, President and CEO of Nomura Asset Management Co., Ltd. (Current)
|
Name
(Date of Birth)
|
Responsibilities and Status within Nomura/
Other Principal Business Activities
|
Business Experience
|
||||
Tomoyuki Teraguchi
(Aug. 4, 1962)
|
Executive Managing Director
Chief of Staff and Chief Compliance Officer
Representative Director and Deputy President of Nomura Securities Co., Ltd.
|
Apr. 1986
|
Joined the Company
|
|||
Apr. 2009
|
Senior Managing Director of Nomura Securities Co., Ltd.
|
|||||
Apr. 2016
|
Senior Managing Director of the Company
Representative Executive Officer of Nomura Securities Co., Ltd.
|
|||||
|
|
Apr. 2017
|
Senior Managing Director of the Company
Representative Executive Officer and Senior Corporate Managing Director of Nomura Securities Co., Ltd.
|
|||
|
|
Apr. 2019
|
Executive Managing Director and Chief Compliance Officer of the Company
Representative Director and Executive Vice President of Nomura Securities Co., Ltd.
|
|||
|
|
Apr. 2020
|
Executive Managing Director, Chief of Staff and Chief Compliance Officer of the Company (Current)
Representative Director and Deputy President of Nomura Securities Co., Ltd. (Current)
|
|||
Takumi Kitamura
(Nov. 26, 1966)
|
Executive Managing Director
Chief Financial Officer
Director and Senior Corporate Managing
Director of Nomura Securities Co., Ltd.
|
Apr. 1990
|
Joined the Company
|
|||
Apr. 2016
|
Executive Managing Director and Chief Financial Officer of the Company
Executive Managing Director and Financial Officer of Nomura Securities Co., Ltd.
|
|||||
|
|
Apr. 2019
|
Executive Managing Director and Chief Financial Officer of the Company (Current)
Director and Senior Corporate Managing Director of Nomura Securities Co., Ltd. (Current)
|
|||
Sotaro Kato
(Oct. 9, 1969)
|
Executive Managing Director
Chief Risk Officer
Director and Senior Corporate Managing
Director of Nomura Securities Co., Ltd.
|
Sep. 2002
|
Joined the Company
|
|||
Apr. 2020
|
Executive Managing Director and Chief Risk Officer of the Company (based in New York) (Current)
Director and Senior Corporate Managing Director of Nomura Securities Co., Ltd. (Current)
|
1. | align with Nomura values and strategies; |
2. | reflect group, divisional and individual performance; |
3. | establish appropriate performance measurement with a focus on risk; |
4. | align employee and shareholder interests; |
5. | establish appropriate compensation structures; and |
6. | ensure robust governance and control processes. |
Compensation
Components
|
Objectives
|
Specific Elements
|
||||||
Fixed Compensation
|
•
|
Rewards individuals for their knowledge, skills, competencies and experiences
|
•
|
Base salary
|
||||
|
•
|
Reflects local labor market standards
|
|
|
||||
|
•
|
Reflects practices of local labor markets to deliver allowances as a part of fixed compensation to individuals
|
•
•
|
Housing allowances
Overtime pay
|
||||
Variable Compensation
|
•
|
Rewards team and individual performances, and their contribution to results as well as the Company’s strategic and future value
|
•
•
|
Cash bonuses
Deferred compensation
|
||||
|
•
|
Reflects appropriate internal and market-based peer comparisons
|
|
|
||||
|
•
|
Reflects broad views on compensation, including individual performances, approaches to risk, compliance and cross-divisional cooperation
|
|
|
• | align employee interest with that of shareholders; |
• | increase employee retention through providing opportunities to grow personal wealth over the period from grant to vesting; and |
• | encourage cross-divisional and cross-regional collaboration by focusing individuals on a common goal of long-term increase in corporate value. |
Type of award
|
|
Key features
|
||
Restricted Stock Unit (“RSU”) awards
|
•
|
Settled in the Company’s common stock.
|
||
•
|
Graded vesting period generally over three years.
|
|||
•
|
Extended vesting period of up to seven years for certain senior management and employees in order to meet local regulatory requirements based on the role they perform in Nomura.
|
|||
•
|
New type of award introduced in 2018 as the primary type of deferred compensation award in Nomura. Granted in May 2018 in respect of the prior fiscal year.
|
|||
Notional Stock Unit
(“NSU”) awards
|
•
|
Linked to the price of Company’s common stock and cash-settled.
|
||
•
|
Graded vesting period generally over three years. Extended vesting period of up to seven years for certain senior management and employees based on the role they perform in Nomura in order to meet local regulatory requirements.
|
|||
•
|
Used in countries where equity-settled RSU awards are less favorably treated from a tax or other perspective.
|
|||
•
|
Following the introduction of RSU awards, NSU awards are less commonly used in Nomura.
|
|||
•
|
Granted in May each year in respect of the prior fiscal year and also quarterly to new employees as a recruitment incentive to replace awards forfeited from prior employers.
|
|||
Stock Acquisition Right (“SAR”) Plan A awards
|
•
|
Exercisable into 100 of the Company’s common stock.
|
||
•
|
Exercise price not less than the fair value of the Company’s common stock on grant date.
|
|||
•
|
Cliff vesting period of two years.
|
|||
•
|
Expire approximately seven years after grant date.
|
|||
•
|
Not subject to claw back.
|
|||
•
|
Granted in November each year in respect of various performance periods.
|
|
Number of
Directors or
Executive
Officers
(1)
|
|
Millions of yen
|
|||||||||||||||||
|
Year ended March 31, 2020
|
|||||||||||||||||||
|
Basic Compensation
(2)(3)
|
|
Bonus
|
|
Deferred Compensation
(4)
|
|
Total
|
|
||||||||||||
Directors
|
8
|
¥ |
253
|
¥ |
100
|
¥ |
15
|
¥ |
368
|
|||||||||||
(Outside Directors included in above)
|
(6
|
) |
(129
|
) |
( —
|
) |
( —
|
) |
(129
|
) | ||||||||||
Executive Officers
|
8
|
560
|
538
|
203
|
1,301
|
|||||||||||||||
Total
|
16
|
¥ |
813
|
¥ |
638
|
¥ |
218
|
¥ |
1,669
|
|||||||||||
(1) | Compensation to Directors who were concurrently serving as Executive Officers is included in that of Executive Officers. |
(2) | Basic compensation of ¥813 million includes other compensation (such as commuter pass allowances) of ¥750 thousand. |
(3) | In addition to basic compensation of Executive Officers, ¥27 million of corporate housing costs, such as housing allowance and related tax adjustments, were provided. |
(4) | Deferred compensation (such as RSU, SAR Plan A and B) granted during and prior to the fiscal year ended March 31, 2020 is recognized as expense in the financial statements for the fiscal year ended March 31, 2020. |
(5) | Subsidiaries of the Company paid ¥61 million to Outside Directors as compensation etc. for their directorship at those subsidiaries for the year ended March 31, 2020. |
(6) | The Company abolished retirement bonuses to Directors in 2001. |
|
|
|
|
|
Millions of yen
|
|||||||||||||||||||||||||||||||
|
|
|
|
|
Fixed Remuneration
(Basic Compensation)
|
Variable Compensation
(1)
|
|
|
||||||||||||||||||||||||||||
Name
|
Company
|
|
Category
|
|
Base Salary
|
|
Equity
Compensation
(RSUs)
|
|
Total
|
|
Cash
Bonus
|
|
Deferred
Compensation
(RSUs, etc.)
|
|
Total
|
|
Total
|
|
||||||||||||||||||
Nobuyuki Koga
|
Nomura
|
Chairman of the Board of Directors
|
¥ |
87
|
¥ |
—
|
¥ |
87
|
¥ |
83
|
¥ |
83
|
¥ |
167
|
¥ |
254
|
||||||||||||||||||||
Koji Nagai(2)(3)
|
Nomura
|
Director,
Representative
Executive
Officer
(Group CEO)
|
¥ |
94
|
¥ |
17
|
¥ |
112
|
¥ |
155
|
¥ |
155
|
¥ |
311
|
¥ |
422
|
||||||||||||||||||||
Syoichi Nagamatsu(2)
|
Nomura
|
Director,
Representative Executive Officer,
Deputy President
|
¥ |
72
|
¥ |
14
|
¥ |
86
|
¥ |
106
|
¥ |
106
|
¥ |
211
|
¥ |
297
|
||||||||||||||||||||
Kentaro Okuda(2)(4)
|
Nomura
|
Executive Managing Director, Deputy President
(Group
Co-COO)
|
¥ |
82
|
¥ |
15
|
¥ |
97
|
¥ |
90
|
¥ |
90
|
¥ |
181
|
¥ |
277
|
||||||||||||||||||||
Toshio Morita(2)
|
Nomura
|
Executive Managing Director
(Group
Co-COO)
|
¥ |
80
|
¥ |
15
|
¥ |
95
|
¥ |
90
|
¥ |
90
|
¥ |
181
|
¥ |
275
|
||||||||||||||||||||
Yuji Nakata
|
Nomura
|
Executive Managing Director
|
¥ |
66
|
¥ |
13
|
¥ |
79
|
¥ |
46
|
¥ |
46
|
¥ |
93
|
¥ |
172
|
||||||||||||||||||||
Tomoyuki Teraguchi(2)
|
Nomura
|
Executive Managing Director
|
¥ |
59
|
¥ |
13
|
¥ |
72
|
¥ |
18
|
¥ |
18
|
¥ |
37
|
¥ |
109
|
(1) | Variable Compensation indicates the amount determined as remuneration based on the performance during the fiscal year ended March 31, 2020. |
(2) | The amount reflects voluntary salary cut, conducted in May 2019. |
(3) | In addition to basic compensation, ¥24 million of corporate housing costs, such as housing allowance and related tax adjustments, were provided. |
(4) | In addition to basic compensation, ¥3 million of corporate housing costs, such as housing allowance and related tax adjustments, were provided. |
|
March 31, 2020
|
|||||||||||||||
Series of SARs
|
Allotment Date
|
Number of
Shares under
SARs
|
|
Exercise Period
of SARs
|
Exercise
Price per
Share under
SARs
|
|
Paid-in
Amount for
SARs
|
|
||||||||
Stock Acquisition Rights No.46
|
June 5, 2012
|
115,300
|
From April 20, 2015
to April 19, 2020
|
¥ |
1
|
¥ |
0
|
|||||||||
Stock Acquisition Rights No.47
|
June 5, 2012
|
372,000
|
From April 20, 2016
to April 19, 2021
|
1
|
0
|
|||||||||||
Stock Acquisition Rights No.48
|
June 5, 2012
|
526,800
|
From April 20, 2017
to April 19, 2022
|
1
|
0
|
|||||||||||
Stock Acquisition Rights No.49
|
June 5, 2012
|
39,800
|
From October 20, 2015
to April 19, 2021
|
1
|
0
|
|||||||||||
Stock Acquisition Rights No.50
|
June 5, 2012
|
39,700
|
From October 20, 2016
to April 19, 2022
|
1
|
0
|
|||||||||||
Stock Acquisition Rights No.53
|
June 5, 2013
|
93,700
|
From April 20, 2015
to April 19, 2020
|
1
|
0
|
|||||||||||
Stock Acquisition Rights No.54
|
June 5, 2013
|
456,300
|
From April 20, 2016
to April 19, 2021
|
1
|
0
|
|||||||||||
Stock Acquisition Rights No.55
|
November 19, 2013
|
2,678,200
|
From November 19, 2015
to November 18, 2020
|
821
|
0
|
|||||||||||
Stock Acquisition Rights No.56
|
June 5, 2014
|
189,200
|
From April 20, 2015
to April 19, 2020
|
1
|
0
|
|||||||||||
Stock Acquisition Rights No.57
|
June 5, 2014
|
652,400
|
From April 20, 2016
to April 19, 2021
|
1
|
0
|
|||||||||||
Stock Acquisition Rights No.58
|
June 5, 2014
|
1,014,500
|
From April 20, 2017
to April 19, 2022
|
1
|
0
|
|||||||||||
Stock Acquisition Rights No.60
|
June 5, 2014
|
375,400
|
From March 31, 2016
to March 30, 2021
|
1
|
0
|
|||||||||||
Stock Acquisition Rights No.61
|
June 5, 2014
|
1,374,600
|
From March 31, 2017
to March 30, 2022
|
1
|
0
|
|||||||||||
Stock Acquisition Rights No.62
|
November 18, 2014
|
2,673,700
|
From November 18, 2016
to November 17, 2021
|
738
|
0
|
|||||||||||
Stock Acquisition Rights No.63
|
June 5, 2015
|
546,100
|
From April 20, 2016
to April 19, 2021
|
1
|
0
|
|||||||||||
Stock Acquisition Rights No.64
|
June 5, 2015
|
928,200
|
From April 20, 2017
to April 19, 2022
|
1
|
0
|
|||||||||||
Stock Acquisition Rights No.65
|
June 5, 2015
|
1,497,500
|
From April 20, 2018
to April 19, 2023
|
1
|
0
|
|||||||||||
Stock Acquisition Rights No.68
|
November 18, 2015
|
2,568,800
|
From November 18, 2017
to November 17, 2022
|
802
|
0
|
|||||||||||
Stock Acquisition Rights No.69
|
June 7, 2016
|
1,034,100
|
From April 20, 2017
to April 19, 2022
|
1
|
0
|
|||||||||||
Stock Acquisition Rights No.70
|
June 7, 2016
|
1,552,200
|
From April 20, 2018
to April 19, 2023
|
1
|
0
|
|||||||||||
Stock Acquisition Rights No.71
|
June 7, 2016
|
2,028,300
|
From April 20, 2019
to April 19, 2024
|
1
|
0
|
|
March 31, 2020
|
|||||||||||||||
Series of SARs
|
Allotment Date
|
Number of
Shares under
SARs
|
|
Exercise Period
of SARs
|
Exercise
Price per
Share under
SARs
|
|
Paid-in
Amount for
SARs
|
|
||||||||
Stock Acquisition Rights No.72
|
June 7, 2016
|
259,200
|
From October 30, 2016
to October 29, 2021
|
¥ |
1
|
¥ |
0
|
|||||||||
Stock Acquisition Rights No.73
|
June 7, 2016
|
105,400
|
From April 30, 2017
to April 29, 2022
|
1
|
0
|
|||||||||||
Stock Acquisition Rights No.74
|
November 11, 2016
|
2,535,400
|
From November 11, 2018
to November 10, 2023
|
593
|
0
|
|||||||||||
Stock Acquisition Rights No.75
|
June 9, 2017
|
1,188,600
|
From April 20, 2018
to April 19, 2023
|
1
|
0
|
|||||||||||
Stock Acquisition Rights No.76
|
June 9, 2017
|
1,456,900
|
From April 20, 2019
to April 19, 2024
|
1
|
0
|
|||||||||||
Stock Acquisition Rights No.77
|
June 9, 2017
|
4,258,000
|
From April 20, 2020
to April 19, 2025
|
1
|
0
|
|||||||||||
Stock Acquisition Rights No.78
|
June 9, 2017
|
811,800
|
From April 20, 2021
to April 19, 2026
|
1
|
0
|
|||||||||||
Stock Acquisition Rights No.79
|
June 9, 2017
|
809,900
|
From April 20, 2022
to April 19, 2027
|
1
|
0
|
|||||||||||
Stock Acquisition Rights No.80
|
June 9, 2017
|
136,200
|
From April 20, 2023
to April 19, 2028
|
1
|
0
|
|||||||||||
Stock Acquisition Rights No.81
|
June 9, 2017
|
136,200
|
From April 20, 2024
to April 19, 2029
|
1
|
0
|
|||||||||||
Stock Acquisition Rights No.82
|
June 9, 2017
|
276,700
|
From October 30, 2017
to October 29, 2022
|
1
|
0
|
|||||||||||
Stock Acquisition Rights No.83
|
June 9, 2017
|
63,900
|
From April 30, 2018
to April 29, 2023
|
1
|
0
|
|||||||||||
Stock Acquisition Rights No.84
|
November 17, 2017
|
2,488,900
|
From November 17, 2019
to November 16, 2024
|
684
|
0
|
|||||||||||
Stock Acquisition Rights No.85
|
November 20, 2018
|
2,507,900
|
From November 20, 2020
to November 19, 2025
|
573
|
0
|
(1) | SARs (including those granted to Directors and Executive Officers of Nomura which are stated in the table below) are issued in conjunction with deferred compensation plan. |
(2) | The number of shares issuable under SARs is subject to adjustments under certain circumstances including stock splits. |
|
March 31, 2020
|
|||||||
|
|
|
Numbers of Holders
|
|
||||
Series of SARs
|
Number of
Shares under
SARs
|
|
Directors and
Executive Officers
(excluding
Outside Directors)
|
|
||||
Stock Acquisition Rights No.47
|
1,700
|
1
|
||||||
Stock Acquisition Rights No.48
|
7,600
|
2
|
||||||
Stock Acquisition Rights No.54
|
4,900
|
1
|
||||||
Stock Acquisition Rights No.58
|
26,400
|
2
|
||||||
Stock Acquisition Rights No.60
|
9,500
|
2
|
||||||
Stock Acquisition Rights No.61
|
41,400
|
3
|
||||||
Stock Acquisition Rights No.63
|
6,900
|
1
|
||||||
Stock Acquisition Rights No.64
|
20,600
|
2
|
||||||
Stock Acquisition Rights No.65
|
57,400
|
3
|
||||||
Stock Acquisition Rights No.69
|
45,100
|
3
|
||||||
Stock Acquisition Rights No.70
|
93,800
|
5
|
||||||
Stock Acquisition Rights No.71
|
113,000
|
6
|
||||||
Stock Acquisition Rights No.75
|
88,900
|
5
|
||||||
Stock Acquisition Rights No.76
|
88,700
|
5
|
||||||
Stock Acquisition Rights No.77
|
109,900
|
7
|
|
March 31,
|
|||||||||||
|
2018
|
|
2019
|
|
2020
|
|
||||||
Japan
|
15,819
|
15,852
|
15,748
|
|||||||||
Europe
|
3,057
|
2,909
|
2,691
|
|||||||||
Americas
|
2,362
|
2,357
|
2,120
|
|||||||||
Asia and Oceania
|
6,810
|
6,746
|
6,070
|
|||||||||
Total
|
28,048
|
27,864
|
26,629
|
|||||||||
Name
|
Number of
Shareholdings
|
|
||
Koji Nagai
|
382,001
|
|||
Kentaro Okuda
|
103,125
|
|||
Toshio Morita
|
283,642
|
|||
Hisato Miyashita
|
84,200
|
|||
Hiroshi Kimura
|
359
|
|||
Kazuhiko Ishimura
|
—
|
|||
Noriaki Shimazaki
|
16,808
|
|||
Mari Sono
|
—
|
|||
Michael Lim Choo San
|
—
|
|||
Laura Simone Unger
|
(1,000ADR
|
)
(1)
|
||
Total
|
870,135
|
|||
(1) | ADRs are not included in the total. |
Name
|
Number of
Shareholdings
|
|
||
Kentaro Okuda
|
See above
|
|||
Toshio Morita
|
See above
|
|||
Junko Nakagawa
|
138,558
|
|||
Tomoyuki Teraguchi
|
135,910
|
|||
Takumi Kitamura
|
46,749
|
|||
Sotaro Kato
|
3,840
|
|||
Total
|
325,057
|
|||
(1) | Financial instruments business prescribed in the Financial Instruments and Exchange Law; |
(2) | Banking business prescribed in the Banking Law and trust business prescribed in the Trust Business Law; and |
(3) | Any other financial services and any business incidental or related to such financial services. |
(4) | Other than as prescribed in the items above, any other business ancillary or related to survey and research in connection with the economy, financial or capital markets, or infrastructure or undertaking the outsourcing thereof. |
• | a dealer in securities, |
• |
a trader in securities that elects to use a
mark-to-market
method of accounting for your securities holdings,
|
• |
a
tax-exempt
organization,
|
• | a life insurance company, |
• | a person liable for alternative minimum tax, |
• | a person that actually or constructively owns 10% or more of the combined voting power of our voting stock or of the total value of our stock, |
• | a person that holds shares or ADSs as part of a straddle or a hedging, conversion, integrated or constructive sale transaction, |
• | a person that purchases or sells shares or ADSs as part of a wash sale for tax purposes, or |
• | a person whose functional currency is not the U.S. dollar. |
• | a citizen or resident of the U.S., |
• | a corporation created or organized in or under the laws of the U.S. or any political subdivision thereof, |
• | an estate whose income is subject to U.S. federal income tax regardless of its source, or |
• | a trust if a U.S. court can exercise primary supervision over the trust’s administration and one or more U.S. persons are authorized to control all substantial decisions of the trust. |
• | at least 75% of our gross income for the taxable year is passive income, or |
• | at least 50% of the value, determined on the basis of a quarterly average, of our assets is attributable to assets that produce or are held for the production of passive income. |
• | any gain you realize on the sale or other disposition of your shares or ADSs, and |
• | any excess distribution that we make to you (generally, any distributions to you during a single taxable year that are greater than 125% of the average annual distributions received by you in respect of the shares or ADSs during the three preceding taxable years or, if shorter, your holding period for the shares or ADSs). |
• | the gain or excess distribution will be allocated ratably over your holding period for the shares or ADSs, |
• | the amount allocated to the taxable year in which you realized the gain or excess distribution, or to prior years before the first year in which we were a PFIC with respect to you, will be taxed as ordinary income, |
• | the amount allocated to each other previous year will be taxed at the highest tax rate in effect for that year, and |
• | the interest charge generally applicable to underpayments of tax will be imposed in respect of the tax attributable to each such year. |
• | the overall tax consequences of the acquisition, ownership and disposition of shares or ADSs, including specifically the tax consequences under Japanese law, |
• | the laws of the jurisdiction of which they are resident, and |
• | any tax treaty between Japan and their country of residence. |
• | Resource Allocation—At the beginning of each financial year, the EMB determines the allocation of management resources and financial resources such as risk-weighted asset and unsecured funding to business units and establishes usage limits for these resources; |
• | Business Plan—At the beginning of each financial year, the EMB approves the business plan and budget of Nomura. Introduction of significant new businesses, changes to business plans, the budget and the allocation of management resources during the year are also approved by the EMB; and |
• | Reporting—The EMB reports the status of its deliberations to the BoD. |
Risk Category
|
Definition
|
|
Market risk
|
Risk of loss arising from fluctuations in values of financial assets and liabilities (including
off-balance
sheet items) due to fluctuations in market risk factors (interest rates, foreign exchange rates, prices of securities and others).
|
|
Credit risk
|
Risk of loss arising from an obligor’s default, insolvency or administrative proceeding which results in the obligor’s failure to meet its contractual obligations in accordance with agreed terms. This includes both on and
off-balance
sheet exposures. It is also the risk of loss arising through a credit valuation adjustment (“CVA”) associated with deterioration in the creditworthiness of a counterparty.
|
|
Operational risk
|
Risk of financial loss or
non-financial
impact arising from inadequate or failed internal processes, people and systems, or from external events. Operational risk includes in its definition Compliance, Legal, IT and Cyber Security, Fraud, Third Party and other
non-financial
risks. Operational risk does not include strategic risk and reputational risk, however, some operational risks can lead to reputational issues and as such operational and reputational risks may be closely linked.
|
|
Model risk
|
Risk of financial loss, incorrect decision making, or damage to the firm’s credibility arising from model errors or incorrect or inappropriate model application.
|
|
Funding and Liquidity risk
|
Risk of loss arising from difficulty in securing the necessary funding or from a significantly higher cost of funding than normal levels due to deterioration of Nomura’s creditworthiness or deterioration in market conditions.
|
|
Business risk
|
Risk of failure of revenues to cover costs due to deterioration of the earnings environment or deterioration of the efficiency or effectiveness of business operations. Business risk is managed by the senior management at Nomura.
|
|
Billions of yen
|
|||||||||||
|
As of
|
|||||||||||
|
March 31,
2018
|
|
March 31,
2019
|
|
March 31,
2020
|
|
||||||
Equity
|
¥ |
1.21
|
¥ |
1.07
|
¥ |
8.88
|
||||||
Interest rate
|
3.10
|
2.85
|
22.35
|
|||||||||
Foreign exchange
|
3.20
|
1.88
|
5.08
|
|||||||||
Subtotal
|
7.52
|
5.79
|
36.31
|
|||||||||
Less: Diversification Benefit
|
(1.13
|
) |
(1.30
|
) |
(11.00
|
) | ||||||
VaR
|
¥ |
6.38
|
¥ |
4.49
|
¥ |
25.31
|
||||||
|
Billions of yen
|
|||||||||||
|
For the twelve months ended
|
|||||||||||
|
March 31,
2018
|
|
March 31,
2019
|
|
March 31,
2020
|
|
||||||
Maximum daily VaR
(1)
|
¥ |
8.98
|
¥ |
10.61
|
¥ |
32.89
|
||||||
Average daily VaR
(1)
|
4.25
|
4.58
|
6.67
|
|||||||||
Minimum daily VaR
(1)
|
3.05
|
3.05
|
3.62
|
(1) | Represents the maximum, average and minimum VaR based on all daily calculations for the twelve months ended March 31, 2018, March 31, 2019, and March 31, 2020. |
• | Evaluation of likelihood that a counterparty defaults on its payments and obligations; |
• | Assignment of internal ratings to all active counterparties; |
• | Approval of extensions of credit and establishment of credit limits; |
• | Measurement, monitoring and management of Nomura’s current and potential future credit exposures; |
• | Setting credit terms in legal documentation; and |
• | Use of appropriate credit risk mitigants including netting, collateral and hedging. |
• | Establishing the amount of counterparty credit risk that Nomura is willing to take to an individual counterparty or counterparty group (setting of credit limits); |
• | Determining the level of delegated authority for setting credit limits (including tenor); |
• | The frequency of credit reviews (renewal of credit limits); |
• | Reporting counterparty credit risk to senior management within Nomura; and |
• | Reporting counterparty credit risk to stakeholders outside of Nomura. |
|
Billions of yen
|
|||||||||||||||||||||||||||||||||||
|
Years to Maturity
|
Cross-
Maturity
Netting
(1)
|
|
Total
Fair Value
|
|
Collateral
obtained
|
|
Replacement
cost
(3)
|
|
|||||||||||||||||||||||||||
Credit Rating
|
Less than
1 year
|
|
1 to 3
years
|
|
3 to 5
years
|
|
5 to 7
years
|
|
More than
7 years
|
|
||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
(a)
|
|
(b)
|
|
(a)-(b)
|
|
||||||||||||||||||
AAA
|
¥ |
41
|
¥ |
33
|
¥ |
12
|
¥ |
4
|
¥ |
65
|
¥ |
(134)
|
¥ |
21
|
¥ |
20
|
¥ |
1
|
||||||||||||||||||
AA
|
704
|
318
|
144
|
108
|
686
|
(1,528
|
) |
432
|
48
|
384
|
||||||||||||||||||||||||||
A
|
785
|
511
|
416
|
185
|
1,280
|
(2,873
|
) |
304
|
126
|
178
|
||||||||||||||||||||||||||
BBB
|
282
|
224
|
185
|
134
|
761
|
(1,206
|
) |
380
|
79
|
301
|
||||||||||||||||||||||||||
BB and lower
|
136
|
147
|
52
|
34
|
108
|
(216
|
) |
261
|
243
|
18
|
||||||||||||||||||||||||||
Other
(2)
|
78
|
86
|
135
|
152
|
953
|
(1,419
|
) |
(15
|
) |
60
|
0
|
|||||||||||||||||||||||||
Sub-total
|
¥ |
2,026
|
¥ |
1,319
|
¥ |
944
|
¥ |
617
|
¥ |
3,853
|
¥ |
(7,376
|
) | ¥ |
1,383
|
¥ |
576
|
¥ |
882
|
|||||||||||||||||
Listed
|
1,027
|
88
|
6
|
—
|
—
|
(562
|
) |
559
|
194
|
365
|
||||||||||||||||||||||||||
Total
|
¥ |
3,053
|
¥ |
1,407
|
¥ |
950
|
¥ |
617
|
¥ |
3,853
|
¥ |
(7,938
|
) | ¥ |
1,942
|
¥ |
770
|
¥ |
1,247
|
|||||||||||||||||
(1) |
Represents netting of derivative liabilities against derivatives assets entered into with the same counterparty across different maturity bands. Derivative assets and derivative liabilities with the same counterparty in the same maturity band are net within the relevant maturity band. Cash collateral netting against net derivative assets in accordance with ASC
210-20
“
Balance Sheet—Offsetting
Derivatives and Hedging
|
(2) | “Other” comprises unrated counterparties and certain portfolio level valuation adjustments not allocated to specific counterparties. |
(3) | Zero balances represent instances where total collateral received is in excess of the total fair value; therefore, Nomura’s credit exposure is zero. |
|
Billions of Yen
|
|
||
Top 10 Country Exposures
(1)
|
(As of March 31, 2020)
|
|
||
United States
|
4,880
|
|||
Japan
|
2,713
|
|||
United Kingdom
|
710
|
|||
India
|
210
|
|||
Singapore
|
207
|
|||
France
|
144
|
|||
South Korea
|
130
|
|||
China
|
116
|
|||
Hong Kong S.A.R.
|
113
|
|||
Saudi Arabia
|
106
|
(1) | The table represents the Top 10 country exposures as of March 31, 2020 based on country of risk, combining counterparty and inventory exposures |
- |
Counterparty exposures include cash and cash equivalents held at banks; the outstanding default fund and initial margin balances posted by Nomura to central clearing counterparties as legally required under its direct and affiliate clearing memberships; the aggregate
marked-to-market
exposure by counterparty of derivative transactions and securities financing transactions (net of collateral where the collateral is held under a legally enforceable margin agreement); and the fair value of total commitment amount less any applicable reserves
|
- | Inventory exposures are the market value of debt and equity securities, and equity and credit derivatives, using the net of long versus short positions. |
1) | 1st Line of Defense: The business which owns and manages its risks |
2) |
2nd Line of Defense: The Operational Risk Management (“ORM”) function, which
co-ordinates
the Operational Risk Management Framework and its implementation
|
3) | 3rd Line of Defense: Internal Audit, who provide independent assurance |
• | Policy framework: Sets standards for managing operational risk and details how to monitor adherence to these standards. |
• | Training and awareness: Action taken by ORM to improve business understanding of operational risk. |
• | Event Reporting: This process is used to identify and report any event which resulted in or had the potential to result in a loss or gain or other impact associated with inadequate or failed internal processes, people and systems, or from external events. |
• | Risk and Control Self-Assessment (“RCSA”): This process is used to identify the inherent risks the business faces, the key controls associated with those risks and relevant actions to mitigate the residual risks. Global ORM are responsible for developing the RCSA process and supporting the business in its implementation. |
• | Key Risk Indicators (“KRI”): KRIs are metrics used to monitor the business’ exposure to operational risk and trigger appropriate responses as thresholds are breached. |
• | Scenario Analysis: The process used to assess and quantify potential high impact, low likelihood operational risk events. During the process actions may be identified to enhance the control environment which are then tracked via the Operational Risk Management Framework. |
• | Analysis and reporting: A key aspect of ORM’s role is to analyze, report, and challenge operational risk information provided by business units, and work with business units to develop action plans to mitigate risks. |
• | Operational risk capital calculation: Calculate operational risk capital as required under applicable Basel standards and local regulatory requirements. |
Business Line
|
Description
|
Beta Factor
|
|
|||
Retail Banking
|
Retail deposit and loan-related services
|
12%
|
||||
Commercial Banking
|
Deposit and loan-related services except for Retail Banking business
|
15%
|
||||
Payment and Settlement
|
Payment and settlement services for clients’ transactions
|
18%
|
||||
Retail Brokerage
|
Securities-related services mainly for individuals
|
12%
|
||||
Trading and Sales
|
Market-related business
|
18%
|
||||
Corporate Finance
|
M&A, underwriting, secondary and private offerings, and other funding services for clients
|
18%
|
||||
Agency Services
|
Agency services for clients such as custody
|
15%
|
||||
Asset Management
|
Fund management services for clients
|
12%
|
1) | Transaction committees are in place to provide formal governance over the review and decision-making process for individual transactions. |
2) | The new product approval process allows business unit sponsors to submit applications for new products and obtain approval from relevant departments prior to execution of the new products. The process is designed to capture and assess risks across various risk classes as a result of the new product or business. |
• | Sensitivity analysis is used to quantify the impact of a market move in one or two associated risk factors (for example, equity prices, equity volatilities) in order primarily to capture those risks which may not be readily identified by other risk models; |
• | Scenario analysis is used to quantify the impact of a specified event across multiple asset classes and risk classes. This is a primary approach used in performing stress testing at the different hierarchical levels of the Nomura Group; |
• | Nomura Group establishes several stress scenarios to validate risk appetite for capital and liquidity soundness, taking into account the business environment, business’s risk profile, economic environment and forecasts. |
• | Group-wide stress to assess the capital adequacy of the Nomura Group under severe but plausible market scenarios is conducted on a quarterly basis at a minimum; and |
• | Reverse stress testing, a process of considering the vulnerabilities of the firm and hence how it may react to situations where it becomes difficult to continue its business and reviewing the results of that analysis, is conducted on an annual basis at a minimum. |
Type of Services:
|
Amount of Fee (U.S. Dollars)
|
|
Taxes and other governmental charges
|
As applicable. The depositary may offset any taxes or governmental charges it is obligated to withhold, if applicable, against the proceeds from sale of the property received.
|
|
Transfers of the Company’s shares to or from the name of the depositary (or its nominee) or the Custodian (or its nominee) in connection with deposits or withdrawals
|
Such registration fees as may be in effect for the registration of transfers of the Company’s shares on the Company’s share register (or any entity that presently carries out the duties of registrar).
|
|
Cable, telex and facsimile transmission expenses
|
As applicable.
|
|
Expenses incurred by the depositary in the conversion of foreign currency
|
As applicable.
|
|
Execution and delivery of Receipts in connection with deposits, stock splits or exercise of subscription rights
|
$5.00 or less per 100 ADSs (or portion thereof).
|
|
Surrender of Receipts in connection with a withdrawal or termination of the Deposit Agreement
|
$5.00 or less per 100 ADSs (or portion thereof).
|
|
Any cash distribution pursuant to the Deposit Agreement, including, but not limited to, cash distribution(s) made in connection with cash dividends; distributions in securities, property or subscription rights; and stock splits.
|
$.02 or less per ADS (or portion thereof). Only the cash amounts net of this fee, if applicable, are distributed.
|
|
Distribution by the depositary of securities (other than common shares of the Company) that accrued on the underlying shares to owners of the Receipts
|
Treating for the purpose of this fee all such securities as if they were common shares of the Company, $5.00 or less per 100 ADSs (or portion thereof).
|
|
General depositary services
|
$.02 or less per ADS (or portion thereof), accruing on the last day of each calendar year, except where the fee for cash distribution described above was assessed during that calendar year.
|
|
Any other charge payable by the depositary, any of the depositary’s agents, including the Custodian, or the agents of the depositary’s agents in connection with the servicing of the Company’s shares or other deposited securities
|
As applicable.
|
|
Millions of yen
|
|||||||
|
Year ended March 31
|
|||||||
|
2019
|
|
2020
|
|
||||
Audit Fees
|
¥ |
3,414
|
¥ |
3,409
|
||||
Audit-Related Fees
|
179
|
136
|
||||||
Tax Fees
|
293
|
113
|
||||||
All Other Fees
|
39
|
7
|
||||||
Total
|
¥ |
3,925
|
¥ |
3,665
|
||||
Month
|
Total
Number of
Shares
Purchased
|
|
Average Price
Paid per
Share
(in yen)
|
|
Total
Number of
Shares
Purchased
as Part of
Publicly
Announced
Program
|
|
Maximum
Number of
Shares that
May Yet Be
Purchased
Under the
Program
|
|
||||||||
April 1 to 30, 2019
|
937
|
¥ |
416
|
—
|
—
|
|||||||||||
May 1 to 31, 2019
|
1,049
|
387
|
—
|
—
|
||||||||||||
June 1 to 30, 2019
|
1,203
|
354
|
—
|
300,000,000
|
||||||||||||
July 1 to 31, 2019
|
1,724
|
378
|
—
|
300,000,000
|
||||||||||||
August 1 to 31, 2019
|
45,819,214
|
404
|
45,817,600
|
254,182,400
|
||||||||||||
September 1 to 30, 2019
|
50,074,124
|
456
|
50,072,700
|
204,109,700
|
||||||||||||
October 1 to 31, 2019
|
63,977,892
|
481
|
63,976,200
|
140,133,500
|
||||||||||||
November 1 to 30, 2019
|
34,922,851
|
544
|
34,921,100
|
105,212,400
|
||||||||||||
December 1 to 31, 2019
|
47,518,385
|
561
|
47,515,800
|
57,696,600
|
||||||||||||
January 1 to 31, 2020
|
45,000,953
|
567
|
44,998,000
|
12,698,600
|
||||||||||||
February 1 to 29, 2020
|
12,062,257
|
562
|
12,060,900
|
637,700
|
||||||||||||
March 1 to 31, 2020
|
1,192
|
442
|
—
|
—
|
||||||||||||
Total
|
299,381,781
|
¥ |
501
|
299,362,300
|
—
|
|||||||||||
Corporate Governance Practices Followed
by NYSE-listed U.S. Companies
|
Corporate Governance Practices Followed by the Company
|
|
A NYSE-listed U.S. company must have a majority of Directors meeting the independence requirements under Section 303A of the NYSE Listed Company Manual.
|
Under the Companies Act, a company which adopts the Company with Three Board Committees structure is not required to have a majority of outside directors, but is required to have a majority of outside directors on each of the audit, nomination and compensation committees.
The Company currently has six outside directors among its ten Directors.
|
|
A NYSE-listed U.S. company must have an audit committee that satisfies the requirements under Section 303A of the NYSE Listed Company Manual, including those imposed by Rule
10A-3
under the U.S. Securities Exchange Act of 1934. The audit committee must be composed entirely of independent directors and have at least three members.
|
The Company has an Audit Committee consisting of three Directors, two of whom are outside directors in compliance with the requirements under the Companies Act. All three Audit Committee members are independent directors under Rule
10A-3
under the U.S. Securities Exchange Act of 1934 with one member qualified as audit committee financial expert.
|
|
A NYSE-listed U.S. company must have a nominating/corporate governance committee with responsibilities described under Section 303A of the NYSE Listed Company Manual. The nominating/corporate governance committee must be composed entirely of independent directors.
|
The Company has a Nomination Committee consisting of three Directors, two of whom are outside directors and the chairman is an outside director in compliance with the requirements under the Companies Act.
|
|
A NYSE-listed U.S. company must have a compensation committee composed entirely of independent directors. Compensation committee members must satisfy the additional independence
|
The Company has a Compensation Committee consisting of three Directors, two of whom are outside directors and the chairman is an outside
|
Corporate Governance Practices Followed
by NYSE-listed U.S. Companies
|
Corporate Governance Practices Followed by the Company
|
|
requirements under Section 303A.02(a)(ii) of the NYSE Listed Company Manual. A compensation committee must also have authority to retain or obtain the advice of compensation and other advisers, subject to prescribed independence criteria that the committee must consider prior to engaging any such adviser.
|
director in compliance with the requirements under the Companies Act.
|
|
A NYSE-listed U.S. company must generally obtain shareholder approval with respect to any equity compensation plan.
|
Under the Companies Act, Restricted Stock Unit (“RSU”) and Stock Acquisition Right (“SAR”) awards are deemed to be compensation for the services performed by the Company’s Directors and Executive Officers and do not require shareholders’ approval. The Compensation Committee establishes the policy with respect to the determination of the individual compensation of each of the Company’s Directors and Executive Officers (including RSU and SAR awards as equity compensation) and makes determinations in accordance with that compensation policy.
|
|
A NYSE-listed U.S. company must adopt and disclose corporate governance guidelines.
|
Under the Companies Act, the Company is not required to adopt and disclose corporate governance guidelines. However, in response to Japan’s Corporate Governance Code, which was incorporated into the Tokyo Stock Exchange’s Securities Listing Regulations, the Company has established and publicly disclosed the “Nomura Holdings Corporate Governance Guidelines.”
|
|
The
non-management
directors of a NYSE-listed U.S. company must meet at regularly scheduled executive sessions without management.
|
Under the Companies Act, outside directors of the Company are not required to meet at regularly scheduled executive sessions without management. However, in accordance with the “Nomura Holdings Corporate Governance Guidelines,” outside directors hold meetings consisting solely of outside directors in order to discuss matters such as the business and corporate governance of the Company.
|
|
A NYSE-listed U.S. company must adopt and disclose a code of business conduct and ethics for directors, officers and employees, and promptly disclose any waivers of the code for directors or executive officers.
|
Under the Companies Act, the Company is not required to adopt and disclose a code of business conduct and ethics for directors, officers or employees. However, the Company has adopted the “Nomura Group Code of Conduct” Please see Item 16B of this annual report for further information regarding the “Nomura Group Code of Conduct.”
|
Exhibit
Number |
Description
|
|
1.1
|
Articles of Incorporation of Nomura Holdings, Inc. (English translation) (filed on June 25, 2015 as an exhibit to the Annual Report on Form
20-F
(File No.
001-15270)
and incorporated herein by reference)
|
|
1.2
|
Share Handling Regulations of Nomura Holdings, Inc. (English translation) (filed on June 25, 2015 as an exhibit to the Annual Report on Form
20-F
(File No.
001-15270)
and incorporated herein by reference)
|
|
1.3
|
Regulations of the Board of Directors of Nomura Holdings, Inc. (English translation)
|
|
1.4
|
Regulations of the Nomination Committee of Nomura Holdings, Inc. (English translation) (filed on June 23, 2016 as an exhibit to the Annual Report on Form
20-F
(File No.
001-15270)
and incorporated herein by reference)
|
|
1.5
|
Regulations of the Audit Committee of Nomura Holdings, Inc. (English translation)
|
|
1.6
|
Regulations of the Compensation Committee of Nomura Holdings, Inc. (English translation) (filed on June 27, 2012 as an exhibit to the Annual Report on Form
20-F
(File No.
001-15270)
and incorporated herein by reference)
|
|
2.1
|
Form of Deposit Agreement among Nomura Holdings, Inc., The Bank of New York Mellon as depositary and all owners and holders from time to time of American Depositary Receipts, including the form of American Depositary Receipt (filed on April 28, 2010 as an exhibit to the Registration Statement on Form
F-6
(File No.
333-166346)
and incorporated herein by reference)
|
|
2.2
|
Description of rights of each class of securities registered under Section 12 of the Securities Exchange Act of 1934 (filed on June 25, 2019 as an exhibit to the Annual Report on Form
20-F
(File No.
001-15270)
and incorporated herein by reference)
|
|
4.1
|
Limitation of Liability Agreement (filed on June 30, 2011 as an exhibit to the Annual Report on Form
20-F
(File No.
001-15270)
and incorporated herein by reference)
(1)
|
|
4.2
|
Limitation of Liability Agreement (English translation) (filed on June 25, 2015 as an exhibit to the Annual Report on Form
20-F
(File No.
001-15270)
and incorporated herein by reference)
(2)
|
|
4.3
|
Limitation of Liability Agreement (filed on June 25, 2015 as an exhibit to the Annual Report on Form
20-F
(File No.
001-15270)
and incorporated herein by reference)
(3)
|
|
8.1
|
Subsidiaries of Nomura Holdings, Inc.—See Item 4.C. “
Organizational Structure
|
|
11.1
|
Nomura Group Code of Conduct 2020 (English translation)
|
|
11.2
|
Nomura Group Code of Ethics for Financial Professionals (English translation)
|
|
12.1
|
Certification of the principal executive officer required by 17 C.F.R. 240.
13a-14(a)
|
|
12.2
|
Certification of the principal financial officer required by 17 C.F.R. 240.
13a-14(a)
|
|
13.1
|
Certification of the chief executive officer required by 18 U.S.C. Section 1350
|
|
13.2
|
Certification of the chief financial officer required by 18 U.S.C. Section 1350
|
|
15.1
|
Consent of Ernst & Young ShinNihon LLC with respect to its report on the audit of the financial statements included in this annual report
|
|
101.INS
|
Inline XBRL Instance Document—the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document
|
|
101.SCH
|
Inline XBRL Taxonomy Extension Schema Document
|
|
101.CAL
|
Inline XBRL Taxonomy Extension Calculation Linkbase Document
|
|
101.DEF
|
Inline XBRL Taxonomy Extension Definition Linkbase Document
|
|
101.LAB
|
Inline XBRL Taxonomy Extension Label Linkbase Document
|
|
101.PRE
|
Inline XBRL Taxonomy Extension Presentation Linkbase Document
|
|
104
|
The cover page for the Company’s Annual Report on Form
20-F
for the year ended March 31, 2020, has been formatted in Inline XBRL
|
(1) | The Company and Michael Lim Choo San entered into a Limitation of Liability Agreement substantially in the form of this exhibit. |
(2) | The Company and each of Hiroshi Kimura, Noriaki Shimazaki, Hisato Miyashita, Mari Sono and Kazuhiko Ishimura entered into a Limitation of Liability Agreement substantially in the form of this exhibit. |
(3) | The Company and Laura Simone Unger entered into a Limitation of Liability Agreement substantially in the form of this exhibit. |
|
Page
|
|
||
Consolidated Financial Statements of Nomura Holdings, Inc.:
|
|
|
|
|
F-
2
|
||||
F-
7
|
||||
F-
10
|
||||
F-
11
|
||||
F-
12
|
||||
F-
14
|
||||
F-
16
|
|
Valuation—Less Liquid Financial Instruments
|
|
Description of the Matter
|
The Company holds investment positions in the fixed income and equity markets both for trading and customer facilitation. The Company had JPY 949 billion and JPY 668 billion of financial instruments assets and liabilities, respectively, categorized within Level 3 of the fair value hierarchy. In determining the fair value of these financial instruments, the Company used unobservable valuation inputs which reflect their assumptions and specific data. These inputs are significant to the fair value of the financial instruments and are supported by little or no market activity as of March 31, 2020. The methodologies applied by management to determine the fair value of such instruments are described in Note 2 to the consolidated financial statements.
Auditing the fair value of the Company’s Level 3 financial instruments was complex and highly judgmental due to the subjectivity of the judgments used and estimations made by management in determining the fair value for these financial instruments especially considering the impact of
COVID-19
on global financial markets. In particular, to value certain financial instruments, management used a variety of valuation techniques which involved certain underlying assumptions and significant unobservable valuation inputs, including weighted average cost of capital (WACC), growth rates, liquidity discounts, market multiples including enterprise value over earnings before interest, taxes, depreciation, and amortization (EV/ EBITDA) ratios, volatilities and correlations which are significant to the value of these investments.
|
|
How We Addressed the Matter in Our Audit
|
We obtained an understanding, evaluated the design and tested the operating effectiveness of controls that address the risk of material misstatement relating to management’s assessment of the significant inputs and estimates included in fair value measurement. This included the testing of model validation controls by various departments within the Company. It also included the testing of model performance and suitability controls as a result of significant market volatility due to the impact of
COVID-19.
Our audit procedures to evaluate the valuation methodologies used by the Company included, among others, testing significant unobservable inputs, estimates and the mathematical accuracy of the Company’s valuation models. We independently developed fair value estimates and compared them to the Company’s results, and involved our valuation specialists to assist with the application of these procedures, on a sample basis. We also agreed significant inputs and underlying data used in the Company’s valuations to agreements, information available from third party sources and market data, where available. We evaluated subsequent events and transactions and considered whether they corroborate or contradict the Company’s
year-end
valuations.
|
|
|
Income Taxes—Valuation Allowance
|
|
Description of the Matter
|
As disclosed in Note 16 to the consolidated financial statements at March 31, 2020, the Company had deferred tax assets of JPY 151 billion, net of a JPY 388 billion valuation allowance. The gross deferred tax assets are reduced by a valuation allowance if, based upon the weight of all available evidence, it is more likely than not that some portion, or all, of the deferred tax assets will not be realized.
Auditing management’s analysis of the assessment for realizing the deferred tax asset was complex and highly judgmental because the assessment process involves significant judgment. For example, assumptions used may be affected by future market events, economic conditions and decisions made by the management, including the impact associated with rebuilding the business platform and
COVID-19.
These assumptions feed into the revenue and cost projections used to assess whether the deferred tax assets will be realized.
|
How We Addressed the Matter in Our Audit
|
We obtained an understanding, evaluated the design and tested the operating effectiveness of controls that address the risks of material misstatement relating to management’s assessment for realizing the deferred tax assets. This included controls over management’s projections of future taxable income, that included the impact of rebuilding the business platform and
COVID-19,
and the future reversal of existing taxable temporary differences, and management’s identification and use of available tax planning strategies.
Our audit procedures to evaluate the realizability of deferred tax assets included, among others, inspecting the supporting documents and meeting minutes of the Board of Directors and Executive Management Board, and assessing whether management’s estimate of future taxable income and schedule of future deductible temporary differences to be reversed are consistent with the business plan. We evaluated the reasonableness of assumptions used by the Company to develop the projections of future taxable income and tested the completeness and accuracy of the underlying data used in its projections. For example, we compared the projections of future taxable income with the actual results of prior periods, as well as management’s consideration of current industry and economic trends with the corresponding actual results and evaluated the sensitivity of the outcomes by making reasonably possible changes in the assumptions of the projections.
|
|
|
Provisions for conduct and litigation
|
|
Description of the Matter
|
As disclosed in Note 21 to the consolidated financial statements, the Company is involved in investigations, lawsuits and other legal proceedings. The Company recognizes a liability for those contingencies for which it is probable that a liability has been incurred at the date of the consolidated financial statements and the amount is reasonably estimable. As part of this, management performs an assessment of the materiality of contingencies where a loss is either reasonably possible or it is reasonably possible that an exposure to loss exists in excess of the amount accrued. If it is reasonably possible that such a loss or an additional loss may have been incurred and the effect on the consolidated financial statements is material, the Company discloses the nature of the loss contingency and an estimate of the possible loss or range of loss or a statement that such an estimate cannot be made within the notes to the consolidated financial statements.
Auditing management’s determination of whether a loss contingency is probable and reasonably estimable, reasonably possible or remote, and the related disclosures, is highly subjective, complex and requires significant judgment. Management judgment is needed to determine whether an obligation exists, and a loss contingency should be recorded at March 31, 2020. This includes judgment in the determination of whether an outflow in respect of identified loss contingency is probable and can be estimated reliably. In addition, management judgment is needed to determine if an estimated loss is only reasonably possible rather than probable.
|
|
How We Addressed the Matter in Our Audit
|
We obtained an understanding, evaluated the design and tested the operating effectiveness of controls that address the risks of material misstatement relating to management’s assessment for timely identification of contingencies that may arise out of lawsuits and regulatory investigations including the Company’s assessment of whether they are probable or reasonably possible and the associated measurement of the best estimate.
|
|
|
Our audit procedures to test the assessment of the probability of incurrence of a loss and whether the loss was reasonably estimable included, among others, reading the minutes of the meetings of the Board of Directors and Executive Management Board, and reading relevant regulatory and legal correspondence to assess developments in significant matters, requesting and receiving external legal counsel confirmation letters, meeting with internal and external legal counsel to discuss the allegations, and obtaining a representation letter from the Company’s management. In addition, our audit procedures to test the measurement of the loss contingency and the disclosure of the reasonably possible additional loss in excess of amounts
|
|
recognized as a liability included, among others, evaluating the method of measuring the contingency, testing the accuracy and completeness of the data, reading correspondence received from internal and external counsel used to determine a range of reasonably possible loss and performing a search for new or contrary evidence affecting the estimate.
|
|
Millions of yen
|
|||||||
|
March 31
|
|||||||
|
2019
|
|
2020
|
|
||||
ASSETS
|
|
|
|
|
|
|
||
Cash and cash deposits:
|
|
|
||||||
Cash and cash equivalents
|
¥ |
|
¥ |
|
||||
Time deposits
|
|
|
||||||
Deposits with stock exchanges and other segregated cash
|
|
|
||||||
Total cash and cash deposits
|
|
|
||||||
Loans and receivables:
|
|
|
||||||
Loans receivable (including ¥
|
|
|
||||||
Receivables from customers (including ¥
|
|
|
||||||
Receivables from other than customers
|
|
|
||||||
Allowance for doubtful accounts
|
(
|
) |
(
|
) | ||||
Total loans and receivables
|
|
|
||||||
Collateralized agreements:
|
|
|
||||||
Securities purchased under agreements to resell (including ¥
|
|
|
||||||
Securities borrowed
|
|
|
||||||
Total collateralized agreements
|
|
|
||||||
Trading assets and private equity and debt investments:
|
|
|
||||||
Trading assets (including securities pledged as collateral of ¥
|
|
|
||||||
Private equity and debt investments (including ¥
|
|
|
||||||
Total trading assets and private equity and debt investments
|
|
|
||||||
Other assets:
|
|
|
||||||
Office buildings, land, equipment and facilities (net of accumulated depreciation and amortization of ¥
|
|
|
||||||
Non-trading
debt securities
|
|
|
||||||
Investments in equity securities
|
|
|
||||||
Investments in and advances to affiliated companies
|
|
|
||||||
Other (including ¥
|
|
|
||||||
Total other assets
|
|
|
||||||
Total assets
|
¥ |
|
¥ |
|
||||
|
Millions of yen
|
|||||||
|
March 31
|
|||||||
|
2019
|
|
2020
|
|
||||
LIABILITIES AND EQUITY
|
|
|
|
|
|
|
||
Short-term borrowings (including ¥
|
¥ |
|
¥ |
|
||||
Payables and deposits:
|
|
|
||||||
Payables to customers
|
|
|
||||||
Payables to other than customers
|
|
|
||||||
Deposits received at banks (including ¥
|
|
|
||||||
Total payables and deposits
|
|
|
||||||
Collateralized financing:
|
|
|
||||||
Securities sold under agreements to repurchase (including ¥
|
|
|
||||||
Securities loaned (including ¥
|
|
|
||||||
Other secured borrowings
|
|
|
||||||
Total collateralized financing
|
|
|
||||||
Trading liabilities
|
|
|
||||||
Other liabilities (including ¥
|
|
|
||||||
Long-term borrowings (including ¥
|
|
|
||||||
Total liabilities
|
|
|
||||||
Commitments and contingencies (Note 21)
|
|
|
||||||
Equity:
|
|
|
||||||
Nomura Holdings, Inc. (“NHI”) shareholders’ equity:
|
|
|
||||||
Common stock
|
|
|
||||||
No par value shares;
Authorized— Issued— Outstanding
—
March 31, 2020 |
|
|
||||||
Additional
paid-in
capital
|
|
|
||||||
Retained earnings
|
|
|
||||||
Accumulated other comprehensive income
|
(
|
) |
(
|
) | ||||
Total NHI
shareholders’
equity before treasury stock
|
|
|
||||||
Common stock held in treasury, at cost
—
|
(
|
) |
(
|
) | ||||
Total NHI shareholders’ equity
|
|
|
||||||
Noncontrolling interests
|
|
|
||||||
Total equity
|
|
|
||||||
Total liabilities and equity
|
¥ |
|
¥ |
|
||||
|
Billions of yen
|
|||||||
|
March 31
|
|||||||
|
2019
|
|
2020
|
|
||||
Cash and cash deposits
|
¥ |
|
¥ |
|
||||
Trading assets and private equity and debt investments
|
|
|
||||||
Other assets
|
|
|
||||||
Total assets
|
¥ |
|
¥ |
|
||||
Trading liabilities
|
¥ |
|
¥ |
|
||||
Other liabilities
|
|
|
||||||
Borrowings
|
|
|
||||||
Total liabilities
|
¥ |
|
¥ |
|
||||
|
Millions of yen
|
|||||||||||
Year ended March 31
|
||||||||||||
2018
|
|
2019
|
|
2020
|
|
|||||||
Revenue:
|
|
|
|
|||||||||
Commissions
|
¥ |
|
¥ |
|
¥ |
|
||||||
Fees from investment banking
|
|
|
|
|||||||||
Asset management and portfolio service fees
|
|
|
|
|||||||||
Net gain on trading
|
|
|
|
|||||||||
Gain (loss) on private equity and debt investments
|
(
|
) |
|
(
|
) | |||||||
Interest and dividends
|
|
|
|
|||||||||
Gain (loss) on investments in equity securities
|
|
(
|
) |
(
|
) | |||||||
Other
|
|
|
|
|||||||||
Total revenue
|
|
|
|
|||||||||
Interest expense
|
|
|
|
|||||||||
Net revenue
|
|
|
|
|||||||||
Non-interest
expenses:
|
|
|
|
|||||||||
Compensation and benefits
|
|
|
|
|||||||||
Commissions and floor brokerage
|
|
|
|
|||||||||
Information processing and communications
|
|
|
|
|||||||||
Occupancy and related depreciation
|
|
|
|
|||||||||
Business development expenses
|
|
|
|
|||||||||
Other
|
|
|
|
|||||||||
Total
non-interest
expenses
|
|
|
|
|||||||||
Income (loss) before income taxes
|
|
(
|
) |
|
||||||||
Income tax expense
|
|
|
|
|||||||||
Net income (loss)
|
¥ |
|
¥ |
(
|
) | ¥ |
|
|||||
Less: Net income attributable to noncontrolling interests
|
|
|
|
|||||||||
Net income (loss) attributable to NHI shareholders
|
¥ |
|
¥ |
(
|
) | ¥ |
|
|||||
|
Yen
|
|||||||||||
Per share of common stock:
|
|
|
|
|||||||||
Basic—
|
|
|
|
|||||||||
Net income (loss) attributable to NHI shareholders per share
|
¥ |
|
¥ |
(
|
) | ¥ |
|
|||||
Diluted—
|
|
|
|
|||||||||
Net income (loss) attributable to NHI shareholders per share
|
¥ |
|
¥ |
(
|
) | ¥ |
|
|||||
|
Millions of yen
|
|||||||||||
|
Year ended March 31
|
|||||||||||
|
2018
|
|
2019
|
|
2020
|
|
||||||
Net income (loss)
|
¥ |
|
¥ |
(
|
) | ¥ |
|
|||||
Other comprehensive income (loss):
|
|
|
|
|||||||||
Change in cumulative translation adjustments:
|
|
|
|
|||||||||
Change in cumulative translation adjustments
|
(
|
) |
|
(
|
) | |||||||
Deferred income taxes
|
|
(
|
) |
|
||||||||
Total
|
(
|
) |
|
(
|
) | |||||||
Defined benefit pension plans:
|
|
|
|
|||||||||
Pension liability adjustment
|
(
|
) |
(
|
) |
|
|||||||
Deferred income taxes
|
|
|
|
|||||||||
Total
|
(
|
) |
(
|
) |
|
|||||||
Non-trading
securities:
|
|
|
|
|||||||||
Net unrealized gain (loss) on
non-trading
securities
|
(
|
) |
|
|
||||||||
Deferred income taxes
|
|
|
|
|||||||||
Total
|
(
|
) |
|
|
||||||||
Own credit adjustments:
|
|
|
|
|||||||||
Own credit adjustments
|
(
|
) |
|
|
||||||||
Deferred income taxes
|
|
(
|
) |
(
|
) | |||||||
Total
|
(
|
) |
|
|
||||||||
Total other comprehensive income (loss)
|
(
|
) |
|
|
||||||||
Comprehensive income (loss)
|
|
(
|
) |
|
||||||||
Less: Comprehensive income (loss) attributable to noncontrolling interests
|
(
|
) |
|
|
||||||||
Comprehensive income (loss) attributable to NHI shareholders
|
¥ |
|
¥ |
(
|
) | ¥ |
|
|||||
|
Millions of yen
|
|||||||||||
|
Year ended March 31
|
|||||||||||
|
2018
|
|
2019
|
|
2020
|
|
||||||
Common stock
|
|
|
|
|||||||||
Balance at beginning of year
|
¥ |
|
¥ |
|
¥ |
|
||||||
Balance at end of year
|
|
|
|
|||||||||
Additional
paid-in
capital
|
|
|
|
|||||||||
Balance at beginning of year
|
|
|
|
|||||||||
Stock-based compensation awards
|
(
|
) |
|
(
|
) | |||||||
Changes in ownership interests in subsidiaries
|
(
|
) |
|
(
|
) | |||||||
Balance at end of year
|
|
|
|
|||||||||
Retained earnings
|
|
|
|
|||||||||
Balance at beginning of year
|
|
|
|
|||||||||
Cumulative effect of change in accounting principle
(1)
|
|
|
|
|||||||||
Net income (loss) attributable to NHI shareholders
|
|
(
|
) |
|
||||||||
Cash dividends
|
(
|
) |
(
|
) |
(
|
) | ||||||
Gain (loss) on sales of treasury stock
|
(
|
) |
(
|
) |
(
|
) | ||||||
Cancellation of treasury stock
|
(
|
) |
(
|
) |
|
|||||||
Balance at end of year
|
|
|
|
|||||||||
Accumulated other comprehensive income (loss)
|
|
|
|
|||||||||
Cumulative translation adjustments
|
|
|
|
|||||||||
Balance at beginning of year
|
|
(
|
) |
|
||||||||
Net change during the year
|
(
|
) |
|
(
|
) | |||||||
Balance at end of year
|
(
|
) |
|
(
|
) | |||||||
Defined benefit pension plans
|
|
|
|
|||||||||
Balance at beginning of year
|
(
|
) |
(
|
) |
(
|
) | ||||||
Pension liability adjustment
|
(
|
) |
(
|
) |
|
|||||||
Balance at end of year
|
(
|
) |
(
|
) |
(
|
) | ||||||
Own credit adjustments
|
|
|
|
|||||||||
Balance at beginning of year
|
|
|
|
|||||||||
Own credit adjustments
|
(
|
) |
|
|
||||||||
Balance at end of year
|
|
|
|
|||||||||
Balance at end of year
|
(
|
) |
(
|
) |
(
|
) | ||||||
(1)
|
Represents the adjustment to initially apply Accounting Standards Update (“ASU”) 2014-09, “
Revenue from Contracts with Customers
Leases
|
|
Millions of yen
|
|||||||||||
|
Year ended March 31
|
|||||||||||
|
2018
|
|
2019
|
|
2020
|
|
||||||
Common stock held in treasury
|
|
|
|
|||||||||
Balance at beginning of year
|
(
|
) |
(
|
) |
(
|
) | ||||||
Repurchases of common stock
|
(
|
) |
(
|
) |
(
|
) | ||||||
Sales of common stock
|
|
|
|
|||||||||
Common stock issued to employees
|
|
|
|
|||||||||
Cancellation of treasury stock
|
|
|
|
|||||||||
Other net change in treasury stock
|
|
|
|
|||||||||
Balance at end of year
|
(
|
) |
(
|
) |
(
|
) | ||||||
Total NHI shareholders’ equity
|
|
|
|
|||||||||
Balance at end of year
|
|
|
|
|||||||||
Noncontrolling interests
|
|
|
|
|||||||||
Balance at beginning of year
|
|
|
|
|||||||||
Cash dividends
|
(
|
) |
(
|
) |
(
|
) | ||||||
Net income attributable to noncontrolling interests
|
|
|
|
|||||||||
Accumulated other comprehensive income (loss) attributable to noncontrolling interests
|
|
|
|
|||||||||
Cumulative translation adjustments
|
|
|
(
|
) | ||||||||
Net unrealized gain (loss) on
non-trading
securities
|
(
|
) |
|
|
||||||||
Purchase/sale (disposition) of subsidiary shares, etc., net
|
(
|
) |
|
|
||||||||
Other net change in noncontrolling interests
|
|
(
|
) |
|
||||||||
Balance at end of year
|
|
|
|
|||||||||
Total equity
|
|
|
|
|||||||||
Balance at end of year
|
¥ |
|
¥ |
|
¥ |
|
||||||
|
Millions of yen
|
|||||||||||
Year ended March 31
|
||||||||||||
|
2018
|
|
2019
|
|
2020
|
|
||||||
Cash flows from operating activities:
|
|
|
|
|||||||||
Net income (loss)
|
¥ |
|
¥ |
(
|
) | ¥ |
|
|||||
Adjustments to reconcile net income (loss) to net cash used in operating activities:
|
|
|
|
|||||||||
Depreciation and amortization
|
|
|
|
|||||||||
Impairment of goodwill
|
|
|
|
|||||||||
Stock-based compensation
|
|
|
|
|||||||||
(Gain) loss on investments in equity securities
|
(
|
) |
|
|
||||||||
(Gain) loss on investments in subsidiaries and affiliates
|
(
|
) |
|
(
|
) | |||||||
Equity in earnings of affiliates, net of dividends received
|
(
|
) |
(
|
) |
(
|
) | ||||||
Loss on disposal of office buildings, land, equipment and facilities
|
|
|
(
|
) | ||||||||
Deferred income taxes
|
|
|
(
|
) | ||||||||
Changes in operating assets and liabilities:
|
|
|
|
|||||||||
Time deposits
|
(
|
) |
|
(
|
) | |||||||
Deposits with stock exchanges and other segregated cash
(2)
|
(
|
) |
|
(
|
) | |||||||
Trading assets and private equity and debt investments
(1)
|
(
|
) |
|
(
|
) | |||||||
Trading liabilities
(1)
|
|
(
|
) |
|
||||||||
Securities purchased under agreements to resell, net of securities sold under agreements to repurchase
|
(
|
) |
(
|
) |
|
|||||||
Securities borrowed, net of securities loaned
|
|
|
|
|||||||||
Other secured borrowings
|
|
|
|
|||||||||
Loans and receivables, net of allowance for doubtful accounts
(1)
|
(
|
) |
|
(
|
) | |||||||
Payables
(1)
|
|
(
|
) |
|
||||||||
Bonus accrual
|
(
|
) |
(
|
) |
|
|||||||
Accrued income taxes, net
|
(
|
) |
|
(
|
) | |||||||
Other, net
|
(
|
) |
(
|
) |
(
|
) | ||||||
Net cash used in operating activities
(2)
|
(
|
) |
(
|
) |
(
|
) | ||||||
Cash flows from investing activities:
|
|
|
|
|||||||||
Payments for purchases of office buildings, land, equipment and facilities
|
(
|
) |
(
|
) |
(
|
) | ||||||
Proceeds from sales of office buildings, land, equipment and facilities
|
|
|
|
|||||||||
Payments for purchases of investments in equity securities
|
(
|
) |
|
|
||||||||
Proceeds from sales of investments in equity securities
|
|
|
|
|||||||||
Decrease (increase) in loans receivable at banks, net
|
(
|
) |
(
|
) |
|
|||||||
Decrease (increase) in
non-trading
debt securities, net
|
|
|
(
|
) | ||||||||
Business combinations or disposals, net
|
(
|
) |
|
(
|
) | |||||||
Decrease (increase) in investments in affiliated companies, net
|
|
(
|
) |
|
||||||||
Other, net
|
(
|
) |
(
|
) |
|
|||||||
Net cash provided by (used in) investing activities
|
(
|
) |
(
|
) |
|
|||||||
Cash flows from financing activities:
|
|
|
|
|||||||||
Increase in long-term borrowings
|
|
|
|
|||||||||
Decrease in long-term borrowings
|
(
|
) |
(
|
) |
(
|
) | ||||||
Increase in short-term borrowings, net
|
|
|
|
|||||||||
Increase (decrease) in deposits received at banks, net
|
(
|
) |
|
(
|
) | |||||||
Proceeds from sales of common stock held in treasury
|
|
|
|
|||||||||
Payments for repurchases of common stock held in treasury
|
(
|
) |
(
|
) |
(
|
) | ||||||
Payments for cash dividends
|
(
|
) |
(
|
) |
(
|
) | ||||||
Contribution from noncontrolling interests
|
|
|
|
|||||||||
Net cash provided by
|
|
|
|
|||||||||
Effect of exchange rate changes on cash, cash equivalents, restricted cash and restricted cash equivalents
(2)
|
(
|
) |
|
(
|
) | |||||||
Net increase (decrease) in cash, cash equivalents, restricted cash and restricted cash equivalents
(2)
|
(
|
) |
|
|
||||||||
Cash, cash equivalents, restricted cash and restricted cash equivalents at beginning of year
(2)
|
|
|
|
|||||||||
Cash, cash equivalents, restricted cash and restricted cash equivalents at end of year
(2)
|
¥ |
|
¥ |
|
¥ |
|
||||||
Supplemental information:
|
|
|
|
|||||||||
Cash paid during the year for
—
|
|
|
|
|||||||||
Interest
|
¥ |
|
¥ |
|
¥ |
|
||||||
Income tax payments, net
|
¥ |
|
¥ |
|
¥ |
|
||||||
(1) |
Due to changes in accounting policy which Nomura adopted on April 1, 2018, certain reclassifications of amounts previously reported have been made to conform to the current year presentation. See Note 1
“Summary of accounting policies: New accounting pronouncements adopted during the current year”
|
(2) |
In accordance with ASU
2016-18
“Restricted Cash”
|
|
Millions of yen
|
|||||||||||
|
Year ended March 31
|
|||||||||||
|
2018
|
|
2019
|
|
2020
|
|
||||||
Cash and cash equivalents reported in
Cash and cash equivalents
|
¥ |
|
¥ |
|
¥ |
|
||||||
Restricted cash and restricted cash equivalents reported in
Deposits with stock exchanges and other segregated cash
|
|
|
|
|||||||||
Total cash, cash equivalent, restricted cash and restricted cash equivalents
|
¥ |
|
¥ |
|
¥ |
|
||||||
|
•
|
The ability of clients to perform on their contractual obligations to Nomura arising from financial instruments for determination of fair value measurements or allowances for doubtful accounts;
|
|
•
|
The volatility and dislocation in global financial markets for determination of fair value measurements;
|
|
•
|
The expected duration of declines in global equity markets for determination of fair value measurements and impairment of equity method investments;
|
|
•
|
The future use of non-financial assets within Nomura for determination of whether impairments are required; and
|
|
•
|
The future profitability of Nomura to realize deferred tax assets.
|
|
Millions of yen
|
|||||||
|
March 31
|
|||||||
|
2019
|
|
2020
|
|
||||
Land
|
¥ |
|
¥ |
|
||||
Office buildings
|
|
|
||||||
Equipment and facilities
|
|
|
||||||
Software
|
|
|
||||||
Construction in progress
|
|
|
||||||
Operating lease ROU assets
|
—
|
|
||||||
Total
|
¥ |
|
¥ |
|
Office buildings
|
|
|||
Equipment and facilities
|
|
|||
Software
|
|
Pronouncement
|
Summary of new guidance
|
Expected adoption
date and method of
adoption
|
Effect on these
consolidated statements |
|||
ASU
2016-02,
“
Leases
(1)
|
•
Replaces ASC 840 “
Leases
•
Requires all lessees to recognize a right of use asset and corresponding lease liability on balance sheet.
•
Lessor accounting is largely unchanged from current guidance.
•
Simplifies the accounting for sale leaseback and
“build-to-suit”
leases.
•
Requires extensive new qualitative and quantitative footnote disclosures on lease arrangements.
|
Modified retrospective adoption from April 1, 2019.
(2)
|
¥
Other Asset—Office buildings, land, equipment, and facilities
Other liabilities
¥
Retained earnings
See Note 8 “Leases” where the amended disclosures have been made.
|
(1)
|
As subsequently amended by ASU
2018-01
“
Land Easement Practical Expedient for Transition to Topic 842
2018-10
“
Codification Improvements to Topic 842, Leases
2018-11
“
Leases (Topic 842): Targeted Improvements
2018-20
“
Leases (Topic 842): Narrow-Scope Improvements for Lessors
2019-01
“
Leases (Topic 842): Codification Improvements.
|
(2)
|
Nomura used certain practical expedients permitted by ASC 842 including adopting the new requirements through a cumulative-effect adjustment to retained earnings on adoption date.
|
Pronouncement
|
Summary of new guidance
|
Expected adoption
date and method of
adoption
|
Effect on these
consolidated statements |
|||
ASU
2016-13,
“
Measurement of Credit Losses on Financial Instruments
(3)
|
•
Introduces a new model for recognition and measurement of credit losses against certain financial instruments such as loans, debt securities and receivables which are not carried at fair value with changes in fair value recognized through earnings. The model also applies to off balance sheet credit exposures such as written loan commitments, standby letters of credit and issued financial guarantees not accounted for as insurance, which are not carried at fair value through earnings.
•
The new model based on lifetime current expected credit losses (CECL) measurement, to be recognized at the time an
in-scope
instrument is originated, acquired or issued.
•
Replaces existing incurred credit losses model under current GAAP.
•
Permits electing the fair value option for certain financial instruments on adoption date.
•
Requires enhanced qualitative and quantitative disclosures around credit risk, the methodology used to estimate and monitor expected credit losses and changes in estimates of expected credit losses.
|
Modified retrospective adoption from April 1, 2020.
|
For financial instruments subject to CECL, ¥
increase in
Allowance for doubtful accounts
, ¥
Other liabilities
, ¥
Deferred tax assets
and cumulative effect adjustment to decrease
Retained
earnings
, net of tax, of ¥
For financial instruments elected for the FVO, ¥
Loans receivable
increase in
Other
liabilities
and cumulative effect adjustment to decrease
Retained
earnings
,
Allowances for credit losses as determined on adoption date under the new model increased as a result of the COVID-19 pandemic because of the increased credit risk caused by the impact of the pandemic on borrowers. Fair value measurements used
|
Pronouncement
|
Summary of new guidance
|
Expected adoption
date and method of
adoption
|
Effect on these
consolidated statements |
|||
|
|
|
on adoption date were also lower because of increased credit risk
and impact on financial markets caused by the pandemic.
|
|||
ASU
2019-12,
“
Simplifying the Accounting for Income Taxes
|
•
Simplifies the accounting for income taxes by removing certain exceptions to the general principles in ASC 740
“Income Taxes”
•
Requires an entity to recognize a franchise tax (or similar tax) that is partially based on income as an income-based tax and account for any incremental amount incurred as a
non-income—
based tax.
•
Makes other minor amendments for simplification and clarification of income taxes accounting.
|
Effective from April 1, 2021.
(4)
•
Modified retrospective adoption for the amendments related to changes in ownership of foreign equity method investments or foreign subsidiaries.
•
Full or modified retrospective adoption for the amendments related to franchise taxes that are partially based on income.
•
Prospective adoption for all other amendments.
|
Currently evaluating the potential impact.
|
(3)
|
As subsequently amended by ASU
2018-19
“
Codification Improvements to Topic 326, Financial Instruments—Credit Losses
2019-04
“
Codification Improvements to Topic 326, Financial Instruments—Credit Losses, Topic 815, Derivatives and Hedging, and Topic 825, Financial Instruments
2019-05
“
Financial Instruments—Credit Losses (Topic 326): Targeted Transition Relief.
2019-09
“Codification Improvements to Topic 326, Financial Instruments—Credit Losses”
ASU2019-10
“Financial Instruments—Credit Losses (Topic 326), Derivatives and Hedging (Topic 815), and Leases (Topic 842): Effective Dates”.
|
(4)
|
Unless Nomura early adopts which is under evaluation.
|
|
Billions of yen
|
|||||||||||||||||||
March 31, 2019
|
||||||||||||||||||||
Level 1
|
|
Level 2
|
|
Level 3
|
|
Counterparty
and
Cash Collateral
Netting
(1)
|
|
Balance as of
March 31, 2019
|
|
|||||||||||
Assets:
|
|
|
|
|
|
|||||||||||||||
Trading assets and private equity and debt investments
(2)
|
|
|
|
|
|
|||||||||||||||
Equities
(3)
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||||
Private equity and debt investments
(4)
|
|
|
|
|
|
|||||||||||||||
Japanese government securities
|
|
|
|
|
|
|||||||||||||||
Japanese agency and municipal securities
|
|
|
|
|
|
|||||||||||||||
Foreign government, agency and municipal securities
|
|
|
|
|
|
|||||||||||||||
Bank and corporate debt securities and loans for trading purposes
|
|
|
|
|
|
|||||||||||||||
Commercial mortgage-backed securities (“CMBS”)
|
|
|
|
|
|
|||||||||||||||
Residential mortgage-backed securities (“RMBS”)
|
|
|
|
|
|
|||||||||||||||
Issued/Guaranteed by government sponsored entity
|
|
|
|
|
|
|||||||||||||||
Other
|
|
|
|
|
|
|||||||||||||||
Real estate-backed securities
|
|
|
|
|
|
|||||||||||||||
Collateralized debt obligations (“CDOs”) and other
(5)
|
|
|
|
|
|
|||||||||||||||
Investment trust funds and other
|
|
|
|
|
|
|||||||||||||||
Total trading assets and private equity and debt investments
|
|
|
|
|
|
|||||||||||||||
Derivative assets
(6)
|
|
|
|
|
|
|||||||||||||||
Equity contracts
|
|
|
|
|
|
|||||||||||||||
Interest rate contracts
|
|
|
|
|
|
|||||||||||||||
Credit contracts
|
|
|
|
|
|
|||||||||||||||
Foreign exchange contracts
|
|
|
|
|
|
|||||||||||||||
Commodity contracts
|
|
|
|
|
|
|||||||||||||||
Netting
|
|
|
|
(
|
) |
(
|
) | |||||||||||||
Total derivative assets
|
|
|
|
(
|
) |
|
||||||||||||||
Subtotal
|
¥ |
|
¥ |
|
¥ |
|
¥ |
(
|
) | ¥ |
|
|||||||||
Loans and receivables
(7)
|
|
|
|
|
|
|||||||||||||||
Collateralized agreements
(8)
|
|
|
|
|
|
|||||||||||||||
Other assets
|
|
|
|
|
|
|||||||||||||||
Non-trading
debt securities
|
|
|
|
|
|
|||||||||||||||
Other
(2)(3)
|
|
|
|
|
|
|||||||||||||||
Total
|
¥ |
|
¥ |
|
¥ |
|
¥ |
(
|
) | ¥ |
|
|||||||||
Liabilities:
|
|
|
|
|
|
|||||||||||||||
Trading liabilities
|
|
|
|
|
|
|||||||||||||||
Equities
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||||
Japanese government securities
|
|
|
|
|
|
|||||||||||||||
Japanese agency and municipal securities
|
|
|
|
|
|
|||||||||||||||
Foreign government, agency and municipal securities
|
|
|
|
|
|
|||||||||||||||
Bank and corporate debt securities
|
|
|
|
|
|
|||||||||||||||
Residential mortgage-backed securities (“RMBS”)
|
|
|
|
|
|
|||||||||||||||
Collateralized debt obligations (“CDOs”) and other
(5)
|
|
|
|
|
|
|||||||||||||||
Investment trust funds and other
|
|
|
|
|
|
|||||||||||||||
Total trading liabilities
|
|
|
|
|
|
|||||||||||||||
Derivative liabilities
(6)
|
|
|
|
|
|
|||||||||||||||
Equity contracts
|
|
|
|
|
|
|||||||||||||||
Interest rate contracts
|
|
|
|
|
|
|||||||||||||||
Credit contracts
|
|
|
|
|
|
|||||||||||||||
Foreign exchange contracts
|
|
|
|
|
|
|||||||||||||||
Commodity contracts
|
|
|
|
|
|
|||||||||||||||
Netting
|
|
|
|
(
|
) |
(
|
) | |||||||||||||
Total derivative liabilities
|
|
|
|
(
|
) |
|
||||||||||||||
Subtotal
|
¥ |
|
¥ |
|
¥ |
|
¥ |
(
|
) | ¥ |
|
|||||||||
Short-term borrowings
(9)
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||||
Payables and deposits
(10)
|
|
|
|
|
|
|||||||||||||||
Collateralized financing
(8)
|
|
|
|
|
|
|||||||||||||||
Long-term borrowings
(9)(11)(12)
|
|
|
|
|
|
|||||||||||||||
Other liabilities
(13)
|
|
|
|
|
|
|||||||||||||||
Total
|
¥ |
|
¥ |
|
¥ |
|
¥ |
(
|
) | ¥ |
|
|||||||||
|
Billions of yen
|
|||||||||||||||||||
March 31, 2020
|
||||||||||||||||||||
Level 1
|
|
Level 2
|
|
Level 3
|
|
Counterparty
and
Cash Collateral
Netting
(1)
|
|
Balance as of
March 31, 2020
|
|
|||||||||||
Assets:
|
|
|
|
|
|
|||||||||||||||
Trading assets and private equity and debt investments
(2)
|
|
|
|
|
|
|||||||||||||||
Equities
(3)
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||||
Private equity and debt investments
(4)
|
|
|
|
|
|
|||||||||||||||
Japanese government securities
|
|
|
|
|
|
|||||||||||||||
Japanese agency and municipal securities
|
|
|
|
|
|
|||||||||||||||
Foreign government, agency and municipal securities
|
|
|
|
|
|
|||||||||||||||
Bank and corporate debt securities and loans for trading purposes
|
|
|
|
|
|
|||||||||||||||
Commercial mortgage-backed securities (“CMBS”)
|
|
|
|
|
|
|||||||||||||||
Residential mortgage-backed securities (“RMBS”)
|
|
|
|
|
|
|||||||||||||||
Issued/Guaranteed by government sponsored entity
|
|
|
|
|
|
|||||||||||||||
Other
|
|
|
|
|
|
|||||||||||||||
Real estate-backed securities
|
|
|
|
|
|
|||||||||||||||
Collateralized debt obligations (“CDOs”) and other
(5)
|
|
|
|
|
|
|||||||||||||||
Investment trust funds and other
|
|
|
|
|
|
|||||||||||||||
Total trading assets and private equity and debt investments
|
|
|
|
|
|
|||||||||||||||
Derivative assets
(6)
|
|
|
|
|
|
|||||||||||||||
Equity contracts
|
|
|
|
|
|
|||||||||||||||
Interest rate contracts
|
|
|
|
|
|
|||||||||||||||
Credit contracts
|
|
|
|
|
|
|||||||||||||||
Foreign exchange contracts
|
|
|
|
|
|
|||||||||||||||
Commodity contracts
|
|
|
|
|
|
|||||||||||||||
Netting
|
|
|
|
(
|
) |
(
|
) | |||||||||||||
Total derivative assets
|
|
|
|
(
|
) |
|
||||||||||||||
Subtotal
|
¥ |
|
¥ |
|
¥ |
|
¥ |
(
|
) | ¥ |
|
|||||||||
Loans and receivables
(7)
|
|
|
|
|
|
|||||||||||||||
Collateralized agreements
(8)
|
|
|
|
|
|
|||||||||||||||
Other assets
|
|
|
|
|
|
|||||||||||||||
Non-trading
debt securities
|
|
|
|
|
|
|||||||||||||||
Other
(2)(3)
|
|
|
|
|
|
|||||||||||||||
Total
|
¥ |
|
¥ |
|
¥ |
|
¥ |
(
|
) | ¥ |
|
|||||||||
Liabilities:
|
|
|
|
|
|
|||||||||||||||
Trading liabilities
|
|
|
|
|
|
|||||||||||||||
Equities
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||||
Japanese government securities
|
|
|
|
|
|
|||||||||||||||
Japanese agency and municipal securities
|
|
|
|
|
|
|||||||||||||||
Foreign government, agency and municipal securities
|
|
|
|
|
|
|||||||||||||||
Bank and corporate debt securities
|
|
|
|
|
|
|||||||||||||||
Residential mortgage-backed securities (“RMBS”)
|
|
|
|
|
|
|||||||||||||||
Collateralized debt obligations (“CDOs”) and other
(5)
|
|
|
|
|
|
|||||||||||||||
Investment trust funds and other
|
|
|
|
|
|
|||||||||||||||
Total trading liabilities
|
|
|
|
|
|
|||||||||||||||
Derivative liabilities
(6)
|
|
|
|
|
|
|||||||||||||||
Equity contracts
|
|
|
|
|
|
|||||||||||||||
Interest rate contracts
|
|
|
|
|
|
|||||||||||||||
Credit contracts
|
|
|
|
|
|
|||||||||||||||
Foreign exchange contracts
|
|
|
|
|
|
|||||||||||||||
Commodity contracts
|
|
|
|
|
|
|||||||||||||||
Netting
|
|
|
|
(
|
) |
(
|
) | |||||||||||||
Total derivative liabilities
|
|
|
|
(
|
) |
|
||||||||||||||
Subtotal
|
¥ |
|
¥ |
|
¥ |
|
¥ |
(
|
) | ¥ |
|
|||||||||
Short-term borrowings
(9)
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||||
Payables and deposits
(10)
|
|
|
|
|
|
|||||||||||||||
Collateralized financing
(8)
|
|
|
|
|
|
|||||||||||||||
Long-term borrowings
(9)(11)(12)
|
|
|
|
|
|
|||||||||||||||
Other liabilities
(13)
|
|
|
|
|
|
|||||||||||||||
Total
|
¥ |
|
¥ |
|
¥ |
|
¥ |
(
|
) | ¥ |
|
|||||||||
(1) | Represents the amount offset under counterparty netting of derivative assets and liabilities as well as cash collateral netting against net derivatives. |
(2) |
Certain investments that are measured at fair value using net asset value per share as a practical expedient have not been classified in the fair value hierarchy. As of March 31, 2019 and March 31, 2020, the fair values of these investments which are included in
Trading assets and private equity and debt investments
Other assets—Others
|
(3) | Includes equity investments that would have been accounted for under the equity method had Nomura not chosen to elect the fair value option. |
(4) |
Private equity and debt investments
non-traded
financial instruments including ownership or other forms of junior capital (such as mezzanine loan). Includes equity investments that would have been accounted for under the equity method had Nomura not chosen to elect the fair value option.
|
(5) | Includes collateralized loan obligations (“CLOs”) and asset-backed securities (“ABS”) such as those secured on credit card loans, auto loans and student loans. |
(6) | Each derivative classification includes derivatives with multiple risk underlyings. For example, interest rate contracts include complex derivatives referencing interest rate risk as well as foreign exchange risk or other factors such as prepayment rates. Credit contracts include credit default swaps as well as derivatives referencing corporate and government debt securities. |
(7) | Includes loans for which the fair value option has been elected. |
(8) | Includes collateralized agreements or collateralized financing for which the fair value option has been elected. |
(9) | Includes structured notes for which the fair value option has been elected. |
(10) | Includes embedded derivatives bifurcated from deposits received at banks. If unrealized gains are greater than unrealized losses, deposits are reduced by the excess amount. |
(11) | Includes embedded derivatives bifurcated from issued structured notes. If unrealized gains are greater than unrealized losses, borrowings are reduced by the excess amount. |
(12) | Includes liabilities recognized from secured financing transactions that are accounted for as financings rather than sales. Nomura elected the fair value option for these liabilities. |
(13) | Includes loan commitments for which the fair value option has been elected. |
|
March 31, 2019
|
|||||||||||||
Financial Instrument
|
Fair
value in billions of yen |
Valuation
technique
|
Significant
unobservable
valuation input |
Range of
valuation
inputs
(1)
|
Weighted
Average
(2)
|
Impact of
increases in significant unobservable valuation inputs
(3)(4)
|
Interrelationships
between valuation inputs
(5)
|
|||||||
Assets:
|
|
|
|
|
|
|
|
|||||||
Trading assets and private equity and debt investments
|
|
|
|
|
|
|
|
|||||||
Equities
|
¥
|
DCF
|
Liquidity discounts
|
|
|
|
|
|||||||
Private equity and debt investments
|
|
Market
multiples
|
EV/EBITDA ratios
|
|
|
|
|
|||||||
Foreign government, agency and municipal securities
|
|
DCF
|
Credit spreads
Recovery rates
|
|
|
|
|
|||||||
Bank and corporate debt securities and loans for trading purposes
|
|
DCF
|
Credit spreads
Recovery rates
|
|
|
|
|
|||||||
Residential mortgage backed securities (“RMBS”)
|
|
DCF
|
Yields
Prepayment rates Loss severities |
|
|
|
|
|||||||
Real estate-backed securities
|
|
DCF
|
Yields
Loss severities
|
|
|
|
|
|||||||
Collateralized debt obligations (“CDOs”) and other
|
|
DCF
|
Yields
Prepayment rates Default probabilities
Loss severities |
|
|
|
|
|||||||
|
March 31, 2019
|
|||||||||||||
Financial Instrument
|
Fair
value in billions of yen |
Valuation
technique
|
Significant
unobservable
valuation input |
Range of
valuation
inputs
(1)
|
Weighted
Average
(2)
|
Impact of
increases in significant unobservable valuation inputs
(3)(4)
|
Interrelationships
between valuation inputs
(5)
|
|||||||
Derivatives, net:
|
|
|
|
|
|
|
|
|||||||
Equity contracts
|
¥ (
|
Option models
|
Dividend yield
Volatilities Correlations |
|
|
|
|
|||||||
Interest rate contracts
|
(
|
DCF/
Option models
|
Interest rates
Volatilities Volatilities Correlations |
|
|
|
|
|||||||
Credit contracts
|
(
|
DCF/
Option models
|
Credit spreads
Recovery rates Volatilities Correlations |
|
|
|
|
|||||||
Foreign exchange contracts
|
|
Option models
|
Interest rates
Volatilities Volatilities Correlations |
(
|
|
|
|
|||||||
Loans and receivables
|
|
DCF
|
Credit spreads
|
|
|
|
|
|||||||
Collateralized agreements
|
|
DCF
|
Repo rate
|
|
|
|
|
|||||||
Other assets
|
|
|
|
|
|
|
|
|||||||
Other
(6)
|
|
DCF
|
WACC
Growth rates Liquidity discounts |
|
|
|
|
|||||||
|
|
Market multiples
|
EV/EBITDA ratios
PE Ratios Price/Book ratios Liquidity discounts |
|
|
|
|
|||||||
Liabilities:
|
|
|
|
|
|
|
|
|||||||
Short-term borrowings
|
|
DCF/
Option models
|
Volatilities
Correlations |
|
|
|
|
|||||||
Long-term borrowings
|
|
DCF/
Option models
|
Volatilities
Volatilities Correlations |
( |
|
|
|
|||||||
|
March 31, 2020
|
|||||||||||||
Financial Instrument
|
Fair
value in billions of yen |
Valuation
technique
|
Significant
unobservable
valuation input |
Range of
valuation
inputs
(1)
|
Weighted
Average
(2)
|
Impact of
increases in significant unobservable valuation inputs
(3)(4)
|
Interrelationships
between valuation inputs
(5)
|
|||||||
Assets:
|
|
|
|
|
|
|
|
|||||||
Trading assets and private equity and debt investments
|
|
|
|
|
|
|
|
|||||||
Equities
|
¥
|
DCF
|
Liquidity discounts
|
|
|
|
|
|||||||
|
|
Market multiples
|
Liquidity discounts
|
|
|
|
|
|||||||
Private equity and debt investments
|
|
DCF
|
WACC
Growth rates
Liquidity discounts |
|
|
|
|
|||||||
|
|
Market multiples
|
EV/EBITDA ratios
PE Ratios Liquidity discounts |
|
|
|
|
|||||||
Foreign government, agency and municipal securities
|
|
DCF
|
Credit spreads
Recovery rates |
|
|
|
|
|||||||
Bank and corporate debt securities and loans for trading purposes
|
|
DCF
|
Credit spreads
Recovery rates |
|
|
|
|
|||||||
Residential mortgage backed securities (“RMBS”)
|
|
DCF
|
Yields
Prepayment rates Loss severities |
|
|
|
|
|||||||
Real estate-backed securities
|
|
DCF
|
Loss severities
|
|
|
|
|
|||||||
Collateralized debt obligations (“CDOs”) and other
|
|
DCF
|
Yields
Prepayment rates Default probabilities Loss severities |
|
|
|
|
|||||||
|
March 31, 2020
|
|||||||||||||
Financial Instrument
|
Fair
value in billions of yen |
Valuation
technique
|
Significant
unobservable
valuation input |
Range of
valuation
inputs
(1)
|
Weighted
Average
(2)
|
Impact of
increases in significant unobservable valuation inputs
(3)(4)
|
Interrelationships
between valuation inputs
(5)
|
|||||||
Derivatives, net:
|
|
|
|
|
|
|
|
|||||||
Equity contracts
|
¥
|
Option models
|
Dividend yield
Volatilities Correlations |
( |
|
|
|
|||||||
Interest rate contracts
|
(
|
DCF/
Option models
|
Interest rates
Volatilities Volatilities Correlations |
(
( |
|
|
|
|||||||
Credit contracts
|
(
|
DCF/
Option models
|
Credit spreads
Recovery rates
Volatilities
Correlations |
|
|
|
|
|||||||
Foreign exchange contracts
|
|
Option models
|
Interest rates
Volatilities Volatilities Correlations |
(
( |
|
|
|
|||||||
Loans and receivables
|
|
DCF
|
Credit spreads
Recovery rates |
|
|
|
|
|||||||
Collateralized agreements
|
|
DCF
|
Repo rate
|
|
|
|
|
|||||||
Other assets
|
|
|
|
|
|
|
|
|||||||
Other
(6)
|
|
DCF
|
WACC
Growth rates Liquidity discounts |
|
|
|
|
|||||||
|
|
Market multiples
|
EV/EBITDA ratios
PE Ratios
Price/Book ratios
Liquidity discounts
|
|
|
|
|
|||||||
Liabilities:
|
|
|
|
|
|
|
|
|||||||
Short-term borrowings
|
|
DCF/
Option models
|
Volatilities
Correlations |
|
|
|
|
|||||||
Long-term borrowings
|
|
DCF/
Option models
|
Volatilities
Volatilities Correlations |
|
|
|
|
|||||||
(1) | Range information is provided in percentages, coefficients and multiples and represents the highest and lowest level significant unobservable valuation input used to value that type of financial instrument. A wide dispersion in the range does not necessarily reflect increased uncertainty or subjectivity in the valuation input and is typically just a consequence of the different characteristics of the financial instruments themselves. |
(2) |
Weighted average information for
non-derivative
instruments is calculated by weighting each valuation input by the fair value of the financial instrument.
|
(3) | The above table only considers the impact of an increase in each significant unobservable valuation input on the fair value measurement of the financial instrument. However, a decrease in the significant unobservable valuation input would have the opposite effect on the fair value measurement of the financial instrument. For example, if an increase in a significant unobservable valuation input would result in a lower fair value measurement, a decrease in the significant unobservable valuation input would result in a higher fair value measurement. |
(4) | The impact of an increase in the significant unobservable input on the fair value measurement for a derivative assumes Nomura is long risk to the input e.g., long volatility. Where Nomura is short such risk, the impact of an increase would have a converse effect on the fair value measurement of the derivative. |
(5) | Consideration of the interrelationships between significant unobservable inputs is only relevant where more than one unobservable valuation input is used to determine the fair value measurement of the financial instrument. |
(6) |
Valuation technique(s) and unobservable valuation inputs in respect of equity securities reported within
Other assets
|
|
|
|
|
|
Billions of yen
|
|
||||||||||||||||||||||||||||||||||
|
|
|
|
|
Year ended March 31, 2019
|
|
||||||||||||||||||||||||||||||||||
|
|
Balance
as of
April 1,
2018
|
|
|
Total gains
(losses)
recognized
in net revenue
(1)
|
|
|
Total gains
(losses)
recognized in
other
comprehensive
income
|
|
|
Purchases
/ issues
(2)
|
|
|
Sales /
redemptions
(2)
|
|
|
Settlements
|
|
|
Foreign
exchange
movements
|
|
|
Transfers
into
Level 3
(4)(5)
|
|
|
Transfers
out of
Level 3
(5)
|
|
|
Balance
as of
March 31,
2019
|
|
||||||||||
Assets:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Trading assets and private equity and debt investments
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equities
|
|
¥
|
|
|
|
¥
|
(
|
)
|
|
¥
|
|
|
|
¥
|
|
|
|
¥
|
(
|
)
|
|
¥
|
|
|
|
¥
|
|
|
|
¥
|
|
|
|
¥
|
(
|
)
|
|
¥
|
|
|
Private equity and debt investments
|
|
|
|
|
|
|
(
|
)
|
|
|
|
|
|
|
|
|
|
|
(
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Japanese agency and municipal securities
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign government, agency and municipal securities
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(
|
)
|
|
|
|
|
Bank and corporate debt securities and loans for trading
purposes |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(
|
)
|
|
|
|
|
Commercial mortgage-backed securities (“CMBS”)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Residential mortgage-backed securities (“RMBS”)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(
|
)
|
|
|
|
|
Real estate-backed securities
|
|
|
|
|
|
|
(
|
)
|
|
|
|
|
|
|
|
|
|
|
(
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Collateralized debt obligations (“CDOs”) and other
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(
|
)
|
|
|
|
|
Investment trust funds and other
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total trading assets and private equity and debt investments
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Derivatives, net
(3)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity contracts
|
|
|
(
|
)
|
|
|
(
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(
|
)
|
|
|
|
|
|
|
(
|
)
|
|
|
|
|
|
|
(
|
)
|
Interest rate contracts
|
|
|
(
|
)
|
|
|
(
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(
|
)
|
Credit contracts
|
|
|
|
|
|
|
(
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(
|
)
|
|
|
|
|
|
|
(
|
)
|
|
|
|
|
|
|
(
|
)
|
Foreign exchange contracts
|
|
|
|
|
|
|
(
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(
|
)
|
|
|
|
|
|
|
|
|
Commodity contracts
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total derivatives, net
|
|
|
(
|
)
|
|
|
(
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Subtotal
|
|
¥
|
|
|
|
¥
|
(
|
)
|
|
¥
|
|
|
|
¥
|
|
|
|
¥
|
(
|
)
|
|
¥
|
(
|
)
|
|
¥
|
|
|
|
¥
|
|
|
|
¥
|
(
|
)
|
|
¥
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loans and receivables
|
|
¥
|
|
|
|
¥
|
|
|
|
¥
|
|
|
|
¥
|
|
|
|
¥
|
(
|
)
|
|
¥
|
|
|
|
¥
|
|
|
|
¥
|
|
|
|
¥
|
(
|
)
|
|
¥
|
|
|
Collateralized agreements
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other assets
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other
|
|
|
|
|
|
|
(
|
)
|
|
|
|
|
|
|
|
|
|
|
(
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
¥
|
|
|
|
¥
|
(
|
)
|
|
¥
|
|
|
|
¥
|
|
|
|
¥
|
(
|
)
|
|
¥
|
(
|
)
|
|
¥
|
|
|
|
¥
|
|
|
|
¥
|
(
|
)
|
|
¥
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Liabilities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Trading liabilities
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equities
|
|
¥
|
|
|
|
¥
|
|
|
|
¥
|
|
|
|
¥
|
|
|
|
¥
|
(
|
)
|
|
¥
|
|
|
|
¥
|
|
|
|
¥
|
|
|
|
¥
|
(
|
)
|
|
¥
|
|
|
Foreign government, agency and municipal securities
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Bank and corporate debt securities
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Collateralized debt obligations (“CDOs”) and other
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Investment trust funds and other
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total trading liabilities
|
|
¥
|
|
|
|
¥
|
|
|
|
¥
|
|
|
|
¥
|
|
|
|
¥
|
(
|
)
|
|
¥
|
|
|
|
¥
|
|
|
|
¥
|
|
|
|
¥
|
(
|
)
|
|
¥
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Short-term borrowings
|
|
|
|
|
|
|
(
|
)
|
|
|
|
|
|
|
|
|
|
|
(
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(
|
)
|
|
|
|
|
Payables
and
deposits
|
|
|
(
|
)
|
|
|
(
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Collateralized financing
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Long-term borrowings
|
|
|
|
|
|
|
(
|
)
|
|
|
|
|
|
|
|
|
|
|
(
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(
|
)
|
|
|
|
|
Other liabilities
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
¥
|
|
|
|
¥
|
(
|
)
|
|
¥
|
|
|
|
¥
|
|
|
|
¥
|
(
|
)
|
|
¥
|
|
|
|
¥
|
|
|
|
¥
|
|
|
|
¥
|
(
|
)
|
|
¥
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Billions of yen
|
|||||||||||||||||||||||||||||||||||||
|
|
|
Year ended March 31, 2020
|
|||||||||||||||||||||||||||||||||||||
|
Balance
as of
April 1,
2019
|
|
Total gains
(losses)
recognized
in net revenue
(1)
|
|
Total gains
(losses)
recognized in
other
comprehensive
income
|
|
Purchases
/ issues
(2)
|
|
Sales /
redemptions
(2)
|
|
Settlements
|
|
Foreign
exchange
movements
|
|
Transfers
into
Level 3
(4)(5)
|
|
Transfers
out of
Level 3
(5)
|
|
Balance
as of
March 31,
2020
|
|
||||||||||||||||||||
Assets:
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||
Trading assets and private equity and debt investments
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||
Equities
|
¥ |
|
¥ |
(
|
) | ¥ |
|
¥ |
|
¥ |
(
|
) | ¥ |
|
¥ |
|
¥ |
|
¥ |
(
|
) | ¥ |
|
|||||||||||||||||
Private equity and debt investments
|
|
|
|
|
(
|
) |
|
(
|
) |
|
|
|
||||||||||||||||||||||||||||
Japanese agency and municipal securities
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||
Foreign government, agency and municipal securities
|
|
|
|
|
(
|
) |
|
|
|
(
|
) |
|
||||||||||||||||||||||||||||
Bank and corporate debt securities and loans for
|
|
(
|
) |
|
|
(
|
) |
|
(
|
) |
|
(
|
) |
|
||||||||||||||||||||||||||
Commercial mortgage-backed securities (“CMBS”)
|
|
(
|
) |
|
|
(
|
) |
|
|
|
|
|
||||||||||||||||||||||||||||
Residential mortgage-backed securities (“RMBS”)
|
|
(
|
) |
|
|
(
|
) |
|
|
|
(
|
) |
|
|||||||||||||||||||||||||||
Real estate-backed securities
|
|
|
|
|
(
|
) |
|
(
|
) |
|
|
|
||||||||||||||||||||||||||||
Collateralized debt obligations (“CDOs”) and other
|
|
(
|
) |
|
|
(
|
) |
|
(
|
) |
|
(
|
) |
|
||||||||||||||||||||||||||
Investment trust funds and other
|
|
|
|
|
(
|
) |
|
|
|
|
|
|||||||||||||||||||||||||||||
Total trading assets and private equity and debt investments
|
|
(
|
) |
|
|
(
|
) |
|
(
|
) |
|
(
|
) |
|
||||||||||||||||||||||||||
Derivatives, net
(3)
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||
Equity contracts
|
(
|
) |
|
|
|
|
(
|
) |
|
|
(
|
) |
|
|||||||||||||||||||||||||||
Interest rate contracts
|
(
|
) |
|
|
|
|
(
|
) |
|
(
|
) |
|
(
|
) | ||||||||||||||||||||||||||
Credit contracts
|
(
|
) |
|
|
|
|
|
|
(
|
) |
|
(
|
) | |||||||||||||||||||||||||||
Foreign exchange contracts
|
|
(
|
) |
|
|
|
|
(
|
) |
|
|
|
||||||||||||||||||||||||||||
Commodity contracts
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||
Total derivatives, net
|
(
|
) |
|
|
|
|
(
|
) |
(
|
) |
|
|
(
|
) | ||||||||||||||||||||||||||
Subtotal
|
¥ |
|
¥ |
(
|
) | ¥ |
|
¥ |
|
¥ |
(
|
) | ¥ |
(
|
) | ¥ |
(
|
) | ¥ |
|
¥ |
(
|
) | ¥ |
|
|||||||||||||||
Loans and receivables
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
(
|
) | ¥ |
|
¥ |
(
|
) | ¥ |
|
¥ |
(
|
) | ¥ |
|
|||||||||||||||||
Collateralized agreements
|
|
|
|
|
(
|
) |
|
(
|
) |
|
|
|
||||||||||||||||||||||||||||
Other assets
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||
Other
|
|
(
|
) |
|
|
(
|
) |
|
(
|
) |
|
|
|
|||||||||||||||||||||||||||
Total
|
¥ |
|
¥ |
(
|
) | ¥ |
|
¥ |
|
¥ |
(
|
) | ¥ |
(
|
) | ¥ |
(
|
) | ¥ |
|
¥ |
(
|
) | ¥ |
|
|||||||||||||||
Liabilities:
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||
Trading liabilities
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||
Equities
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||||||||||||||
Foreign government, agency and municipal securities
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||
Bank and corporate debt securities
|
|
(
|
) |
|
|
(
|
) |
|
|
|
|
|
||||||||||||||||||||||||||||
Collateralized debt obligations (“CDOs”) and other
|
|
|
|
|
(
|
) |
|
|
|
|
|
|||||||||||||||||||||||||||||
Investment trust funds and other
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||
Total trading liabilities
|
¥ |
|
¥ |
(
|
) | ¥ |
|
¥ |
|
¥ |
(
|
) | ¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||||||||||||
Short-term borrowings
|
|
|
|
|
(
|
) |
|
|
|
(
|
) |
|
||||||||||||||||||||||||||||
Payables and deposits
|
|
|
|
|
|
|
|
|
(
|
) |
|
|||||||||||||||||||||||||||||
Long-term borrowings
|
|
|
|
|
(
|
) |
|
(
|
) |
|
(
|
) |
|
|||||||||||||||||||||||||||
Other liabilities
|
|
(
|
) |
|
|
(
|
) |
|
|
|
|
|
||||||||||||||||||||||||||||
Total
|
¥ |
|
¥ |
(
|
) | ¥ |
|
¥ |
|
¥ |
(
|
) | ¥ |
|
¥ |
(
|
) | ¥ |
|
¥ |
(
|
) | ¥ |
|
||||||||||||||||
(1) |
Includes gains and losses reported primarily within
Net gain on trading, Gain on private equity and debt investments,
Gain (loss) on investments in equity securities, Revenue—Other
Non-interest expenses—Other, Interest and dividends
Interest expense
|
(2) |
Amounts reported in
Purchases / issues
Sales / redemptions
|
(3) | Each derivative classification includes derivatives with multiple risk underlyings. For example, interest rate contracts include complex derivatives referencing interest rate risk as well as foreign exchange risk or other factors such as prepayment rates. Credit contracts include credit default swaps as well as derivatives referencing corporate and government debt securities. |
(4) |
Amounts of gains and losses on these transfers which were recognized in the period when the
Transfers into Level 3
|
(5) |
Transfers into Level 3
Transfers out of Level 3
Quantitative and qualitative information regarding significant unobservable inputs
|
|
Billions of yen
|
|||||||
March 31
|
||||||||
2019
|
|
2020
|
|
|||||
Unrealized gains/(losses)
(1)
|
||||||||
Assets:
|
|
|
||||||
Trading assets and private equity and debt investments
|
|
|
||||||
Equities
|
¥ |
(
|
) | ¥ |
(
|
) | ||
Private equity and debt investments
|
(
|
) |
|
|||||
Japanese agency and municipal securities
|
|
|
||||||
Foreign government, agency and municipal securities
|
|
(
|
) | |||||
Bank and corporate debt securities and loans for trading purposes
|
|
(
|
) | |||||
Commercial mortgage-backed securities (“CMBS”)
|
|
(
|
) | |||||
Residential mortgage-backed securities (“RMBS”)
|
|
(
|
) | |||||
Real estate-backed securities
|
|
|
||||||
Collateralized debt obligations (“CDOs”) and other
|
(
|
) |
(
|
) | ||||
Investment trust funds and other
|
|
|
||||||
Total trading assets and private equity and debt investments
|
(
|
) |
(
|
) | ||||
Derivatives, net
(2)
|
|
|
||||||
Equity contracts
|
(
|
) |
|
|||||
Interest rate contracts
|
(
|
) |
(
|
) | ||||
Credit contracts
|
(
|
) |
|
|||||
Foreign exchange contracts
|
(
|
) |
(
|
) | ||||
Commodity contracts
|
|
|
||||||
Total derivatives, net
|
(
|
) |
(
|
) | ||||
Subtotal
|
¥ |
(
|
) | ¥ |
(
|
) | ||
Loans and receivables
|
|
(
|
) | |||||
Collateralized agreements
|
|
|
||||||
Other assets
|
|
|
||||||
Other
|
(
|
) |
(
|
) | ||||
Total
|
¥ |
(
|
) | ¥ |
(
|
) | ||
|
Billions of yen
|
|||||||
March 31
|
||||||||
2019
|
|
2020
|
|
|||||
Unrealized gains/(losses)
(1)
|
||||||||
Liabilities
:
|
|
|
||||||
Trading liabilities
|
|
|
||||||
Equities
|
¥ |
|
¥ |
|
||||
Foreign government, agency and municipal securities
|
|
|
||||||
Bank and corporate debt securities
|
|
(
|
) | |||||
Collateralized debt obligations (“CDOs”) and other
|
|
|
||||||
Total trading liabilities
|
¥ |
|
¥ |
(
|
) | |||
Short-term borrowings
|
(
|
) |
|
|||||
Payables and deposits
|
(
|
) |
|
|||||
Long-term borrowings
|
(
|
) |
|
|||||
Total
|
¥ |
(
|
) | ¥ |
|
|||
(1) |
Includes gains and losses reported within
Net gain on trading, Gain on private equity and debt investments
Gain on investments in equity securities, Revenue—Other
Non-interest expenses—Other, Interest and dividends
Interest expense
|
(2) | Each derivative classification includes derivatives with multiple risk underlyings. For example, interest rate contracts include complex derivatives referencing interest rate risk as well as foreign exchange risk or other factors such as prepayment rates. Credit contracts include credit default swaps as well as derivatives referencing corporate and government debt securities. |
|
Billions of yen
|
|||||||||||||||
|
March 31, 2019
|
|||||||||||||||
|
Fair value
|
|
Unfunded
commitments
(1)
|
|
Redemption frequency
(if currently eligible)
(2)
|
|
Redemption notice
(3)
|
|
||||||||
Hedge funds
|
¥ |
|
¥ |
|
|
Same
day-
days
|
||||||||||
Venture capital funds
|
|
|
|
|
||||||||||||
Private equity funds
|
|
|
|
|
||||||||||||
Real estate funds
|
|
|
|
|
||||||||||||
Total
|
¥ |
|
¥ |
|
|
|
||||||||||
|
Billions of yen
|
|||||||||||||||
|
March 31, 2020
|
|||||||||||||||
|
Fair value
|
|
Unfunded
commitments
(1)
|
|
Redemption frequency
(if currently eligible)
(2)
|
|
Redemption notice
(3)
|
|
||||||||
Hedge funds
|
¥ |
|
¥ |
|
|
Same
day-
days
|
||||||||||
Venture capital funds
|
|
|
|
|
||||||||||||
Private equity funds
|
|
|
|
|
||||||||||||
Real estate funds
|
|
|
|
|
||||||||||||
Total
|
¥ |
|
¥ |
|
|
|
||||||||||
(1) | The contractual amount of any unfunded commitments Nomura is required to make to the entities in which the investment is held. |
(2) | The range in frequency with which Nomura can redeem investments. |
(3) | The range in notice period required to be provided before redemption is possible. |
• |
Equity method investments reported within
Trading assets and private equity and debt investments
Other assets
|
• |
Loans reported within
Loans and receivables
|
• |
Reverse repurchase and repurchase agreements reported within
Collateralized agreements
Collateralized financing
|
• |
All structured notes issued on or after April 1, 2008 reported within
Short-term borrowings
Long-term borrowings
|
|
•
|
Certain structured deposit issuances reported within
Deposits received at banks.
|
|
•
|
Financial liabilities reported within
Long-term borrowings
|
|
•
|
Financial reinsurance contracts reported within
Other assets
|
|
Billions of yen
|
|||||||||||
|
Year ended March 31
|
|||||||||||
|
2018
|
|
2019
|
|
2020
|
|
||||||
|
Gains/(Losses)
(1)
|
|||||||||||
Assets:
|
|
|
|
|||||||||
Trading assets and private equity and debt investments
(2)
|
|
|
|
|||||||||
Trading assets
|
¥ |
|
¥ |
|
¥ |
|
||||||
Private equity and debt investments
|
(
|
) |
|
(
|
) | |||||||
Loans and receivables
|
(
|
) |
(
|
) |
|
|||||||
Collateralized agreements
(3)
|
|
|
|
|||||||||
Other assets
(2)
|
|
(
|
) |
(
|
) | |||||||
Total
|
¥ |
(
|
) | ¥ |
(
|
) | ¥ |
(
|
) | |||
Liabilities:
|
|
|
|
|||||||||
Short-term borrowings
(4)
|
¥ |
(
|
) | ¥ |
|
¥ |
|
|||||
Collateralized financing
(3)
|
|
|
(
|
) | ||||||||
Long-term borrowings
(4)(5)
|
(
|
) |
(
|
) |
|
|||||||
Other liabilities
(6)
|
(
|
) |
|
|
||||||||
Total
|
¥ |
(
|
) | ¥ |
(
|
) | ¥ |
|
||||
(1) |
Includes gains and losses reported primarily within
Net gain on trading
Revenue—Other
|
(2) | Includes equity investments that would have been accounted for under the equity method had Nomura not chosen to elect the fair value option. |
(3) | Includes reverse repurchase and repurchase agreements. |
(4) | Includes structured notes and other financial liabilities. |
(5) | Includes secured financing transactions arising from transfers of financial assets which did not meet the criteria for sales accounting. |
(6) | Includes unfunded written loan commitments. |
|
Billions of Yen
|
|||||||
|
Year ended March 31
|
|||||||
|
2019
|
|
2020
|
|
||||
Changes recognized as a credit (debit) to other comprehensive income
|
¥ |
|
¥ |
|
||||
Credit (debit) amounts reclassified to earnings
|
(
|
) |
(
|
) | ||||
Cumulative credit (debit) balance recognized in accumulated other comprehensive income
|
|
|
|
Billions of yen
|
|||||||||||||||||||
March 31, 2019
|
||||||||||||||||||||
Japan
|
|
U.S.
|
|
EU & U
.
K
.
|
|
Other
|
|
Total
(1)
|
|
|||||||||||
Government, agency and municipal securities
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
|
Billions of yen
|
|||||||||||||||||||
March 31, 2020
|
||||||||||||||||||||
Japan
|
|
U.S.
|
|
EU & U
.
K
.
|
|
Other
|
|
Total
(1)
|
|
|||||||||||
Government, agency and municipal securities
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
(1) |
Other than above, there were ¥
Other assets—Non-trading debt securities
|
|
Billions of yen
|
|||||||||||||||||||
|
March 31, 2019
(1)
|
|||||||||||||||||||
|
|
|
|
|
Fair value by level
|
|||||||||||||||
|
Carrying
value
|
|
Fair
value |
|
Level 1
|
|
Level 2
|
|
Level 3
|
|
||||||||||
Assets:
|
|
|
|
|
|
|||||||||||||||
Cash and cash equivalents
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||||
Time deposits
|
|
|
|
|
|
|||||||||||||||
Deposits with stock exchanges and other segregated cash
|
|
|
|
|
|
|||||||||||||||
Loans receivable
(2)
|
|
|
|
|
|
|||||||||||||||
Securities purchased under agreements to resell
|
|
|
|
|
|
|||||||||||||||
Securities borrowed
|
|
|
|
|
|
|||||||||||||||
Total
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||||
Liabilities:
|
|
|
|
|
|
|||||||||||||||
Short-term borrowings
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||||
Deposits received at banks
|
|
|
|
|
|
|||||||||||||||
Securities sold under agreements to repurchase
|
|
|
|
|
|
|||||||||||||||
Securities loaned
|
|
|
|
|
|
|||||||||||||||
Long-term borrowings
|
|
|
|
|
|
|||||||||||||||
Total
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||||
|
Billions of yen
|
|||||||||||||||||||
|
March 31, 2020
(1)
|
|||||||||||||||||||
|
|
|
|
|
Fair value by level
|
|||||||||||||||
|
Carrying
value
|
|
Fair
value |
|
Level 1
|
|
Level 2
|
|
Level 3
|
|
||||||||||
Assets:
|
|
|
|
|
|
|||||||||||||||
Cash and cash equivalents
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||||
Time deposits
|
|
|
|
|
|
|||||||||||||||
Deposits with stock exchanges and other segregated cash
|
|
|
|
|
|
|||||||||||||||
Loans receivable
(2)
|
|
|
|
|
|
|||||||||||||||
Securities purchased under agreements to resell
|
|
|
|
|
|
|||||||||||||||
Securities borrowed
|
|
|
|
|
|
|||||||||||||||
Total
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||||
Liabilities:
|
|
|
|
|
|
|||||||||||||||
Short-term borrowings
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||||
Deposits received at banks
|
|
|
|
|
|
|||||||||||||||
Securities sold under agreements to repurchase
|
|
|
|
|
|
|||||||||||||||
Securities loaned
|
|
|
|
|
|
|||||||||||||||
Other secured borrowings
|
|
|
|
|
|
|||||||||||||||
Long-term borrowings
|
|
|
|
|
|
|||||||||||||||
Total
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||||
(1) | Includes financial instruments which are carried at fair value on a recurring basis. |
(2) | Carrying values are shown after deducting relevant allowances for credit losses. |
|
Billions of yen
|
|||||||||||||||
|
March 31, 2019
|
|||||||||||||||
|
Gross fair value of
derivative assets
|
|
Impact of
master netting
agreements
|
|
Impact of
collateral
|
|
Net exposure to
credit risk
|
|
||||||||
Financial institutions
|
¥ |
|
¥ |
(
|
) | ¥ |
(
|
) | ¥ |
|
|
Billions of yen
|
|||||||||||||||
|
March 31, 2020
|
|||||||||||||||
|
Gross fair value of
derivative assets
|
|
Impact of
master netting
agreements
|
|
Impact of
collateral
|
|
Net exposure to
credit risk
|
|
||||||||
Financial institutions
|
¥ |
|
¥ |
(
|
) | ¥ |
(
|
) | ¥ |
|
|
|
|
Billions of yen
|
|||||||||
|
|
|
March 31, 2019
|
|||||||||
|
|
|
Derivative
assets
|
|
Derivative
liabilities
|
|
||||||
|
Total Notional
(1)
|
|
Fair value
|
|
Fair value
(1)
|
|
||||||
Derivatives used for trading and
non-trading
purposes
(2)(3)
:
|
|
|
|
|||||||||
Equity contracts
|
¥ |
|
¥ |
|
¥ |
|
||||||
Interest rate contracts
|
|
|
|
|||||||||
Credit contracts
|
|
|
|
|||||||||
Foreign exchange contracts
|
|
|
|
|||||||||
Commodity contracts
|
|
|
|
|||||||||
Total
|
¥ |
|
¥ |
|
¥ |
|
||||||
Derivatives designated as hedging instruments:
|
|
|
|
|||||||||
Interest rate contracts
|
¥ |
|
¥ |
|
¥ |
|
||||||
Foreign exchange contracts
|
|
|
|
|||||||||
Total
|
¥ |
|
¥ |
|
¥ |
|
||||||
Total derivatives
|
¥ |
|
¥ |
|
¥ |
|
||||||
|
|
|
Billions of yen
|
|||||||||
|
|
|
March 31, 2020
|
|||||||||
|
|
|
Derivative
assets
|
|
Derivative
liabilities
|
|
||||||
|
Total Notional
(1)
|
|
Fair value
|
|
Fair value
(1)
|
|
||||||
Derivatives used for trading and
non-trading
purposes
(2)(3)
:
|
|
|
|
|||||||||
Equity contracts
|
¥ |
|
¥ |
|
¥ |
|
||||||
Interest rate contracts
|
|
|
|
|||||||||
Credit contracts
|
|
|
|
|||||||||
Foreign exchange contracts
|
|
|
|
|||||||||
Commodity contracts
|
|
|
|
|||||||||
Total
|
¥ |
|
¥ |
|
¥ |
|
||||||
Derivatives designated as hedging instruments:
|
|
|
|
|||||||||
Interest rate contracts
|
¥ |
|
¥ |
|
¥ |
|
||||||
Foreign exchange contracts
|
|
|
|
|||||||||
Total
|
¥ |
|
¥ |
|
¥ |
|
||||||
Total derivatives
|
¥ |
|
¥ |
|
¥ |
|
||||||
(1) | Includes the amount of embedded derivatives bifurcated in accordance with ASC 815. |
(2) | Each derivative classification includes derivatives referencing multiple risk components. For example, interest rate contracts include complex derivatives referencing interest rate risk as well as foreign exchange risk or other factors such as prepayment rates. Credit contracts include credit default swaps as well as derivatives referencing corporate and government securities. |
(3) |
As of March 31, 2019 and 2020, the amounts reported include derivatives used for
non-trading
purposes which are not designated as fair value or net investment hedges. These amounts have not been separately presented since such amounts were not significant.
|
|
Billions of yen
|
Billions of yen
|
||||||||||||||
|
March 31, 2019
|
March 31, 2020
|
||||||||||||||
|
Derivative
assets
|
|
Derivative
liabilities
(1)
|
|
Derivative
assets
|
|
Derivative
liabilities
(1)
|
|
||||||||
Equity contracts
|
|
|
|
|
||||||||||||
OTC settled bilaterally
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||
Exchange-traded
|
|
|
|
|
||||||||||||
Interest rate contracts
|
|
|
|
|
||||||||||||
OTC settled bilaterally
|
|
|
|
|
||||||||||||
OTC centrally-cleared
|
|
|
|
|
||||||||||||
Exchange-traded
|
|
|
|
|
||||||||||||
Credit contracts
|
|
|
|
|
||||||||||||
OTC settled bilaterally
|
|
|
|
|
||||||||||||
OTC centrally-cleared
|
|
|
|
|
||||||||||||
Exchange-traded
|
|
|
|
|
||||||||||||
Foreign exchange contracts
|
|
|
|
|
||||||||||||
OTC settled bilaterally
|
|
|
|
|
||||||||||||
Commodity contracts
|
|
|
|
|
||||||||||||
OTC settled bilaterally
|
|
|
|
|
||||||||||||
Exchange-traded
|
|
|
|
|
||||||||||||
Total gross derivative balances
(2)
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||
Less: Amounts offset in the consolidated balance sheets
(3)
|
(
|
) |
(
|
) |
(
|
) |
(
|
) | ||||||||
Total net amounts reported on the face of the consolidated balance sheets
(4)
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
|
Billions of yen
|
Billions of yen
|
||||||||||||||
|
March 31, 2019
|
March 31, 2020
|
||||||||||||||
|
Derivative
assets
|
|
Derivative
liabilities
(1)
|
|
Derivative
assets
|
|
Derivative
liabilities
(1)
|
|
||||||||
Less: Additional amounts not offset in the consolidated balance sheets
(5)
|
|
|
|
|
||||||||||||
Financial instruments and
non-cash
collateral
|
¥ |
(
|
¥ |
(
|
¥ |
(
|
) | ¥ |
(
|
) | ||||||
Net amount
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||
(1)
|
Includes the amount of embedded derivatives bifurcated in accordance with ASC 815.
|
(2)
|
Includes all gross derivative asset and liability balances irrespective of whether they are transacted under a master netting agreement or whether Nomura has obtained sufficient evidence of enforceability of the master netting agreement. As of March 31, 2019, the gross balance of derivative assets and derivative liabilities which are not documented under master netting agreements or are documented under master netting agreements for which Nomura has not yet obtained sufficient evidence of enforceability was
¥
|
(3) |
Represents amounts offset through counterparty netting of derivative assets and liabilities as well as cash collateral netting against net derivatives under master netting and similar agreements for which Nomura has obtained sufficient evidence of enforceability in accordance with ASC 815. As of March 31, 2019, Nomura offset a total of ¥
|
(4) |
Net derivative assets and net derivative liabilities are generally reported within
Trading assets and private equity investments—Trading assets
Trading liabilities
Short-term borrowings
Long-term borrowings
|
(5) |
Represents amounts which are not permitted to be offset on the face of the consolidated balance sheets in accordance with ASC
210-20
and ASC 815 but which provide Nomura with a legally enforceable right of offset in the event of counterparty default. Amounts relating to derivative and collateral agreements where Nomura has not yet obtained sufficient evidence of enforceability of such offsetting rights are excluded. As of March 31, 2019, a total of ¥
|
|
Billions of yen
|
|||||||||||
|
Year ended March 31
|
|||||||||||
|
2018
|
|
2019
|
|
2020
|
|
||||||
Derivatives used for trading and
non-trading
purposes
(1)(2)
:
|
|
|
|
|||||||||
Equity contracts
|
¥ |
|
¥ |
(
|
) | ¥ |
|
|||||
Interest rate contracts
|
(
|
) |
|
(
|
) | |||||||
Credit contracts
|
|
(
|
) |
(
|
) | |||||||
Foreign exchange contracts
|
|
(
|
) |
|
||||||||
Commodity contracts
|
|
|
(
|
) | ||||||||
Total
|
¥ |
|
¥ |
|
¥ |
(
|
) | |||||
(1) | Each derivative classification includes derivatives referencing multiple risk components. For example, interest rates contracts include complex derivatives referencing interest rate risk as well as foreign exchange risk or other factors such as prepayment rates. Credit contracts include credit default swaps as well as derivatives referencing corporate and government securities. |
(2) |
Includes net gains (losses) on derivatives used for
non-trading
purposes which are not designated as fair value or net investment hedges. For the years ended March 31, 2018, 2019 and 2020, these amounts have not been separately presented as net gains (losses) for these
non-trading
derivatives were not significant.
|
Line items in the statement of financial
position in which the hedged item is included: |
Billions of yen
|
|||||||||||||||
Carrying amount of the hedged liabilities
|
Cumulative gains/(losses) of fair value hedging
adjustment included in the carrying amount of the hedged liabilities |
|||||||||||||||
March 31, 2019
|
|
March 31, 2020
|
|
March 31, 2019
|
|
March 31, 2020
|
|
|||||||||
Long-term borrowings
|
¥ |
|
¥ |
|
¥ |
(
|
¥ |
(
|
||||||||
Total
|
¥ |
|
¥ |
|
¥ |
(
|
¥ |
(
|
||||||||
|
Billions of yen
|
|||||||||||
|
Year ended March 31
|
|||||||||||
|
2018
|
|
2019
|
|
2020
|
|
||||||
Derivatives designated as hedging instruments:
|
|
|
|
|||||||||
Interest rate contracts
|
¥ |
(
|
) | ¥ |
|
¥ |
(
|
) | ||||
Foreign exchange contracts
|
|
|
|
|||||||||
Total
|
¥ |
|
¥ |
|
¥ |
(
|
) | |||||
|
Billions of yen
|
|||||||||||
|
Year ended March 31
|
|||||||||||
|
2018
|
|
2019
|
|
2020
|
|
||||||
Hedged items:
|
|
|
|
|||||||||
Long-term borrowings
|
¥ |
|
¥ |
(
|
) | ¥ |
|
|||||
Non-trading
debt securities
|
(
|
) |
|
|
||||||||
Total
|
¥ |
(
|
) | ¥ |
(
|
) | ¥ |
|
||||
|
Billions of yen
|
|||||||||||
|
Year ended March 31
|
|||||||||||
|
2018
|
|
2019
|
|
2020
|
|
||||||
Hedging instruments:
|
|
|
|
|||||||||
Foreign exchange contracts
|
¥ |
(
|
) | ¥ |
|
¥ |
|
|||||
Total
|
¥ |
(
|
) | ¥ |
|
¥ |
|
|||||
(1) |
The portion of gains (losses) representing the amount of hedge ineffectiveness and the amount excluded from the assessment of hedge effectiveness are recognized within
Revenue—Other
|
|
Billions of yen
|
|||||||||||||||||||||||||||
|
March 31, 2019
|
|||||||||||||||||||||||||||
|
|
|
Maximum potential payout/Notional
|
Notional
|
|
|||||||||||||||||||||||
|
|
|
|
|
Years to maturity
|
Purchased
credit
protection
|
|
|||||||||||||||||||||
|
Carrying value
(Asset) / Liability
(1)
|
|
Total
|
|
Less than
1 year
|
|
1 to 3
years
|
|
3 to 5
years
|
|
More than
5 years
|
|
||||||||||||||||
Single-name credit default swaps
|
¥ |
(
|
) | ¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
|||||||||||||
Credit default indices
|
(
|
) |
|
|
|
|
|
|
||||||||||||||||||||
Other credit risk related portfolio products
|
|
|
|
|
|
|
|
|||||||||||||||||||||
Credit-risk related options and swaptions
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
|||||||||||||||||||||
Total
|
¥ |
(
|
) | ¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
|||||||||||||
|
Billions of yen
|
|||||||||||||||||||||||||||
|
March 31, 2020
|
|||||||||||||||||||||||||||
|
|
|
Maximum potential payout/Notional
|
Notional
|
|
|||||||||||||||||||||||
|
|
|
|
|
Years to maturity
|
Purchased
credit
protection
|
|
|||||||||||||||||||||
|
Carrying value
(Asset) / Liability
(1)
|
|
Total
|
|
Less than
1 year
|
|
1 to 3
years
|
|
3 to 5
years
|
|
More than
5 years
|
|
||||||||||||||||
Single-name credit default swaps
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||||||||
Credit default indices
|
|
|
|
|
|
|
|
|||||||||||||||||||||
Other credit risk related portfolio products
|
|
|
|
|
|
|
|
|||||||||||||||||||||
Credit-risk related options and swaptions
|
|
|
—
|
—
|
|
—
|
|
|||||||||||||||||||||
Total
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||||||||
(1) | Carrying value amounts are shown on a gross basis prior to cash collateral or counterparty netting. Asset balances represent positive fair value amounts caused by tightening of credit spreads of underlyings since inception of the credit derivative contracts. |
|
Billions of yen
|
|||||||||||||||||||||||||||
|
March 31, 2019
|
|||||||||||||||||||||||||||
|
Maximum potential payout/Notional
|
|||||||||||||||||||||||||||
|
AAA
|
|
AA
|
|
A
|
|
BBB
|
|
BB
|
|
Other
(1)
|
|
Total
|
|
||||||||||||||
Single-name credit default swaps
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||||||||
Credit default indices
|
|
|
|
|
|
|
|
|||||||||||||||||||||
Other credit risk related portfolio products
|
|
|
|
|
|
|
|
|||||||||||||||||||||
Credit-risk related options and swaptions
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
|||||||||||||||||||||
Total
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||||||||
|
Billions of yen
|
|||||||||||||||||||||||||||
|
March 31, 2020
|
|||||||||||||||||||||||||||
|
Maximum potential payout/Notional
|
|||||||||||||||||||||||||||
|
AAA
|
|
AA
|
|
A
|
|
BBB
|
|
BB
|
|
Other
(1)
|
|
Total
|
|
||||||||||||||
Single-name credit default swaps
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||||||||
Credit default indices
|
|
|
|
|
|
|
|
|||||||||||||||||||||
Other credit risk related portfolio products
|
|
|
|
|
|
|
|
|||||||||||||||||||||
Credit-risk related options and swaptions
|
—
|
—
|
—
|
—
|
|
—
|
|
|||||||||||||||||||||
Total
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||||||||
(1) | “Other” includes credit derivatives where the credit rating of the underlying reference asset is below investment grade or where a rating is unavailable. |
|
Millions of yen
|
|||||||
|
Year ended March 31
|
|||||||
|
2019
|
|
2020
|
|
||||
Commissions
|
¥ |
|
¥ |
|
||||
Fees from investment banking
|
|
|
||||||
Asset management and portfolio service fees
|
|
|
||||||
Other revenue
|
|
|
||||||
Total
|
¥ |
|
¥ |
|
||||
Type of service provided to
customers
|
|
Overview of key services provided
|
|
Key revenue recognition policies,
assumptions and
significant judgments
|
Trade execution and clearing services
|
|
•
Buying and selling of securities on behalf of customers
•
Clearing of securities and derivatives on behalf of customers
|
|
•
Execution and clearing commissions recognized at a point in time, namely trade date.
•
Commissions recognized net of soft dollar credits provided to customers where Nomura is acting as agent in providing investment research and similar services to the customer.
|
|
|
|
|
|
Financial advisory services
|
|
•
Provision of financial advice to customers in connection with a specific forecasted transaction or transactions
•
Provision of financial advice not in connection with a specific forecasted transaction or transactions such as general corporate intelligence and similar research
•
Issuance of fairness opinions
•
Structuring complex financial instruments for customers
|
|
•
Fees contingent on the success of an underlying transaction are variable consideration recognized when the underlying transaction has been completed since only at such point is it probable that a significant reversal of revenue will not occur.
•
Retainer and milestone fees are recognized either over the period to which they relate or are deferred until consummation of the underlying transaction depending on whether the underlying performance obligation is satisfied at a point in time or over time.
•
Judgment is required to make this determination with factors influencing this determination including, but not limited to, whether the fee is in connection with an engagement designed to
|
Type of service provided to
customers
|
Overview of key services provided
|
Key revenue recognition policies,
assumptions and
significant judgments
|
||
|
|
achieve a specific transaction or outcome for the customer (such as the purchase or sale of a business), the nature and extent of benefit to be provided to the customer prior to, and in addition to such specific transaction or outcome and the fee structure for the engagement.
•
Retainer and milestone fees recognized over time are normally recognized on a straight-line basis over the term of the contract based on time elapsed.
|
||
Asset management services
|
•
Management of funds, investment trusts and other investment vehicles
•
Provision of investment advisory services
•
Distribution of fund units
•
Providing custodial and administrative services to customers
|
•
Management fees earned by Nomura in connection with managing a fund, investment trust or other vehicle generally recognized on a straight-line basis based on time elapsed.
•
Performance-based fees are variable consideration recognized when the performance metric has been determined since only at such point is it probable that a significant reversal of revenue will not occur.
•
Distribution fees are recognized at a point in time when the fund units have been sold to third party investors.
•
Custodial and administrative fees recognized on a straight-line basis over time based on time elapsed.
|
Type of service provided to
customers
|
|
Overview of key services provided
|
|
Key revenue recognition policies,
assumptions and
significant judgments
|
|
|
|
|
|
Underwriting and syndication services
|
|
•
Underwriting of debt, equity and other financial instruments on behalf of customers
•
Distributing securities on behalf of issuers
•
Arranging loan financing for customers
•
Syndicating loan financing on behalf of customers
|
|
•
Underwriting and syndication revenues recognized at a point in time when the underlying transaction is complete.
•
Commitment fees where drawn down of the facility is deemed remote recognized on a straight-line basis over the life of the facility based on time elapsed.
•
Underwriting and syndication costs recognized either as a reduction of revenue or on a gross basis depending on whether Nomura is acting as principal or agent for such amounts.
|
|
Millions of yen
|
|||||||
|
March 31, 2019
|
|
March 31, 2020
|
|
||||
Customer contract receivables
|
¥ |
|
¥ |
|
||||
Contract liabilities
(1)
|
|
|
(1) | Contract liabilities primarily rise from investment advisory services and recognized in connection with the term of the contract based on time elapsed. |
|
Billions of yen
|
|||||||||||||||
|
March 31, 2019
|
|||||||||||||||
|
Assets
|
Liabilities
|
||||||||||||||
|
Reverse
repurchase
agreements
|
|
Securities
borrowing
transactions
|
|
Repurchase
agreements
|
|
Securities
lending
transactions
|
|
||||||||
Total gross balance
(1)
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||
Less: Amounts offset in the consolidated balance sheets
(2)
|
(
|
) |
|
(
|
) |
|
||||||||||
Total net amounts of reported on the face of the consolidated balance sheets
(3)
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||
Less: Additional amounts not offset in the consolidated balance sheets
(4)
|
|
|
|
|
||||||||||||
Financial instruments and
non-cash
collateral
|
(
|
) |
(
|
) |
(
|
) |
(
|
) | ||||||||
Cash collateral
|
(
|
) |
|
|
|
|||||||||||
Net amount
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||
|
Billions of yen
|
|||||||||||||||
|
March 31, 2020
|
|||||||||||||||
|
Assets
|
Liabilities
|
||||||||||||||
|
Reverse
repurchase
agreements
|
|
Securities
borrowing
transactions
|
|
Repurchase
agreements
|
|
Securities
lending
transactions
|
|
||||||||
Total gross balance
(1)
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||
Less: Amounts offset in the consolidated balance sheets
(2)
|
(
|
) |
|
(
|
) |
|
||||||||||
Total net amounts of reported on the face of the consolidated balance sheets
(3)
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||
Less: Additional amounts not offset in the consolidated balance sheets
(4)
|
|
|
|
|
||||||||||||
Financial instruments and
non-cash
collateral
|
(
|
) |
(
|
) |
(
|
) |
(
|
) | ||||||||
Cash collateral
|
(
|
) |
|
(
|
) |
|
||||||||||
Net amount
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||
(1) |
Includes all recognized balances irrespective of whether they are transacted under a master netting agreement or whether Nomura has obtained sufficient evidence of enforceability of the master netting agreement. Amounts include transactions carried at fair value through election of the fair value option. As of March 31, 2019, the gross balance of reverse repurchase agreements and repurchase agreements which were not transacted under master netting agreements or are documented under master netting agreements for which Nomura has not yet obtained sufficient evidence of enforceability was ¥
|
|
reverse repurchase agreements and repurchase agreements which were not transacted under master netting agreements or are documented under master netting agreements for which Nomura has not yet obtained sufficient evidence of enforceability was ¥
|
(2) |
Represents amounts offset through counterparty netting under master netting and similar agreements for which Nomura has obtained sufficient evidence of enforceability in accordance with ASC
210-20.
Amounts offset include transactions carried at fair value through election of the fair value option.
|
(3) |
Reverse repurchase agreements and securities borrowing transactions are reported within
Collateralized agreements—Securities purchased under agreements to resell
Collateralized agreements—Securities borrowed
Collateralized financing—Securities sold under agreements to repurchase
Collateralized financing—Securities loaned
Other liabilities
|
(4) |
Represents amounts which are not permitted to be offset on the face of the balance sheet in accordance with ASC 210-20 but which provide Nomura with the right of offset in the event of counterparty default. Amounts relating to agreements where Nomura has not yet obtained sufficient evidence of enforceability of such offsetting rights are excluded.
|
|
Billions of yen
|
|||||||||||||||||||||||
|
March 31, 2020
|
|||||||||||||||||||||||
|
Overnight
and open
(1)
|
|
Up to
30 days
|
|
30 - 90
days
|
|
90 days
-
1 year |
|
Greater
than 1 year
|
|
Total
|
|
||||||||||||
Repurchase agreements
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||||||
Securities lending transactions
|
|
|
|
|
|
|
||||||||||||||||||
Total gross recognized liabilities
(2)
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||||||
(1) | Open transactions do not have an explicit contractual maturity date and are terminable on demand by Nomura or the counterparty. |
(2) |
Repurchase agreements and securities lending transactions are reported within
Collateralized financing—Securities sold under agreements to repurchase
Collateralized financing—Securities loaned
Other liabilities
|
|
Billions of yen
|
|||||||||||
|
March 31, 2020
|
|||||||||||
|
Repurchase
agreements
|
|
Securities
lending
transactions
|
|
Total
|
|
||||||
Equities and convertible securities
|
¥ |
|
¥ |
|
¥ |
|
||||||
Japanese government, agency and municipal securities
|
|
|
|
|||||||||
Foreign government, agency and municipal securities
|
|
|
|
|||||||||
Bank and corporate debt securities
|
|
|
|
|||||||||
Commercial mortgage-backed securities (“CMBS”)
|
|
|
|
|||||||||
Residential mortgage-backed securities (“RMBS”)
(1)
|
|
|
|
|||||||||
Collateralized debt obligations (“CDOs”) and other
|
|
|
|
|||||||||
Investment trust funds and other
|
|
|
|
|||||||||
Total gross recognized liabilities
(2)
|
¥ |
|
¥ |
|
¥ |
|
||||||
(1) |
Includes ¥
|
(2) |
Repurchase agreements and securities lending transactions are reported within
Collateralized financing—Securities sold under agreements to repurchase
Collateralized financing—Securities loaned
Other liabilities
|
|
Billions of yen
|
|||||||
|
March 31
|
|||||||
|
2019
|
|
2020
|
|
||||
The fair value of securities received as collateral, securities borrowed as collateral and securities borrowed without collateral where Nomura is permitted by contract or custom to sell or repledge the securities
|
¥ |
|
¥ |
|
||||
The portion of the above that has been sold (reported within
Trading liabilities
|
|
|
|
Millions of yen
|
|||||||
|
March 31
|
|||||||
|
2019
|
|
2020
|
|
||||
Trading assets:
|
|
|
||||||
Equities and convertible securities
|
¥ |
|
¥ |
|
||||
Government and government agency securities
|
|
|
||||||
Bank and corporate debt securities
|
|
|
||||||
Commercial mortgage-backed securities (“CMBS”)
|
|
|
||||||
Residential mortgage-backed securities (“RMBS”)
|
|
|
||||||
Collateralized debt obligations (“CDOs”) and other
(1)
|
|
|
||||||
Investment trust funds and other
|
|
|
||||||
|
¥ |
|
¥ |
|
||||
Non-trading
debt securities
|
|
|
||||||
Investments in and advances to affiliated companies
|
¥ |
|
¥ |
|
(1) | Includes CLOs and ABS such as those secured on credit card loans, auto loans and student loans. |
|
Millions of yen
|
|||||||
|
March 31
|
|||||||
|
2019
|
|
2020
|
|
||||
Loans and receivables
|
¥ |
|
¥ |
|
||||
Trading assets and private equity
and debt investments
|
|
|
||||||
Office buildings, land, equipment and facilities
|
|
|
||||||
Non-trading
debt securities
|
|
|
||||||
Other
|
|
|
||||||
|
¥ |
|
¥ |
|
||||
|
Billions of yen
|
|||||||||||||||||||||||
|
March 31, 2019
|
|||||||||||||||||||||||
|
Level 1
|
|
Level 2
|
|
Level 3
|
|
Total
|
|
Investment
grade
|
|
Other
|
|
||||||||||||
Government, agency and municipal securities
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||||||
Bank and corporate debt securities
|
|
|
|
|
|
|
||||||||||||||||||
CMBS and RMBS
|
|
|
|
|
|
|
||||||||||||||||||
Total
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||||||
|
Billions of yen
|
|||||||||||||||||||||||
|
March 31, 2020
|
|||||||||||||||||||||||
|
Level 1
|
|
Level 2
|
|
Level 3
|
|
Total
|
|
Investment
grade
|
|
Other
|
|
||||||||||||
Government, agency and municipal securities
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||||||
Bank and corporate debt securities
|
|
|
|
|
|
|
||||||||||||||||||
CMBS and RMBS
|
|
|
|
|
|
|
||||||||||||||||||
Total
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||||||
|
Billions of yen
|
|||||||
|
March 31
|
|||||||
|
2019
|
|
2020
|
|
||||
Assets
|
|
|
||||||
Trading assets
|
|
|
||||||
Loans
|
¥ |
|
¥ |
|
||||
Liabilities
|
|
|
||||||
Long-term borrowings
|
¥ |
|
¥ |
|
||||
|
Billions of yen
|
|||||||
|
March 31
|
|||||||
|
2019
|
|
2020
|
|
||||
Consolidated VIE assets
|
|
|
||||||
Cash and cash equivalents
|
¥ |
|
¥ |
|
||||
Trading assets
|
|
|
||||||
Equities
|
|
|
||||||
Debt securities
|
|
|
||||||
CMBS and RMBS
|
|
|
||||||
Investment trust funds and other
|
|
|
||||||
Derivatives
|
|
|
||||||
Private equity and debt investments
|
|
|
||||||
Office buildings, land, equipment and facilities
|
|
|
||||||
Other
|
|
|
||||||
Total
|
¥ |
|
¥ |
|
||||
Consolidated VIE liabilities
|
|
|
||||||
Trading liabilities
|
|
|
||||||
Derivatives
|
|
|
||||||
Borrowings
|
|
|
||||||
Short-term borrowings
|
|
|
||||||
Long-term borrowings
|
|
|
||||||
Other
|
|
|
||||||
Total
|
¥ |
|
¥ |
|
||||
|
Billions of yen
|
|||||||||||
|
March 31, 2019
|
|||||||||||
|
Carrying amount of variable interests
|
Maximum exposure
to loss to
unconsolidated VIEs
|
|
|||||||||
|
Assets
|
|
Liabilities
|
|
||||||||
Trading assets and liabilities
|
|
|
|
|||||||||
Equities
|
¥ |
|
¥ |
|
¥ |
|
||||||
Debt securities
|
|
|
|
|||||||||
CMBS and RMBS
|
|
|
|
|||||||||
Investment trust funds and other
|
|
|
|
|||||||||
Private equity and debt investments
|
|
|
|
|||||||||
Loans
|
|
|
|
|||||||||
Other
|
|
|
|
|||||||||
Commitments to extend credit and other guarantees
|
|
|
|
|||||||||
Total
|
¥ |
|
¥ |
|
¥ |
|
||||||
|
Billions of yen
|
|||||||||||
|
March 31, 2020
|
|||||||||||
|
Carrying amount of variable interests
|
Maximum exposure
to loss to
unconsolidated VIEs
|
|
|||||||||
|
Assets
|
|
Liabilities
|
|
||||||||
Trading assets and liabilities
|
|
|
|
|||||||||
Equities
|
¥ |
|
¥ |
|
¥ |
|
||||||
Debt securities
|
|
|
|
|||||||||
CMBS and RMBS
|
|
|
|
|||||||||
Investment trust funds and other
|
|
|
|
|||||||||
Private equity and debt investments
|
|
|
|
|||||||||
Loans
|
|
|
|
|||||||||
Other
|
|
|
|
|||||||||
Commitments to extend credit and other guarantees
|
|
|
|
|||||||||
Total
|
¥ |
|
¥ |
|
¥ |
|
||||||
|
Millions of yen
|
|||||||||||
|
March 31, 2019
|
|||||||||||
|
Carried at
amortized cost
|
|
Carried at
fair value
(1)
|
|
Total
|
|
||||||
Loans receivable
|
|
|
|
|||||||||
Loans at banks
|
¥ |
|
¥ |
|
¥ |
|
||||||
Short-term secured margin loans
|
|
|
|
|||||||||
Inter-bank money market loans
|
|
|
|
|||||||||
Corporate loans
|
|
|
|
|||||||||
Total loans receivable
|
¥ |
|
¥ |
|
¥ |
|
||||||
Total
|
¥ |
|
¥ |
|
¥ |
|
||||||
|
Millions of yen
|
|||||||||||
|
March 31, 2020
|
|||||||||||
|
Carried at
amortized cost
|
|
Carried at
fair value
(1)
|
|
Total
|
|
||||||
Loans receivable
|
|
|
|
|||||||||
Loans at banks
|
¥ |
|
¥ |
|
¥ |
|
||||||
Short-term secured margin loans
|
|
|
|
|||||||||
Inter-bank money market loans
|
|
|
|
|||||||||
Corporate loans
|
|
|
|
|||||||||
Total loans receivable
|
¥ |
|
¥ |
|
¥ |
|
||||||
Total
|
¥ |
|
¥ |
|
¥ |
|
||||||
(1) | Includes loans receivable and loan commitments carried at fair value through election of the fair value option. |
• | A specific component for loans which have been individually evaluated for impairment; and |
• | A general component for loans which, while not individually evaluated for impairment, have been collectively evaluated for impairment based on historical loss experience. |
|
Millions of yen
|
|||||||||||||||||||||||
|
Year ended March 31, 2018
|
|||||||||||||||||||||||
|
Allowance for credit losses against loans
|
Allowance
for credit
losses
against
receivables
other than
loans
|
|
Total
allowance
for doubtful
accounts
|
|
|||||||||||||||||||
|
Loans
at banks
|
|
Short-term
secured
margin
loans
|
|
Corporate
loans
|
|
Subtotal
|
|
||||||||||||||||
Opening balance
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||||||
Provision for credit losses
|
|
|
(
|
) |
|
|
|
|||||||||||||||||
Charge-offs
|
|
|
|
|
|
|
||||||||||||||||||
Other
(1)
|
|
|
(
|
) |
(
|
) |
(
|
) |
(
|
) | ||||||||||||||
Ending balance
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||||||
|
Millions of yen
|
|||||||||||||||||||||||
|
Year ended March 31, 2019
|
|||||||||||||||||||||||
|
Allowance for credit losses against loans
|
Allowance
for credit
losses
against
receivables
other than
loans
|
|
Total
allowance
for doubtful
accounts
|
|
|||||||||||||||||||
|
Loans
at banks
|
|
Short-term
secured
margin
loans
|
|
Corporate
loans
|
|
Subtotal
|
|
||||||||||||||||
Opening balance
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||||||
Provision for credit
|
|
|
|
|
|
|
||||||||||||||||||
losses
|
|
|
|
|
|
|
||||||||||||||||||
Charge-offs
|
(
|
) |
|
(
|
) |
(
|
) |
(
|
) |
(
|
) | |||||||||||||
Other
(1)
|
|
|
|
|
(
|
) |
|
|||||||||||||||||
Ending balance
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||||||
|
Millions of yen
|
|||||||||||||||||||||||
|
Year ended March 31, 2020
|
|||||||||||||||||||||||
|
Allowance for credit losses against loans
|
Allowance
for credit
losses
against
receivables
other than
loans
|
|
Total
allowance
for doubtful
accounts
|
|
|||||||||||||||||||
|
Loans
at banks
|
|
Short-term
secured
margin
loans
|
|
Corporate
loans
|
|
Subtotal
|
|
||||||||||||||||
Opening balance
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||||||
Provision for credit
|
|
|
|
|
|
|
||||||||||||||||||
losses
|
|
|
|
|
|
|
||||||||||||||||||
Charge-offs
|
|
|
|
|
(
|
) |
(
|
) | ||||||||||||||||
Other
(1)
|
|
(
|
) |
(
|
) |
(
|
) |
(
|
) |
(
|
) | |||||||||||||
Ending balance
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||||||
(1) | Includes the effect of foreign exchange movements. |
|
Millions of yen
|
|||||||||||||||||||
|
March 31, 2019
|
|||||||||||||||||||
|
Loans at
banks
|
|
Short-term
secured margin
loans
|
|
Inter-bank
money
market loans
|
|
Corporate
loans
|
|
Total
|
|
||||||||||
Allowance by impairment methodology
|
|
|
|
|
|
|||||||||||||||
Evaluated individually
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||||
Evaluated collectively
|
|
|
|
|
|
|||||||||||||||
Total allowance for credit losses
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||||
Loans by impairment methodology
|
|
|
|
|
|
|||||||||||||||
Evaluated individually
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||||
Evaluated collectively
|
|
|
|
|
|
|||||||||||||||
Total loans
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||||
|
Millions of yen
|
|||||||||||||||||||
|
March 31, 2020
|
|||||||||||||||||||
|
Loans at
banks
|
|
Short-term
secured margin
loans
|
|
Inter-bank
money
market loans
|
|
Corporate
loans
|
|
Total
|
|
||||||||||
Allowance by impairment methodology
|
|
|
|
|
|
|||||||||||||||
Evaluated individually
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||||
Evaluated collectively
|
|
|
|
|
|
|||||||||||||||
Total allowance for credit losses
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||||
Loans by impairment methodology
|
|
|
|
|
|
|||||||||||||||
Evaluated individually
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||||
Evaluated collectively
|
|
|
|
|
|
|||||||||||||||
Total loans
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||||
|
Millions of yen
|
|||||||||||||||||||
|
March 31, 2019
|
|||||||||||||||||||
|
AAA-BBB
|
|
BB-CCC
|
|
CC-D
|
|
Others
(1)
|
|
Total
|
|
||||||||||
Secured loans at banks
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||||
Unsecured loans at banks
|
|
|
|
—
|
|
|||||||||||||||
Short-term secured margin loans
|
|
|
|
|
|
|||||||||||||||
Unsecured inter-bank money market loans
|
|
|
|
—
|
|
|||||||||||||||
Secured corporate loans
|
|
|
|
|
|
|||||||||||||||
Unsecured corporate loans
|
|
|
|
|
|
|||||||||||||||
Total
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||||
|
Millions of yen
|
|||||||||||||||||||
|
March 31, 2020
|
|||||||||||||||||||
|
AAA-BBB
|
|
BB-CCC
|
|
CC-D
|
|
Others
(1)
|
|
Total
|
|
||||||||||
Secured loans at banks
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||||
Unsecured loans at banks
|
|
|
|
|
|
|||||||||||||||
Short-term secured margin loans
|
|
|
|
|
|
|||||||||||||||
Unsecured inter-bank money market loans
|
|
|
|
|
|
|||||||||||||||
Secured corporate loans
|
|
|
|
|
|
|||||||||||||||
Unsecured corporate loans
|
|
|
|
|
|
|||||||||||||||
Total
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||||
(1) | Relate to collateralized exposures where a specified ratio of LTV is maintained. |
Rating Range
|
|
Definition
|
AAA
|
|
Highest credit quality. An obligor or facility has extremely strong capacity to meet its financial commitments. ‘AAA range’ is the highest credit rating assigned by Nomura. Extremely low probability of default.
|
|
|
|
AA
|
|
Very high credit quality category. An obligor or facility has very strong capacity to meet its financial commitments. Very low probability of default but above that of ‘AAA range.’
|
|
|
|
A
|
|
High credit quality category. An obligor or facility has strong capacity to meet its financial commitments but is somewhat more susceptible to the adverse effects of changes in circumstances and economic conditions than those in higher-rated categories. Low probability of default but higher than that of ‘AA range.’
|
|
|
|
BBB
|
|
Good credit quality category. An obligor or facility has adequate capacity to meet its financial commitments. However, adverse economic conditions or changing circumstances are more likely to lead to a weakened capacity to meet its financial commitments. Medium probability of default but higher than that of ‘A range.’
|
|
|
|
BB
|
|
Speculative credit quality category. An obligor or facility is less vulnerable in the near term than other lower-ratings. However, it faces major ongoing uncertainties and exposure to adverse business, financial, or economic conditions which could lead to the inadequate capacity to meet its financial commitments. Medium to high probability of default but higher than that of ‘BBB range.’
|
|
|
|
B
|
|
Highly speculative credit quality category. An obligor or facility is more vulnerable than those rated ‘BB range’, but the obligor currently has the capacity to meet its financial commitments. Adverse business, financial, or economic conditions will likely impair the issuer’s or obligor’s capacity or willingness to meet its financial commitments. High probability of default—more than that of ‘BB range.’
|
|
|
|
CCC
|
|
Substantial credit risk. An obligor or facility is currently vulnerable, and is dependent upon favorable business, financial, and economic conditions to meet its financial commitments. Strong probability of default—more than that of ‘B range.’
|
|
|
|
CC
|
|
An obligor or facility is currently highly vulnerable to nonpayment (default category).
|
|
|
|
C
|
|
An obligor or facility is currently extremely vulnerable to nonpayment (default category).
|
|
|
|
D
|
|
Failure of an obligor to make payments in full and on time of any financial obligations, markedly disadvantageous modification to a contractual term compared with the existing obligation, bankruptcy filings, administration, receivership, liquidation or other
winding-up
or cessation of business of an obligor or other similar situations.
|
|
Millions of yen
|
|||||||||||||||||||||||
|
March 31
|
|||||||||||||||||||||||
|
2019
|
2020
|
||||||||||||||||||||||
|
Cost
|
|
Accumulated
depreciation
|
|
Net carrying
amount
|
|
Cost
|
|
Accumulated
depreciation
|
|
Net carrying
amount
|
|
||||||||||||
Real estate
(1)
|
¥ |
|
¥ |
(
|
) | ¥ |
|
¥ |
|
¥ |
(
|
) | ¥ |
|
||||||||||
Aircraft
|
|
(
|
) |
|
|
(
|
) |
|
||||||||||||||||
Total
|
¥ |
|
¥ |
(
|
) | ¥ |
|
¥ |
|
¥ |
(
|
) | ¥ |
|
||||||||||
(1) | Cost, accumulated depreciation and net carrying amounts include amounts relating to real estate utilized by Nomura. |
|
Millions of yen
|
|
||
March 31, 2020
|
|
|||
|
Minimum lease payments
to be received
|
|
||
Years of receipt
|
|
|||
Less than 1 year
|
¥ |
|
||
1 to 2 years
|
|
|||
2 to 3 years
|
|
|||
3 to 4 years
|
|
|||
4 to 5 years
|
|
|||
More than 5 years
|
|
|||
Total
|
¥ |
|
||
|
Millions of yen
|
|
||
|
Year ended
March 31, 2020
|
|
||
Lease expense:
|
|
|||
Operating lease
costs
|
¥ |
|
||
Other income and expenses:
|
|
|||
Gross sublease income
(1)
|
¥ |
|
(1) | Gross sublease income represents income from subleases separate from lease payments made by Nomura on the head lease as lessee. |
|
Millions of yen
|
|
||
|
Year ended
March 31, 2020
|
|
||
Operating cash
flows
for operating leases
|
¥ |
|
||
ROU assets recognized in connection with new operating leases
|
¥ |
|
|
Millions of yen
|
|
||
|
March 31, 2020
|
|
||
|
Operating leases
|
|
||
Years of payment
|
|
|
|
|
Less than 1 year
|
¥ |
|
||
1 to 2 years
|
|
|||
2 to 3 years
|
|
|||
3 to 4 years
|
|
|||
4 to 5 years
|
|
|||
More than 5 years
|
|
|||
Total undiscounted lease payments
|
¥ |
|
||
Less: Impact of discounting
|
(
|
) | ||
Lease liabilities as reported in the consolidated balance sheets
|
¥ |
|
||
|
March
31,
2020
|
|
||
|
Operati
ng leases
|
|
||
Weighted-average discount rate used to measure lease liabilities
|
|
|||
Weighted-average remaining lease term
|
|
|
Millions of yen
|
|||||||
|
March 31
|
|||||||
|
2019
|
|
2020
|
|
||||
Other assets—Other:
|
|
|
||||||
Securities received as collateral
|
¥ |
|
¥ |
|
||||
Goodwill and other intangible assets
|
|
|
||||||
Deferred tax assets
net
|
|
|
||||||
Investments in equity securities for other than operating purposes
(1)
|
|
|
||||||
Prepaid expenses
|
|
|
||||||
Other
|
|
|
||||||
Total
|
¥ |
|
¥ |
|
||||
Other liabilities:
|
|
|
||||||
Obligation to return securities received as collateral
|
¥ |
|
¥ |
|
||||
Accrued income taxes
|
|
|
||||||
Other accrued expenses and provisions
|
|
|
||||||
Other
(2)
|
|
|
||||||
Total
|
¥ |
|
¥ |
|
||||
(1) |
Includes marketable and
non-marketable
equity securities held for other than trading or operating purposes. These investments
comprise
of listed equity securities and unlisted equity securities of ¥
Revenue—Other
|
(2)
|
As a result of adopting ASU 2016-02 as of April 1, 2019, operating lease liabilities are presented through
Other liabilities—Other
|
|
Millions of yen
|
|||||||||||||||||||||||||||||||||||
|
Year ended March 31, 2019
|
|||||||||||||||||||||||||||||||||||
|
Beginning of year
|
Changes during year
|
End of year
|
|||||||||||||||||||||||||||||||||
|
Gross
carrying
amount
|
|
Accumulated
Impairment
|
|
Net
carrying
amount
|
|
Acquisition
|
|
Impairment
(2)
|
|
Other
(1)
|
|
Gross
carrying
amount
|
|
Accumulated
Impairment
|
|
Net
carrying
amount
|
|
||||||||||||||||||
Wholesale
|
¥ |
|
¥ |
(
|
) | ¥ |
|
¥ |
|
¥ |
(
|
) | ¥ |
|
¥ |
|
¥ |
(
|
) | ¥ |
|
|||||||||||||||
Other
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||
Total
|
¥ |
|
¥ |
(
|
) | ¥ |
|
¥ |
|
¥ |
(
|
) | ¥ |
|
¥ |
|
¥ |
(
|
) | ¥ |
|
|||||||||||||||
|
Millions of yen
|
|||||||||||||||||||||||||||||||||||
|
Year ended March 31, 2020
|
|||||||||||||||||||||||||||||||||||
|
Beginning of year
|
Changes during year
|
End of year
|
|||||||||||||||||||||||||||||||||
|
Gross
carrying
amount
|
|
Accumulated
Impairment
|
|
Net
carrying
amount
|
|
Acquisition
|
|
Impairment
|
|
Other
(1)
|
|
Gross
carrying
amount
|
|
Accumulated
Impairment
|
|
Net
carrying
amount
|
|
||||||||||||||||||
Wholesale
|
¥ |
|
¥ |
(
|
) | ¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
(
|
) | ¥ |
|
||||||||||||||||
Other
|
|
|
|
|
|
(
|
) |
|
|
|
||||||||||||||||||||||||||
Total
|
¥ |
|
¥ |
(
|
) | ¥ |
|
¥ |
|
¥ |
|
¥ |
(
|
) | ¥ |
|
¥ |
(
|
) | ¥ |
|
|||||||||||||||
(1) | Includes currency translation adjustments. |
(2) |
For the year ended March 31, 2019, Nomura recognized impairment losses on goodwill of ¥
Non-interest expense—Other
|
|
Millions of yen
|
|||||||||||||||||||||||
|
March 31, 2019
|
March 31, 2020
|
||||||||||||||||||||||
|
Gross
carrying
amount
|
|
Accumulated
amortization
|
|
Net carrying
amount
|
|
Gross
carrying
amount
|
|
Accumulated
amortization
|
|
Net carrying
amount
|
|
||||||||||||
Client relationships
|
¥ |
|
¥ |
(
|
) | ¥ |
|
¥ |
|
¥ |
(
|
) | ¥ |
|
||||||||||
Other
|
|
(
|
) |
|
|
(
|
) |
|
||||||||||||||||
Total
|
¥ |
|
¥ |
(
|
) | ¥ |
|
¥ |
|
¥ |
(
|
) | ¥ |
|
||||||||||
|
Millions of yen
|
|
||
Year ending March 31
|
Estimated
amortization expense
|
|
||
2021
|
¥ |
|
||
2022
|
|
|||
2023
|
|
|||
2024
|
|
|||
2025
|
|
|
Millions of yen
|
|||||||
|
March 31
|
|||||||
|
2019
|
|
2020
|
|
||||
Short-term borrowings
(1)
:
|
|
|
||||||
Commercial paper
|
¥ |
|
¥ |
|
||||
Bank borrowings
|
|
|
||||||
Other
|
|
|
||||||
Total
|
¥ |
|
¥ |
|
||||
Long-term borrowings:
|
|
|
||||||
Long-term borrowings from banks and other financial institutions
(2)
|
¥ |
|
¥ |
|
||||
Bonds and notes issued
(3)
:
|
|
|
||||||
Fixed-rate obligations:
|
|
|
||||||
Japanese yen denominated
|
|
|
||||||
Non-Japanese
yen denominated
|
|
|
||||||
Floating-rate obligations:
|
|
|
||||||
Japanese yen denominated
|
|
|
||||||
Non-Japanese
yen denominated
|
|
|
||||||
Index / Equity-linked obligations:
|
|
|
||||||
Japanese yen denominated
|
|
|
||||||
Non-Japanese
yen denominated
|
|
|
||||||
|
|
|
||||||
Subtotal
|
|
|
||||||
Trading balances of secured borrowings
|
|
|
||||||
Total
|
¥ |
|
¥ |
|
||||
(1) |
Includes secured borrowings of ¥
|
(2) |
Includes secured borrowings of ¥
|
(3) |
Includes secured borrowings of ¥
|
|
Millions of yen
|
|||||||
|
March 31
|
|||||||
|
2019
|
|
2020
|
|
||||
Debt issued by the Company
|
¥ |
|
¥ |
|
||||
Debt issued by subsidiaries—guaranteed by the Company
|
|
|
||||||
Debt issued by subsidiaries—not guaranteed by the Company
(1)
|
|
|
||||||
Total
|
¥ |
|
¥ |
|
||||
(1) | Includes trading balances of secured borrowings. |
|
March 31
|
|||||||
|
2019
|
|
2020
|
|
||||
Short-term borrowings
|
|
% |
|
% | ||||
Long-term borrowings
|
|
% |
|
% | ||||
Fixed-rate obligations
|
|
% |
|
% | ||||
Floating-rate obligations
|
|
% |
|
% | ||||
Index / Equity-linked obligations
|
|
% |
|
% |
Year ending March 31
|
Millions of yen
|
|
||
2021
|
¥ |
|
||
2022
|
|
|||
2023
|
|
|||
2024
|
|
|||
2025
|
|
|||
2026 and thereafter
|
|
|||
Subtotal
|
|
|||
Trading balances of secured borrowings
|
|
|||
Total
|
¥ |
|
||
|
Millions of yen
except per share data presented in yen
|
|||||||||||
|
Year ended March 31
|
|||||||||||
|
2018
|
|
2019
|
|
2020
|
|
||||||
Basic—
|
|
|
|
|||||||||
Net income (loss) attributable to NHI shareholders
|
¥ |
|
¥ |
(
|
) | ¥ |
|
|||||
Weighted average number of shares outstanding
|
|
|
|
|||||||||
Net income (loss) attributable to NHI shareholders per share
|
¥ |
|
¥ |
(
|
) | ¥ |
|
|||||
Diluted
—
|
|
|
|
|||||||||
Net income (loss) attributable to NHI shareholders
|
¥ |
|
¥ |
(
|
) | ¥ |
|
|||||
Weighted average number of shares outstanding
|
|
|
|
|||||||||
Net income (loss) attributable to NHI shareholders per share
|
¥ |
|
¥ |
(
|
) | ¥ |
|
|||||
|
Millions of yen
|
|||||||||||
|
Year ended March 31
|
|||||||||||
|
2018
|
|
2019
|
|
2020
|
|
||||||
Service cost
|
¥ |
|
¥ |
|
¥ |
|
||||||
Interest cost
|
|
|
|
|||||||||
Expected return on plan assets
|
(
|
) |
(
|
) |
(
|
) | ||||||
Amortization of net actuarial losses
|
|
|
|
|||||||||
Amortization of prior service cost
|
(
|
) |
(
|
) |
(
|
) | ||||||
Net periodic benefit cost
|
¥ |
|
¥ |
|
¥ |
|
||||||
|
Millions of yen
|
|||||||
|
As of or for the year
ended March 31 |
|||||||
|
2019
|
|
2020
|
|
||||
Change in projected benefit obligation:
|
|
|
|
|
|
|
||
Projected benefit obligation at beginning of year
|
¥ |
|
¥ |
|
||||
Service cost
|
|
|
||||||
Interest cost
|
|
|
||||||
Actuarial gain
|
|
(
|
) | |||||
Benefits paid
|
(
|
) |
(
|
) | ||||
Amendments of pension benefit plans
|
—
|
(
|
) | |||||
Acquisition, divestitures and other
|
|
|
||||||
Projected benefit obligation at end of year
|
¥ |
|
¥ |
|
||||
Change in plan assets:
|
|
|
|
|
|
|
||
Fair value of plan assets at beginning of year
|
¥ |
|
¥ |
|
||||
Actual return on plan assets
|
|
(
|
) | |||||
Employer contributions
|
|
|
||||||
Benefits paid
|
(
|
) |
(
|
) | ||||
Fair value of plan assets at end of year
|
¥ |
|
¥ |
|
||||
Funded status at end of year
|
(
|
) |
(
|
) | ||||
Amounts recognized in the consolidated balance sheets
|
¥ |
(
|
) | ¥ |
(
|
) | ||
|
Millions of yen
|
|||||||
|
March 31
|
|||||||
|
2019
|
|
2020
|
|
||||
Plans with ABO in excess of plan assets:
|
|
|
|
|
|
|
||
PBO
|
¥ |
|
¥ |
|
||||
ABO
|
|
|
||||||
Fair value of plan assets
|
|
|
||||||
Plans with PBO in excess of plan assets:
|
|
|
|
|
|
|
||
PBO
|
¥ |
|
¥ |
|
||||
ABO
|
|
|
||||||
Fair value of plan assets
|
|
|
|
Millions of yen
|
|
||
|
For the year ended
March 31, 2020
|
|
||
Net actuarial loss
|
¥ |
|
||
Net prior service cost
|
(
|
) | ||
Total
|
¥ |
|
||
|
Millions of yen
|
|
||
|
For the year ending
March 31, 2021
|
|
||
Net actuarial loss
|
¥ |
|
||
Net prior service cost
|
(
|
) | ||
Total
|
¥ |
|
||
|
March 31
|
|||||||
|
2019
|
|
2020
|
|
||||
Discount rate
|
|
% |
|
% | ||||
Rate of increase in compensation levels
|
|
% |
|
% |
|
Year ended March 31
|
|||||||||||
|
2018
|
|
2019
|
|
2020
|
|
||||||
Discount rate
|
|
% |
|
% |
|
% | ||||||
Rate of increase in compensation levels
|
|
% |
|
% |
|
% | ||||||
Expected long-term rate of return on plan assets
|
|
% |
|
% |
|
% |
|
Millions of yen
|
|||||||||||||||
|
March 31, 2019
|
|||||||||||||||
|
Level 1
|
|
Level 2
|
|
Level 3
|
|
Balance as of
March 31,
2019 |
|
||||||||
Pension plan assets:
|
|
|
|
|
||||||||||||
Equities
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||
Private equity and pooled investments
(1)
|
|
|
|
|
||||||||||||
Japanese government securities
|
|
|
|
|
||||||||||||
Foreign government, agency and municipal securities
|
|
|
|
|
||||||||||||
Bank and corporate debt securities
|
|
|
|
|
||||||||||||
Investment trust funds and other
(2)(3)
|
|
|
|
|
||||||||||||
Life insurance company general accounts
|
|
|
|
|
||||||||||||
Other assets
|
|
|
|
|
||||||||||||
Total
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||
|
Millions of yen
|
|||||||||||||||
|
March 31, 2020
|
|||||||||||||||
|
Level 1
|
|
Level 2
|
|
Level 3
|
|
Balance as of
March 31,
2020 |
|
||||||||
Pension plan assets:
|
|
|
|
|
||||||||||||
Equities
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||
Private equity and pooled investments
(1)
|
|
|
|
|
||||||||||||
Japanese government securities
|
|
|
|
|
||||||||||||
Foreign government, agency and municipal securities
|
|
|
|
|
||||||||||||
Bank and corporate debt securities
|
|
|
|
|
||||||||||||
Investment trust funds and other
(2)(3)
|
|
|
|
|
||||||||||||
Life insurance company general accounts
|
|
|
|
|
||||||||||||
Other assets
|
|
|
|
|
||||||||||||
Total
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||
(1)
|
Includes corporate type equity investments.
|
(2)
|
Includes mainly debt investment funds. Hedge funds and real estate funds are also included.
|
(
3
)
|
Certain assets that are measured at fair value using net asset value per share as a practical expedient have not been classified in the fair value hierarchy. As of March 31,
2019
and March 31,
2020
, the fair values of these assets were ¥
|
|
Millions of yen
|
|||||||||||||||
|
Year ended March 31, 2019
|
|
|
|||||||||||||
|
Balance
as of
April 1,
2018
|
|
Unrealized
and realized
gains / loss
|
|
Purchases /
sales and
other
settlement
|
|
Balance
as of
March 31,
2019
|
|
||||||||
Private equity and pooled investments
|
¥ |
|
¥ |
(
|
) | ¥ |
|
¥ |
|
|||||||
Investment trust funds and other
|
|
|
|
|
||||||||||||
Total
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||
|
Millions of yen
|
|||||||||||||||
|
Year ended March 31, 2020
|
|
|
|||||||||||||
|
Balance
as of
April 1,
2019
|
|
Unrealized
and realized
gains / loss
|
|
Purchases /
sales and
other
settlement
|
|
Balance
as of
March 31,
2020
|
|
||||||||
Private equity and pooled investments
|
¥ |
|
¥ |
(
|
) | ¥ |
|
¥ |
|
|||||||
Investment trust funds and other
|
|
(
|
) |
(
|
) |
|
||||||||||
Total
|
¥ |
|
¥ |
(
|
) | ¥ |
|
¥ |
|
|||||||
Year ending March 31
|
Millions of yen
|
|
||
2021
|
¥ |
|
||
2022
|
|
|||
2023
|
|
|||
2024
|
|
|||
2025
|
|
|||
2026-2030
|
|
|
Outstanding
(number of Nomura
shares)
|
|
Weighted-average
grant date fair
value per share
|
|
Weighted-average
remaining life
until expiry
(years)
|
|
||||||
Outstanding as of March 31, 2019
|
|
¥ |
|
|
||||||||
Granted
|
|
|
|
|||||||||
Forfeited
|
(
|
) |
|
|
||||||||
Delivered
|
(
|
) |
|
|
||||||||
Outstanding as of March 31, 2020
|
|
¥ |
|
|
||||||||
• | Expected volatilities based on historical volatility of the Company’s common stock; |
• | Expected dividend yield based on the current dividend rate at the time of grant; |
• | Expected lives of the awards determined based on historical experience; and |
|
•
|
Expected risk-free interest rate based on Japanese Yen swap rate with a maturity equal to the expected lives of the options.
|
|
Year ended March 31
|
|||||||||||
|
2018
|
|
2019
|
|
2020
|
|
||||||
Expected volatility
|
|
% |
|
% |
|
% | ||||||
Expected dividends yield
|
|
% |
|
% |
|
% | ||||||
Expected lives (in years)
|
|
|
|
|||||||||
Risk-free interest rate
|
|
% |
|
% |
|
% |
|
Outstanding
(number of Nomura
shares)
|
|
Weighted-average
exercise price
|
|
Weighted-average
remaining life
until expiry
(years)
|
|
||||||
Outstanding as of March 31, 2019
|
|
¥ |
|
|
||||||||
Granted
|
|
|
|
|||||||||
Exercised
|
(
|
) |
|
|
||||||||
Forfeited
|
(
|
) |
|
|
||||||||
Expired
|
(
|
) |
|
|
||||||||
Outstanding as of March 31, 2020
|
|
¥ |
|
|
||||||||
Exercisable as of March 31, 2020
|
|
¥ |
|
|
||||||||
|
Outstanding
(number of Nomura
shares)
|
|
Weighted-average
grant date fair
value per share
|
|
Weighted-average
remaining life
until expiry
(years)
|
|
||||||
Outstanding as of March 31, 2019
|
|
¥ |
|
|
||||||||
Granted
|
|
|
|
|||||||||
Exercised
|
(
|
) |
|
|
||||||||
Forfeited
|
(
|
) |
|
|
||||||||
Expired
|
(
|
) |
|
|
||||||||
Outstanding as of March 31, 2020
|
|
¥ |
|
|
||||||||
Exercisable as of March 31, 2020
|
|
¥ |
|
|
||||||||
|
NSUs
|
CSUs
|
||||||||||||||
|
Outstanding
(number of units)
|
|
Stock
price
|
|
Outstanding
(number of units)
|
|
Stock
price
|
|
||||||||
Outstanding as of March 31, 2019
|
|
¥ |
|
|
¥ |
|
||||||||||
Granted
|
|
|
(1)
|
|
|
|||||||||||
Vested
|
(
|
) |
|
(2)
|
(
|
) |
|
(2)
|
||||||||
Forfeited
|
(
|
) |
|
(
|
) |
|
||||||||||
Outstanding as of March 31, 2020
|
|
¥ |
|
(3)
|
|
¥ |
|
(3)
|
||||||||
(1) | Weighted-average price of the Company’s common stock used to determine number of awards granted. |
(2) | Weighted-average price of the Company’s common stock used to determine the final cash settlement amount of the awards. |
(3) | The price of the Company’s common stock used to remeasure the fair value of the remaining outstanding unvested awards as of March 31, 2020. |
|
Outstanding
(number of units)
|
|
Index price
(1)
|
|
||||
Outstanding as of March 31, 2019
|
|
$ |
|
|||||
Granted
|
|
|
||||||
Vested
|
(
|
) |
|
(2)
|
||||
Forfeited
|
(
|
) |
|
|||||
Outstanding as of March 31, 2020
|
|
$ |
|
(3)
|
||||
(1) | The price of each unit is determined using 1/1000 th of the index price. |
(2) | Weighted-average index price used to determine the final cash settlement amount of the awards. |
(3) | Index price used to remeasure the total fair value of the remaining outstanding unvested awards as of March 31, 2020. |
|
Millions of yen
|
|||||||||||
|
Year ended March 31
|
|||||||||||
|
2018
|
|
2019
|
|
2020
|
|
||||||
Current:
|
|
|
|
|||||||||
Domestic
|
¥ |
|
¥ |
|
¥ |
|
||||||
Foreign
|
|
|
|
|||||||||
Subtotal
|
|
|
|
|||||||||
Deferred:
|
|
|
|
|||||||||
Domestic
|
|
|
(
|
) | ||||||||
Foreign
|
(
|
) |
(
|
) |
(
|
) | ||||||
Subtotal
|
|
|
(
|
) | ||||||||
Total
|
¥ |
|
¥ |
|
¥ |
|
||||||
|
Year ended March 31
|
|||||||||||
|
2018
|
|
2019
|
|
2020
|
|
||||||
Nomura’s effective statutory tax rate
|
|
% |
|
% |
|
% | ||||||
Impact of:
|
|
|
|
|||||||||
Changes in deferred tax valuation allowances
|
(
|
) |
(
|
) |
(
|
) | ||||||
Additional taxable income
|
|
(
|
) |
|
||||||||
Non-deductible
expenses
(1)
|
|
(
|
) |
|
||||||||
Non-taxable
income
(2)
|
(
|
) |
|
(
|
) | |||||||
Dividends from foreign subsidiaries
|
|
|
|
|||||||||
Tax effect of undistributed earnings of foreign subsidiaries
|
|
(
|
) |
|
||||||||
Different tax rate applicable to income (loss) of foreign subsidiaries
|
|
(
|
) |
(
|
) | |||||||
Effect of changes in foreign tax laws
|
|
|
(
|
) | ||||||||
Effect of changes in domestic tax laws
|
|
|
|
|||||||||
Tax benefit recognized on the devaluation of investment in subsidiaries and affiliates
|
|
|
(
|
) | ||||||||
Other
|
(
|
) |
(
|
) |
|
|||||||
Effective tax rate
|
|
% |
(
|
)% |
|
% | ||||||
(1) |
Non-deductible expenses
|
(2) |
Non-taxable income
during the year ended March 31, 2020 includes approximately
¥
billion of the tax effect from non-taxable dividend income from affiliated Nomura companies, including deemed dividend, (which decreased Nomura’s effective tax rate by
)
.
|
|
Millions of yen
|
|||||||
|
March 31
|
|||||||
|
2019
|
|
2020
|
|
||||
Deferred tax assets
|
|
|
|
|
|
|
||
Depreciation, amortization and valuation of fixed assets
|
¥ |
|
¥ |
|
||||
Investments in subsidiaries and affiliates
|
|
|
||||||
Valuation of financial instruments
|
|
|
||||||
Accrued pension and severance costs
|
|
|
||||||
Other accrued expenses and provisions
|
|
|
||||||
Operating losses
|
|
|
||||||
Lease liabilities
|
—
|
|
||||||
Other
|
|
|
||||||
Gross deferred tax assets
|
|
|
||||||
Less
—
|
(
|
) |
(
|
) | ||||
Total deferred tax assets
|
|
|
||||||
Deferred tax liabilities
|
|
|
|
|
|
|
||
Investments in subsidiaries and affiliates
|
|
|
||||||
Valuation of financial instruments
|
|
|
||||||
Undistributed earnings of foreign subsidiaries
|
|
|
||||||
Valuation of fixed assets
|
|
|
||||||
Right-of-use
assets
|
—
|
|
||||||
Other
|
|
|
||||||
Total deferred tax liabilities
|
|
|
||||||
Net deferred tax assets (liabilities)
|
¥ |
(
|
) | ¥ |
(
|
) | ||
|
Millions of yen
|
|||||||||||
|
Year ended March 31
|
|||||||||||
|
2018
|
|
2019
|
|
2020
|
|
||||||
Balance at beginning of year
|
¥ |
|
¥ |
|
¥ |
|
||||||
Net change during the year
|
(
|
)
(1)
|
|
(2)
|
(
|
)
(3)
|
||||||
Balance at end of year
|
¥ |
|
¥ |
|
¥ |
|
||||||
(1) |
Primarily includes a reduction of ¥
|
(2) |
Primarily includes an increase of ¥
|
(3) |
Primarily includes a reduction of ¥
expiration
of loss carryforwards, an increase of ¥
and
a
r
eduction of ¥
million
related to Japanese subsidiaries and the Company mainly by utilization of loss carryforwards. In total, ¥
|
Jurisdiction
|
Year
|
|
||
Japan
|
|
(1)
|
||
United Kingdom
|
|
|||
United States
|
|
(1) |
The earliest year in which Nomura remains subject to examination for transfer pricing issues is
2014
.
|
|
Millions of yen
|
|||||||||||||||||||
|
For the year ended March 31, 2019
|
|||||||||||||||||||
|
Balance at
beginning
of year
|
|
Other
comprehensive
income (loss)
before
reclassifications
|
|
Reclassifications out of
accumulated other
comprehensive
income (loss)
|
|
Net change
during the
year
|
|
Balance at
end of year
|
|
||||||||||
Cumulative translation adjustments
(1)
|
¥ |
(
|
) | ¥ |
|
¥ |
|
¥ |
|
¥ |
|
|||||||||
Pension liability adjustment
(2)
|
(
|
) |
(
|
) |
|
(
|
) |
(
|
) | |||||||||||
Own credit adjustments
|
|
|
(
|
) |
|
|
||||||||||||||
Total
|
¥ |
(
|
) | ¥ |
|
¥ |
|
¥ |
|
¥ |
(
|
) | ||||||||
(1) |
Change in cumulative translation adjustments, net of tax in other comprehensive income (loss) for the year ended March 31, 2019 includes reclassification adjustment of ¥
million for loss due to substantially complete liquidation of an investment in a foreign entity. The adjustment is recognized in
Non-interest expenses-Other
.
|
(2)
|
See Note 13 “
Employee benefit plans
|
|
Millions of yen
|
|||||||||||||||||||
|
For the year ended March 31, 2020
|
|||||||||||||||||||
|
Balance at
beginning
of year
|
|
Other
comprehensive
income (loss)
before
reclassifications
|
|
Reclassifications out of
accumulated other
comprehensive
income (loss)
|
|
Net change
during the
year
|
|
Balance at
end of year
|
|
||||||||||
Cumulative translation adjustments
|
¥ |
|
¥ |
(
|
) | ¥ |
|
¥ |
(
|
) | ¥ |
(
|
) | |||||||
Pension liability adjustment
(1)
|
(
|
) |
|
|
|
(
|
) | |||||||||||||
Own credit adjustments
|
|
|
(
|
) |
|
|
||||||||||||||
Total
|
¥ |
(
|
) | ¥ |
(
|
) | ¥ |
|
¥ |
|
¥ |
(
|
) | |||||||
(1) |
See Note 13 “
Employee benefit plans
” for further information.
|
|
Millions of yen
|
|||||||||
|
For the year ended March 31
|
|||||||||
|
2019
|
|
2020
|
|
Affected line items in consolidated
statements of income
|
|||||
|
Reclassifications out of
accumulated other
comprehensive income (loss)
|
|
Reclassifications out of
accumulated other
comprehensive income (loss)
|
|
||||||
Cumulative translation adjustments:
|
|
|
|
|||||||
|
¥ |
(
|
) | ¥ |
(
|
) |
Revenue
—
Non-interest
expenses
—
|
|||
|
|
|
Income tax expense
|
|||||||
|
(
|
) |
(
|
) |
Net income (loss)
|
|||||
|
|
|
Net income attributable to noncontrolling interests
|
|||||||
|
¥ |
(
|
) | ¥ |
(
|
) |
Net income (loss) attributable to NHI shareholders
|
|||
|
Millions of yen
|
|||||||||
|
For the year ended March 31
|
|||||||||
|
2019
|
|
2020
|
|
Affected line items in consolidated
statements of income |
|||||
|
Reclassifications out of
accumulated other
comprehensive income (loss)
|
|
Reclassifications out of
accumulated other
comprehensive income (loss)
|
|
||||||
Pension liability adjustment:
|
|
|
|
|||||||
|
¥ |
(
|
) | ¥ |
(
|
) |
Non-interest
expenses
—
and benefits
/
Revenue—Other
|
|||
|
|
|
Income tax expense
|
|||||||
|
(
|
) |
(
|
) |
Net income (loss)
|
|||||
|
|
|
Net income attributable to noncontrolling interests
|
|||||||
|
¥ |
(
|
) | ¥ |
(
|
) |
Net income (loss)
attributable to NHI shareholders |
|||
|
Millions of yen
|
|||||||||
|
For the year ended March 31
|
|||||||||
|
2019
|
|
2020
|
|
Affected line items in consolidated
statements of income |
|||||
|
Reclassifications out of
accumulated other
comprehensive income (loss)
|
|
Reclassifications out of
accumulated other
comprehensive income (loss)
|
|
||||||
Own credit adjustments:
|
|
|
|
|||||||
|
¥ |
|
¥ |
|
Revenue
—
|
|||||
|
(
|
) |
(
|
) |
Income tax expense
|
|||||
|
|
|
Net income (loss)
|
|||||||
|
|
|
Net income attributable to noncontrolling interests
|
|||||||
|
¥ |
|
¥ |
|
Net income (loss) attributable to NHI shareholders
|
|||||
|
Number of Shares
|
|||||||||||
|
Year ended March 31
|
|||||||||||
|
2018
|
|
2019
|
|
2020
|
|
||||||
Common stock outstanding at beginning of year
|
|
|
|
|||||||||
Decrease of common stock by cancellation of treasury stock
|
(
|
) |
(
|
) |
—
|
|||||||
Common stock held in treasury:
|
|
|
|
|||||||||
Repurchases of common stock
|
(
|
) |
(
|
) |
(
|
) | ||||||
Sales of common stock
|
|
|
|
|||||||||
Common stock issued to employees
|
|
|
|
|||||||||
Cancellation of treasury stock
|
|
|
—
|
|||||||||
Other net change in treasury stock
|
|
(
|
) |
—
|
||||||||
Common stock outstanding at end of year
|
|
|
|
|||||||||
|
Millions of yen
|
|||||||
|
March 31
|
|||||||
|
2019
|
|
2020
|
|
||||
Total assets
|
¥ |
|
¥ |
|
||||
Total liabilities
|
|
|
|
Millions of yen
|
|||||||||||
|
Year ended March 31
|
|||||||||||
|
2018
(1)
|
|
2019
|
|
2020
|
|
||||||
Net revenues
|
¥ |
|
¥ |
|
¥ |
|
||||||
Non-interest
expenses
|
|
|
|
|||||||||
Net income attributable to the companies
|
|
|
|
(1) | For JAFCO, financial information while it was an affiliated company of Nomura is included. |
|
Millions of yen
|
|||||||
|
March 31
|
|||||||
|
2019
|
|
2020
|
|
||||
Investments in affiliated companies
|
¥ |
|
¥ |
|
||||
Other receivables from affiliated companies
(1)
|
|
|
||||||
Other payables to affiliated companies
(1)
|
|
|
(1)
|
As a result of adopting ASU 2016-02 as of April 1, 2019, ROU
assets
and operating lease liabilities are included by ¥
|
|
Millions of yen
|
|||||||||||
|
Year ended March 31
|
|||||||||||
|
2018
|
|
2019
|
|
2020
|
|
||||||
Revenues
|
¥ |
|
¥ |
|
¥ |
|
||||||
Non-interest
expenses
|
|
|
|
|||||||||
Purchase of software, securities and tangible assets
|
|
|
|
|
Millions of yen
|
|||||||
|
March 31
|
|||||||
|
2019
|
|
2020
|
|
||||
Carrying amount
|
¥ |
|
¥ |
|
||||
Fair value
|
|
|
|
Millions of yen
|
|||||||||||
|
Year ended March 31
|
|||||||||||
|
2018
|
|
2019
|
|
2020
|
|
||||||
Equity in earnings of equity-method investees
(1)
|
¥ |
|
¥ |
|
¥ |
|
||||||
Dividends from equity-method investees
|
|
|
|
(1) |
Equity in earnings of equity-method investees is reported within
Revenue-Other
|
|
Millions of yen
|
|||||||
|
March 31, 2019
|
|
March 31, 2020
|
|
||||
Commitments to extend credit
|
|
|
||||||
Liquidity facilities to central clearing counterparties
|
¥ |
|
¥ |
|
||||
Other commitments to extend credit
|
|
|
||||||
Total
|
¥ |
|
¥ |
|
||||
Commitments to invest
|
¥ |
|
¥ |
|
|
Millions of yen
|
|||||||||||||||||||
|
Total
contractual
amount
|
|
Years to maturity
|
|||||||||||||||||
|
Less than
1 year
|
|
1 to 3
years
|
|
3 to 5
years
|
|
More than
5 years
|
|
||||||||||||
Commitments to extend credit
|
|
|
|
|
|
|||||||||||||||
Liquidity facilities to central clearing counterparties
|
¥ |
|
¥ |
|
¥ |
—
|
¥ |
—
|
¥ |
—
|
||||||||||
Other commitments to extend credit
|
|
|
|
|
|
|||||||||||||||
Total
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||||
Commitments to invest
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
|
Millions of yen
|
|||||||||||||||||||||||||||
|
Total
|
|
Years of payment
|
|||||||||||||||||||||||||
|
Less than
1 year |
|
1 to 2
years |
|
2 to 3
years |
|
3 to 4
years |
|
4 to 5
years |
|
More than
5 years |
|
||||||||||||||||
Purchase obligations
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥
|
|
Millions of yen
|
|||||||||||||||
|
March 31
|
|||||||||||||||
|
2019
|
2020
|
||||||||||||||
|
Carrying
value
|
|
Maximum
potential
payout /
Notional total
|
|
Carrying
value
|
|
Maximum
potential
payout /
Notional total
|
|
||||||||
Derivative contracts
(1)(2)
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||
Standby letters of credit and other guarantees
(3)
|
|
|
—
|
|
(1) |
Credit derivatives are disclosed in Note 3 “
Derivative instruments and hedging activities
|
(2) | Derivative contracts primarily consist of equity, interest rate and foreign exchange contracts. |
(3) |
The amounts of collaterals held in connection with standby letters of credit and other guarantees as of March 31, 2019 and March 31, 2020 was ¥
|
|
Millions of yen
|
|||||||||||||||||||||||
|
Carrying
value
|
|
Maximum potential payout/Notional
|
|||||||||||||||||||||
|
Total
|
|
Years to Maturity
|
|||||||||||||||||||||
|
Less than
1 year
|
|
1 to 3 years
|
|
3 to 5 years
|
|
More than
5 years
|
|
||||||||||||||||
Derivative contracts
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||||||
Standby letters of credit and other guarantees
|
—
|
|
|
|
|
|
|
Millions of yen
|
|||||||||||||||||||
|
Retail
|
|
Asset
Management
|
|
Wholesale
|
|
Other
(Incl. elimination)
|
|
Total
|
|
||||||||||
Year ended March 31, 2018
|
|
|
|
|
|
|||||||||||||||
Non-interest
revenue
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||||
Net interest revenue
|
|
|
|
(
|
) |
|
||||||||||||||
Net revenue
|
|
|
|
|
|
|||||||||||||||
Non-interest
expenses
|
|
|
|
|
|
|||||||||||||||
Income before income taxes
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||||
Year ended March 31, 2019
|
|
|
|
|
|
|||||||||||||||
Non-interest
revenue
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||||
Net interest revenue
|
|
|
|
(
|
) |
|
||||||||||||||
Net revenue
|
|
|
|
|
|
|||||||||||||||
Non-interest
expenses
|
|
|
|
|
|
|||||||||||||||
Income (loss) before income taxes
|
¥ |
|
¥ |
|
¥ |
(
|
) | ¥ |
(
|
) | ¥ |
(
|
) | |||||||
Year ended March 31, 2020
|
|
|
|
|
|
|||||||||||||||
Non-interest
revenue
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||||
Net interest revenue
|
|
|
|
(
|
) |
|
||||||||||||||
Net revenue
|
|
|
|
|
|
|||||||||||||||
Non-interest
expenses
|
|
|
|
|
|
|||||||||||||||
Income (loss) before income taxes
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
¥ |
|
||||||||||
|
Millions of yen
|
|||||||||||
|
Year ended March 31
|
|||||||||||
|
2018
|
|
2019
|
|
2020
|
|
||||||
Net gain (loss) related to economic hedging transactions
|
¥ |
(
|
) | ¥ |
|
¥ |
|
|||||
Realized gain on investments in equity securities held for operating purposes
|
|
|
|
|||||||||
Equity in earnings of affiliates
|
|
|
|
|||||||||
Corporate items
|
(
|
) |
(
|
) |
(
|
) | ||||||
Other
(1)
(2)
|
|
(
|
) |
|
||||||||
Total
|
¥ |
|
¥ |
(
|
) | ¥ |
|
|||||
(1)
|
Amounts reported for the year ended March 31, 2018 include the gain recognized in earnings in connection with the liquidation of a
non-Japanese
subsidiary during the year.
|
(2)
|
Includes gain of ¥
|
|
Millions of yen
|
|||||||||||
|
Year ended March 31
|
|||||||||||
|
2018
|
|
2019
|
|
2020
|
|
||||||
Net revenue
|
¥ |
|
¥ |
|
¥ |
|
||||||
Unrealized gain (loss) on investments in equity securities held for operating purposes
|
|
(
|
) |
(
|
) | |||||||
Consolidated net revenue
|
¥ |
|
¥ |
|
¥ |
|
||||||
Non-interest
expenses
|
¥ |
|
¥ |
|
¥ |
|
||||||
Unrealized gain (loss) on investments in equity securities held for operating purposes
|
|
|
|
|||||||||
Consolidated
non-interest
expenses
|
¥ |
|
¥ |
|
¥ |
|
||||||
Income (loss) before income taxes
|
¥ |
|
¥ |
(
|
) | ¥ |
|
|||||
Unrealized gain (loss) on investments in equity securities held for operating purposes
|
|
(
|
) |
(
|
) | |||||||
Consolidated income (loss) before income taxes
|
¥ |
|
¥ |
(
|
) | ¥ |
|
|||||
|
Millions of yen
|
|||||||||||
Year ended March 31
|
||||||||||||
2018
|
|
2019
|
|
2020
|
|
|||||||
Net revenue
(1)
:
|
|
|
|
|||||||||
Americas
|
¥ |
|
¥ |
|
¥ |
|
||||||
Europe
|
|
|
|
|||||||||
Asia and Oceania
|
|
|
|
|||||||||
Subtotal
|
|
|
|
|||||||||
Japan
|
|
|
|
|||||||||
Consolidated
|
¥ |
|
¥ |
|
¥ |
|
||||||
Income (loss) before income taxes:
|
|
|
|
|
|
|
|
|
|
|||
Americas
|
¥ |
(
|
) | ¥ |
(
|
) | ¥ |
|
||||
Europe
|
(
|
) |
(
|
) |
(
|
) | ||||||
Asia and Oceania
|
|
|
|
|||||||||
Subtotal
|
(
|
) |
(
|
) |
|
|||||||
Japan
|
|
|
|
|||||||||
Consolidated
|
¥ |
|
¥ |
(
|
) | ¥ |
|
|||||
|
March 31
|
|||||||||||
2018
|
|
2019
|
|
2020
|
|
|||||||
Long-lived assets:
|
|
|
|
|
|
|
|
|
|
|||
Americas
|
¥ |
|
¥ |
|
¥ |
|
||||||
Europe
|
|
|
|
|||||||||
Asia and Oceania
|
|
|
|
|||||||||
Subtotal
|
|
|
|
|||||||||
Japan
|
|
|
|
|||||||||
Consolidated
|
¥ |
|
¥ |
|
¥ |
|
||||||
(1) | There is no revenue derived from transactions with a single major external customer. |
Exhibit
Number |
|
Description
|
1.1
|
|
|
1.2
|
|
|
1.3
|
|
|
1.4
|
|
|
1.5
|
|
|
1.6
|
|
|
2.1
|
|
|
2.2
|
|
|
4.1
|
|
|
4.2
|
|
|
4.3
|
|
|
8.1
|
|
|
11.1
|
|
|
11.2
|
|
|
12.1
|
|
|
12.2
|
|
|
13.1
|
|
|
13.2
|
|
|
15.1
|
|
|
101.INS
|
|
Inline XBRL Instance Document—the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document
|
101.SCH
|
|
Inline XBRL Taxonomy Extension Schema Document
|
101.CAL
|
|
Inline XBRL Taxonomy Extension Calculation Linkbase Document
|
101.DEF
|
|
Inline XBRL Taxonomy Extension Definition Linkbase Document
|
101.LAB
|
|
Inline XBRL Taxonomy Extension Label Linkbase Document
|
101.PRE
|
|
Inline XBRL Taxonomy Extension Presentation Linkbase Document
|
104
|
|
The cover page for the Company’s Annual Report on Form
20-F
for the year ended March 31, 2020, has been formatted in Inline XBRL
|
(1)
|
The Company and Michael Lim Choo San entered into a Limitation of Liability Agreement substantially in the form of this exhibit.
|
(2)
|
The Company and each of Hiroshi Kimura, Noriaki Shimazaki, Hisato Miyashita, Mari Sono and Kazuhiko Ishimura entered into a Limitation of Liability Agreement substantially in the form of this exhibit.
|
(3)
|
The Company and Laura Simone Unger entered into a Limitation of Liability Agreement substantially in the form of this exhibit.
|
NOMURA HOLDINGS, INC.
|
||||
|
|
|
||
By:
|
|
/s/
Kentaro Okuda
|
||
|
|
Name:
|
|
Kentaro Okuda
|
|
|
Title:
|
|
Representative Executive Officer,
President and Group Chief Executive Officer
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
---|
DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
---|
No information found
Customers
Customer name | Ticker |
---|---|
Expeditors International of Washington, Inc. | EXPD |
Terex Corporation | TEX |
No Suppliers Found
Price
Yield
Owner | Position | Direct Shares | Indirect Shares |
---|